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The persistence and widespread occurrence of emerging contaminants (ECs) such as 
perchlorate (ClO4
-), pharmaceutical compounds, artificial sweeteners, and perfluoroalkyl 
substances in the environment has received increasing attention due to the adverse effects 
on human health and aquatic ecosystems they may cause. Conventional wastewater 
treatment plants (WWTPs) collect household sewage which contains various types of 
ECs. Emerging contaminants are consequently released to the environment due to 
incomplete removal of the ECs in the WWTPs. These ECs have been widely found in 
treated wastewater, surface water, groundwater, and even drinking water at 
concentrations ranging from ng L-1 to µg L-1. This thesis describes laboratory 
experiments for evaluating the effectiveness of passive treatment systems and 
photocatalytic technologies for removing these ECs from water. In addition, a field 
investigation is described for tracking wastewater downstream of WWTPs using potential 
tracers in a receiving river.  
Laboratory column experiments were performed to evaluate the effectiveness of 
reactive media zero-valent iron (ZVI), organic carbon (OC, wood chips), and a mixture of 
(ZVI + OC) for simultaneous removal of NO3
-, SO4
2-, and ClO4
- from contaminated water 
associated with mining and blasting sites. Input NO3
- (~10.8 mg L-1 NO3-N) was 
effectively removed through NO3
- reduction to NH4
+ in Column ZVI, through 
denitrification in Column OC, and through the combination of NO3
- reduction by ZVI 
and denitrification by OC in Column (ZVI + OC). Input SO4
2- (~24.5 mg L-1) was 




reduction coupled to OC oxidation. Biological degradation of ClO4
- (input concentration: 




- within three treatment columns was enhanced as a result of a 
decrease in flow rate from 0.5 to 0.1 pore volume (PV) d-1. Addition of ZVI to OC 
reduced the inhibition of ClO4
- removal by NO3
- (NO3-N > 2 mg L
-1), but sulfate did not 
inhibit ClO4
- removal in any treatment column.   
 Environmentally relevant EC contamination is frequently derived from WWTP 
discharge. Two-year water sampling was conducted to identify potential tracers to track 
wastewater downstream from two WWTPs over a 31 km stretch of the Grand River in 
southwestern Ontario, Canada. The results indicate that elevated concentrations of Cl-, 
NH3-N, NO2
-, and ECs including the artificial sweetener acesulfame-K (ACE-K), and 
pharmaceuticals carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), 
ibuprofen (IBU), gemfibrozil (GEM), and naproxen (NAP) were observed near the two 
WWTPs, and their concentrations decreased over distance downstream. A Spearman 
Rank correlation analysis shows strong correlation among ACE-K, CBZ, GEM, NAP, 
and Cl-, suggesting the potential use of these contaminants as co-tracers to track 
wastewater in the study area. However, Cl- was less reliable due to other sources of 
contamination such as road salt applications in winter.   
Laboratory batch experiments were conducted to evaluate the ultraviolet light 
(UV) photocatalytic treatment of artificial sweetener ACE-K and pharmaceuticals CBZ, 
CAF, SMX, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymetham- 
phetamine (MDMA), IBU, GEM, and NAP using two types of catalyst, magnetically 
separable TiO2 (MST) recoverable nanoparticles (γ-Fe2O3@SiO2@TiO2 colloidal 
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nanospheres) and graphene oxide supported TiO2 (GO TiO2) recoverable nanoparticles 
(GO/TiO2/CSA nanocomposites) compared to  commercial P25 TiO2. The synthesized 
GO TiO2
 exhibited comparable or greater photocatalytic ability compared to P25 TiO2 in 
terms of intrinsic reaction rate constants for removal of ACE-K (> 99% removed from 10 
μg L-1) and eight pharmaceuticals (> 92% removed from 1 μg L-1) from water. 
Photocatalytic ability of MST nanoparticles was lower compared to GO and P25 TiO2 
nanoparticles. The non-recoverable P25 nanoparticles have been reported to have adverse 
impact on human health and ecological systems when released to the environment after 
use. The GO TiO2 nanoparticles could potentially be used as a substitute for P25 
nanoparticles in water treatment due to its competitive photocatalytic ability and high 
magnetic recovery.  
Laboratory column experiments were conducted to evaluate the removal of 
pharmaceuticals, artificial sweeteners, and perfluoroalkyl substances using ZVI, biochar 
(BC), and a mixture of (ZVI + BC). The results show that input pharmaceuticals CBZ, 
CAF, SMX, MDA, MDMA, IBU, GEM, and NAP at ~9 µg L-1 were almost completely 
removed (> 97%) in Columns ZVI, BC, and (ZVI + BC). About 80 ̶ 99% of input 
artificial sweetener sucralose (SCL) (~110 µg L-1) was removed in three treatment 
columns. However, artificial sweeteners ACE-K and saccharin (SAC) were partially 
removed; cyclamate (CYC) was not removed in any column. About 60 ̶ 99% of input 
perfluorooctane sulfonic acid (PFOS) (24.0 ̶ 89.6 µg L-1) was removed in Columns BC 
and (ZVI + BC); less of input PFOS was removed in Column ZVI compared to the 
columns containing BC. Partial removal of input perfluorooctanoic acid (PFOA) (~45 µg 
L-1) was observed in Columns BC and (ZVI + BC), but less in Column ZVI. The removal 
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rates of target contaminants within three treatment columns were not enhanced after 
column flow rates were decreased from 0.3 to 0.1 PV d-1, except for ACE-K. 
Laboratory batch experiments were conducted to investigate the removal 
mechanisms of PFOA and PFOS by ZVI and a mixture of (ZVI + BC). The results show 
~20% and ~60% of input PFOA (~20,000 µg L-1) were removed by ZVI and (ZVI + BC); 
~90% and ~94% of input PFOS (~20,000 µg L-1) were removed by ZVI and (ZVI + BC). 
However, only ~17% of input short chain perfluoroalkyl carboxylic acid (PFCA) 
perfluoroheptanoic acid (PFHpA, C7-PFCA) (26 µg L-1) was removed by ZVI alone and 
(ZVI + BC); the input PFCA perfluorohexanoic acid (PFHxA, C6-PFCA) (0.8 µg L-1) 
was not removed by ZVI and (ZVI + BC). Similarly, the input short chain perfluoroalkyl 
sulfonic acids (PFSAs) including 330 µg L-1 of perfluoroheptane sulfonic acid (PFHpS, 
C7-PFSA), 13 µg L-1 of perfluorohexane sulfonic acid (PFHxS, C6-PFSA), and 6 µg L-1 
perfluorobutane sulfonic acid (PFBS, C4-PFSA) were less effectively removed by ZVI 
and (ZVI + BC) compared to PFOS. About 57 ̶ 70% of input PFHpS, 30 ̶ 40% of input 
PFHxS, and 20% of input PFBS were removed by ZVI alone and (ZVI + BC). The 
removal efficiency of short chain PFCAs and PFSAs by ZVI and (ZVI + BC) decreased 
with a decrease in chain length. Sorption and reductive defluorination likely contributed 
to the removal of PFOA and PFOS by ZVI and (ZVI + BC). Fluoride (F-) is the indicative 
by-product of defluorination of PFOA and PFOS; increasing concentrations of F- were 
observed in the supernatants of (PFOA + ZVI) and (PFOS + ZVI) samples. The 
defluorination efficiencies of PFOA and PFOS were back-calculated based on the 
observed F- concentrations. About 10% of input PFOA and 5% of input PFOS (~20,000 
µg L-1) were partially defluorinated (2F defluorinated from 15F of PFOA and 17F of 
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PFOS) by ZVI alone, but not by the mixture of (ZVI + BC). The defluorination efficiency 
of PFOA and PFOS by (ZVI + BC) were likely underestimated due to sorption of F- by 
the reactive media.  
This study demonstrates that ZVI, wood chips, and biochar are promising and 
cost-effective reactive media which can potentially be used in permeable reactive barriers 
or flow-through reactors for effective removal (> 97%) of perchlorate and 
pharmaceuticals (CBZ, CAF, SMX, MDA, MDMA, IBU, GEM, and NAP); for moderate 
removal of artificial sweeteners ACE-K and SCL and perfluoroalkyl substance PFOS; for 
some removal of artificial sweetener SAC and perfluoroalkyl substance PFOA; and for 
no removal of artificial sweetener CYC from contaminated water under ambient 
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1.1.1 Occurrences and Environmental Fate of Emerging Contaminants 
Water pollution, and the associated ecosystem and public health effects is a major 
environmental problem (Schwarzenbach et al., 2006). Conventional contaminants, such 
as organic contaminants (VOCs, PCBs, TCE, etc.) and inorganic contaminants (heavy 
metals, arsenic, nitrate, etc.), have drawn great attention of public and environmental 
researchers due to their high ecotoxicity. The corresponding remedial technologies for 
these contaminants also have been extensively studied and developed. However, there are 
inadequate studies about the occurrence, fate and treatment of emerging contaminants in 
aquatic systems.       
The United States Geological Survey (USGS) defines emerging contaminants as 
“any synthetic or naturally occurring chemical or any microorganism that is not 
commonly monitored in the environment but has the potential to enter the environment 
and cause known or suspected adverse ecological and (or) human health effects”. A 
contaminant could also be “emerging” due to a lack of published health standards or an 
evolving standard, or the discovery of a new source, a new pathway to humans, or the 
development of a new detection method or technology, even though the contaminant 
likely has been in existence in the environment for a long time (Daughton, 2005; 
Murnyak et al., 2011). Emerging contaminants encompass a diverse group of compounds 
and include nanomaterials, perfluorinated compounds (PFCs), pharmaceuticals and 
personal care products (PPCPs), steroids and hormones, surfactants, drinking water 
disinfection byproducts (DBPs), sunscreens/UV filters, brominated flame retardants 
(polybrominated diphenyl ethers), benzotriazoles, naphthenic acids, antimony, siloxanes, 
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musks, algal toxins, perchlorate, dioxane, pesticide transformation products and 
microorganisms, veterinary products as well as food additives such as artificial 
sweeteners (ASs) (acesulfame-K and sucralose) (Lapworth et al., 2012; Richardson & 
Ternes, 2011).  
Emerging contaminants are commonly derived from municipal, agricultural, and 
industrial wastewater sources. Wastewater treatment plant (WWTP) effluents are the 
primary contributions to many environmentally-relevant emerging contaminants due to 
the persistence of the parent compound or their intermediate byproducts, many of which 
cannot be removed using conventional treatment approaches. Terrestrial run-off (from 
roofs, pavements, roads and agricultural land) and atmospheric deposition account for 
secondary sources of emerging contaminants (Farré et al., 2008). Once released into the 
environment, emerging contaminants are likely to be transported and become widely 
distributed in aquatic systems, especially in surface water and groundwater. Therefore, 
extensive studies are currently underway that focus on technologies for removing these 
contaminants from environmental waters through advanced oxidation, photolysis, 
adsorption, microbial degradation and other processes (Andreozzi et al., 2004; Kim & 
Tanaka, 2009; Kim et al., 2009b; Onesios & Bouwer, 2012).  
1.1.2 Occurrence, Fate and Treatment Technologies of Emerging 
Contaminant, Perchlorate 
Perchlorate anion (ClO4
-) consists of four tetrahedral oxygen atoms around a central 
chlorine atom. Perchlorate is found both naturally and anthropogenically. The naturally 
occurring perchlorate is mainly associated with extreme arid environments, such as the 
Chilean nitrate deposits in the Atacama Desert (Srinivasan & Sorial, 2009; Urbansky et 
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al., 2001). Perchlorate also can occur naturally in nitrate fertilizers and be produced 
naturally by atmospheric deposition (Rajagopalan et al., 2006; Srinivasan & Viraraghavan, 
2009). The main anthropogenic source of perchlorate is the manufacture of perchlorate 
containing salts, such as ammonium perchlorate, potassium perchlorate, and sodium 
perchlorate. The perchlorate salts are strong oxidizers (redox potential = +1.38 V) based 
on the central chlorine atom in its highest oxidation state (+7);  they are widely used in 
rocket propellants, military munitions, blasting agents, fireworks, explosives, and some 
consumer products (Urbansky, 2002).  
The major source of perchlorate contamination has been attributed to the 
manufacture or use of perchlorate salts in military activities, rocket propellant, fireworks, 
blasting agents, and military munitions (Bailey et al., 2013; Gullick et al., 2001; Smith et 
al., 2015; Tikkanen, 2006; Wilkin et al., 2007). Perchlorate is highly soluble, mobile, 
stable in water and adsorbs poorly to soil (Xu et al., 2003b), which results in its 
widespread occurrence and persistence in the environment. Perchlorate is widely detected 
in surface water (Wilkin et al., 2007), raw and treated drinking water (Gullick et al., 2001; 
Kim et al., 2009a), groundwater (Izbicki et al., 2015), bottled water (Iannece et al., 2013) 
at concentrations ranging from 5 ng L-1 to 200 µg L-1, and in human breast milk and baby 
formulas at 1.49 ̶ 33.3 μg kg-1 (Her et al., 2010). Perchlorate has been reported to inhibit 
the iodide uptake in animals and humans and causes decreased thyroid hormone 
production, resulting in mental retardation and hearing and speech degradation 
(Vandenberg et al., 2012; Wolff, 1998). The EPA established a chronic oral reference dose 
(RfD) of 0.0007 mg kg-1 d-1) for perchlorate (US EPA, 2005). Thyroid hormone is very 
important for growth, development, and metabolism in the human body, especially for 
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pregnant women and fetuses (Melse-Boonstra & Jaiswal, 2010; Mendez et al., 2010). 
Due to it toxicity, perchlorate has been listed by the US EPA in the drinking water 
contaminant candidate list (US EPA, 2006). The California Department of Health 
Services has established the action level of perchlorate at 6 µg L-1 in drinking water 
(California Department of Health Services (CDHS), 2004). The EPA established an 
Interim Lifetime Drinking Water Health Advisory of perchlorate at 15 µg L-1 (US EPA, 
2009b; US EPA, 2012). Health Canada suggested a guidance value of 6 µg L-1 for 
perchlorate in drinking water  (Health Canada, 2005).  
 The treatment technologies for perchlorate include physical separation 
(adsorption, membrane filtration, ion exchange), chemical and electrochemical reduction, 
and biological or biochemical reduction (Sijimol et al., 2015). Granular activated carbon 
(GAC) sorption and anion exchange are the most common methods for removing 
perchlorate from water. It has been reported that the sorption of perchlorate by GAC are 
through specific chemical interactions between perchlorate and surface functional groups 
and electrostatic forces (Mahmudov & Huang, 2010). The virgin GAC is not a very 
effective adsorbent for removing perchlorate; however, the GAC after appropriate surface 
modification such as ammonia-tailoring (Chen et al., 2005) and pre-adsorption of cationic 
surfactants (Lin et al., 2013) shows competitive removals of perchlorate compared to ion 
exchange and biological treatment. Ion-exchange is the most effective and commonly 
used method from removing perchlorate from drinking water; however, the high cost, 
disposal of the spent resins and brine makes this technology less feasible and 
economically sustainable (Srinivasan & Sorial, 2009; Ye et al., 2012). Chemical reduction 
is a destructive method in which perchlorate is completely reduced to non-toxic Cl-. The 
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high activation energy (120 kJ mol-1) kinetically limits the rate of perchlorate reduction 
(Yang et al., 2016); however, the applications of metallic catalysts (Hurley & Shapley, 
2007; Zhang et al., 2011) and catalytic electrodes (Rusanova et al., 2006) greatly enhance 
perchlorate reductive kinetics during the catalytic and electrochemical reduction. The 
deactivation and fouling of catalysts and electrode by natural water constituents and the 
high cost and toxicity of the catalysts and electrodes challenge the application of these 
technologies (Yang et al., 2016).  
Biological reduction of perchlorate to environmentally innocuous Cl- is identified 
as one of the most effective and cost-efficient technology and has shown promise for 
large scale applications (Srinivasan & Sorial, 2009). Perchlorate reducing 
microorganisms are ubiquitous in the environment; they can use different types of organic 
and inorganic substrates as electron donors (Okeke & Frankenberger Jr., 2005; Xu et al., 
2003b). Effective biological reduction of perchlorate from 5 ̶ 8 mg L-1 to < 0.5 mg L-1 has 
been reported using elemental sulfur (Sahu et al., 2009). A full-scale in-situ biological 
permeable reactive barrier (PRB) containing a mixture of gravel (70%), mushroom 
compost (20%), and soybean oil-soaked woodchips (10%) was used to biologically 
degrade perchlorate in ground water at the Naval Weapons Industrial Reserve Plant 
McGregor in 2002. Perchlorate was removed from an average input concentration of 
13,000 µg L-1 to an undetectable level upon exiting the PRB (US EPA website: 
https://clu-in.org/products/newsltrs/tnandt/view.cfm?issue=0204.cfm#2). A full-scale 
fluidized bed reactor (FBR) system containing GAC (fluidization media), ethanol (an 
electron donor), and inorganic N and P (nutrients for supporting microbial growth) was 
used to treat perchlorate from influent concentration of 6 ̶ 8 mg L-1 to below practical 
7 
 
quantitation limits (0.004 mg L-1) at a water flow of 4,000 gal min-1 for more than 8 
months in California (Hatzinger et al., 2000).  
1.1.3 Occurrence, Fate, and Treatment Technologies of Emerging 
Contaminants, Pharmaceutical Compounds 
Pharmaceuticals and personal care products (PPCPs) represent one of the largest and 
most important groups of emerging contaminants. It is reported that nearly 3000 different 
substances commonly are used as pharmaceutical ingredients, including painkillers, 
antibiotics, antidiabetics, betablockers, contraceptives, lipid regulators, antidepressants 
and impotence drugs (Richardson & Ternes, 2011). The structures and uses of target 
pharmaceuticals evaluated in this thesis are shown in Table 1.1.  
Table 1.1 Selected properties for target pharmaceuticals. 
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Pharmaceutical compounds, such as ibuprofen, naproxen, carbamazepine, caffeine, 
and gemfibrozil, are widely detected in aquatic systems and treated wastewater effluents 
(Kolpin et al., 2002; Martín et al., 2011; Rahman et al., 2010; Ternes, 1998). 
Environmentally-relevant contamination of surface water (Kolpin et al., 2002; Ternes, 
1998) and groundwater (Carrara et al., 2008; Heberer, 2002; Hirsch et al., 1999) is mainly 
associated with sewage effluents. After ingestion and subsequent excretion, human 
pharmaceuticals end up in wastewater treatment plants (WWTPs) in the form of the non-
metabolized parent compounds or metabolites (Farré et al., 2008). Due to the inefficiency 
of conventional WWTPs and some advanced technologies for removing these compounds 
from wastewaters, pharmaceuticals can enter aquatic systems, and thus become widely 
distributed in surface water, groundwater and even in drinking water (Grover et al., 2011; 
Jones et al., 2005; Kleywegt et al., 2011; Metcalfe et al., 2003a; Stackelberg et al., 2007). 
Besides human pharmaceuticals, veterinary drugs used for livestock, poultry, and fish 
farming to treat and prevent diseases account for another important source of 
pharmaceutical contamination to the environment, as liquid manure is used as a fertilizer 
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in agricultural fields from which pharmaceuticals are transported to surface waters and 
groundwater with run-off and infiltration (Farré et al., 2008).        
 The presence of pharmaceuticals in aquatic systems has received growing 
attention because of their frequent detection in environmental waters and the 
ecotoxicological effects that they may cause. Pharmaceuticals are usually found at low 
concentrations of ng L-1 to µg L-1 in the environment, which are unlikely to induce acute 
effects; however, continuous low-dose exposure to these compounds, especially at 
sensitive life stages, may cause chronic effects or even lethal effects on sensitive 
organisms (Caliman & Gavrilescu, 2009; Fent et al., 2006; Oaks et al., 2004). A number 
of pharmaceuticals have been reported to have adverse impacts on reproduction and 
development of biota in the environment: carbamazepine (CBZ) (2.0 ̶ 20 mg L-1), an  
antiepileptic drug, can induce enzymatic and oxidative stress in common carp (Cyprinus 
carpio) (Li et al., 2010b; Malarvizhi et al., 2012); gemfibrozil (GEM), a lipid regulator, 
bioconcentrates and reduces testosterone in goldfish (Carassius auratus), leading to 
potential endocrine disruption at concentration ranging from 1.5 µg L-1 to 10 mg L-1     
(Mimeault et al., 2005); naproxen (NAP), a non-steroidal anti-inflammatory drug 
(NSAID), noticeably inhibits the growth rate of some plankton species at acute toxicity 
concentration (LC50) of 56 ̶ 78 mg L
-1 (El-Bassat et al., 2012). Gillis et al. (2017) report 
the decreasing population and species of freshwater mussel downstream a wastewater 
treatment plant affected by various emerging contaminants. The environmental 
concentrations of most pharmaceuticals are generally below the lowest observed effect 
concentrations (LOECs), with the exception of some pharmaceuticals, such as salicylic 
acid, diclofenac, propranolol, clofibric acid, carbamazepine, and fluoxetine. The chronic 
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toxic LOECs of these compounds are close to environmental levels. Besides the 
ecotoxicology of the pharmaceuticals, another important concern for pharmaceuticals is 
the creation of “Super Bugs”, the development of bacterial resistance due to widespread 
distribution of antibiotics (Richardson & Ternes, 2011).  
 Treatment technologies for removing pharmaceuticals from water include 
physical adsorption, biological degradation, chemical advanced oxidation, and combined 
chemical and biological methods (Wang & Wang, 2016). The sorbents used in physical 
adsorption for removing pharmaceutical compounds include activated carbon (AC), 
graphene and graphene oxide, and carbon nanotubes. Ek et al. (2014) demonstrate 
effective removal (90 ̶ 98%) of seven pharmaceutical residues from sewage treatment 
plant effluents using AC filtration as an additional polishing technique. Yang and Tang 
(2016) report variable removals of pharmaceuticals acetaminophen (43%), caffeine (84%), 
cephalexin (81%), and sulfamethoxazole (34%) using  graphene. Jung et al. (2015c) 
summarize the high potential adsorption capacities of various types of carbon nanotubes 
in removal of different endocrine-disrupting compounds and pharmaceutical compounds 
and their removal mechanisms. Biological degradation is an important removal 
mechanism of pharmaceuticals in the environment involving various microorganism 
communities; however, the removal efficiency varies greatly for different 
pharmaceuticals  (Wang & Wang, 2016).  Joss et al. (2005) report > 90% of ibuprofen, 
but < 10% of carbamazepine are removed in biological WWTP.  
Advanced oxidation processes (AOPs) are considered very effective technologies 
for degradation of toxic and recalcitrant organic contaminants in water, which include 
ozonation (Tay & Madehi, 2015), UV/H2O2 (Kim et al., 2009b), UV/O3 (Kim et al., 
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2009c), UV photolysis and photocatalysis using TiO2 (Calisto et al., 2011; Rosal et al., 
2008), Fenton and Fenton-like oxidation (Ganzenko et al., 2015; Segura et al., 2014), 
gamma radiation (Liu & Wang, 2013), sonolysis (Naddeo et al., 2015), and 
electrochemical oxidation (Moreira et al., 2016). Biological technologies cannot 
completely degrade some recalcitrant pharmaceuticals due to their persistence and 
toxicity to microorganisms. The AOPs often require high operating costs and the 
intermediate products of some organic compounds are perhaps more toxic and 
recalcitrant to oxidation. However, the combined AOPs and biological methods can first 
degrade the persistent large molecule contaminants to biodegradable small molecule 
intermediates during AOPs, and then the intermediates can be degraded during biological 
treatment (Wang & Wang, 2016). Keen et al. (2012) report carbamazepine as one of the 
most recalcitrant pharmaceuticals, but its UV/H2O2 oxidation byproducts can be 
completely mineralized by a mixed bacterial inoculum. In addition, the AOPs can also be 
used as a polishing post-treatment process to enhance the overall removal efficiency of 
bio-recalcitrant pharmaceuticals (Ghatak, 2014; José et al., 2010). Other treatment 
technologies, such as soil aquifer treatment (Onesios & Bouwer, 2012) and constructed 
wetland (Verlicchi & Zambello, 2014) have also been investigated for removing 
pharmaceuticals from water.    
1.1.4 Occurrence, Fate, and Treatment Technologies of Emerging 
Contaminants, Artificial Sweeteners 
Artificial sweeteners, such as acesulfame-K (potassium), cyclamate, saccharin, sucralose 
and aspartame, have been used worldwide for decades as food and drink additives. The 
highly intense sweetness of these artificial sweeteners can greatly reduce sugar intake by 
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using them in food manufacturing. Moreover, artificial sweeteners can help to reduce the 
risk of tooth decay as they are not metabolized like sugar, and do not provide significant 
energy following ingestion making them suitable for diabetics and dietetics (Kroger et al., 
2006). The target artificial sweeteners evaluated in this study are listed in Table 1.2. 
Table 1.2 Selected properties for target artificial sweeteners. 
Compound 
(CAS#) 
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Artificial sweeteners pass through human bodies with little metabolic breakdown 
after ingestion and are excreted via urine and feces, and therefore end up in wastewater 
virtually unchanged (Buerge et al., 2009). Studies also indicate that some of these 
artificial sweeteners reach receiving surface waters and groundwater due to incomplete 
removal in WWTPs. The prevalence and widespread occurrence of artificial sweeteners 
in the aquatic environment has recently been reported (Buerge et al., 2009; Buerge et al., 
2011; Lubick, 2008; Scheurer et al., 2009; Scheurer et al., 2010; Scheurer et al., 2011). 
An investigation on the occurrence of four artificial sweeteners at eight urban sites in 
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Canada showed that acesulfame-K, the most prevalent artificial sweetener, was detected 
in all eight investigated sites, including groundwater and surface water, at high 
concentrations of several µg L-1, and tend to be a good tracer of wastewater; saccharin, 
sucralose, and cyclamate were also detected at some investigated sites (Van Stempvoort 
et al., 2011).  
Acesulfame-K is quite persistent in surface waters and groundwater. In Switzerland, 
it was detected at concentrations of 12 ̶ 46 µg L-1 in untreated and treated water from 
WWTPs, in most investigated surface water samples and 65% of groundwater samples. It 
was detected in tap water samples at concentrations up to 2.6 µg L-1. Sucralose was also 
found to be quite persistent in wastewater with no degradation observed during a 7 h 
residence time in a WWTP. In contrast, cyclamate and saccharin were readily 
biodegraded with removals of 99% and 90% from untreated wastewater, respectively 
(Buerge et al., 2009). In Germany, acesulfame-K was also the predominant artificial 
sweetener in surface waters with concentrations exceeding 2 µg L-1 (Scheurer et al., 
2009), and was the only artificial sweetener detected at concentrations up to several 
hundred ng L-1 in finished drinking water after treatment with granular activated carbon 
(GAC) filters (Scheurer et al., 2010). Similarly, little sucralose was removed in sewage 
treatment plants (STPs). However, more than 94% of saccharin and cyclamate were 
eliminated in STPs (Scheurer et al., 2009). Aspartame and saccharin are likely 
biodegraded easily in the sewage treatment system (Ferrer & Thurman, 2010).  
Artificial sweeteners acesulfame-K and sucralose have been used as tracers to track 
the contamination of environmental waters by domestic wastewater, because they are 
primarily present in wastewater and recalcitrant to natural attenuation processes such as 
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biological degradation (Buerge et al., 2009; Van Stempvoort et al., 2011). Sucralose has 
been used as indicator compound for anthropogenic influence on finished drinking water 
as well as the presence of other recalcitrant contaminants in finished drinking water 
(Mawhinney et al., 2011). The ecotoxicity of artificial sweeteners is controversial and a 
cause for concern, because the long-term health effects resulting from chronic exposure 
to low levels of these compounds are still to a great extent unknown (Kroger et al., 2006). 
Sang et al. (2014a) report that the photo-induced transformation by-products of 
acesulfame-K are >500 times more toxic than the parent compound and may impact 
aquatic ecosystems. In addition, the accumulation of artificial sweeteners in drinking 
water due to incomplete removal of these artificial sweeteners in WWTPs and drinking 
water treatment plants (DWTPs) is a quality concern especially in water shortage and 
reuse areas (Mawhinney et al., 2011).  
Therefore, remedial technologies for removing artificial sweeteners from water 
supplies are consequently being developed. Besides WWTPs and biological degradation, 
many technologies have been studied for removing artificial sweeteners from water, such 
as physical adsorption using AC and chemical oxidation (Sharma et al., 2012). Scheurer 
et al. (2010) and Mailler et al. (2014) report effective removal of saccharin and sucralose 
using GAC filtration, but poor removals for acesulfame-K and cyclamate. Recently, 
advanced oxidation processes have been extensively investigated for removing artificial 
sweeteners from water, and include photochemical and electrochemical oxidation (Lin et 
al., 2016; Perkola et al., 2016), UV/H2O2 photo-oxidation (Keen & Linden, 2013), 
ozonation (Scheurer et al., 2012), ferrate (VI) and radicals based oxidation (Lin et al., 
2016; Sharma et al., 2012). Sharma et al. (2014) provide a review on the advanced 
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oxidation processes (AOPs) for removing sucralose from water using ozonation, ·OH 
radical, UV/H2O2, and ferrate.  The highly strong oxidizing agent hydroxyl radicals (•OH) 
generated during these AOPs effectively degrade sucralose in water. Toth et al. (2012) 
demonstrate effective degradation of five artificial sweeteners acesulfame-K, aspartame, 
rebaudioside, saccharin, and sucralose by ·OH and SO4·
- radicals. In addition, other 
technologies have been studied for removing artificial sweeteners from water, such as soil 
aquifer treatment (Scheurer et al., 2009; Scheurer et al., 2011), conventional multi-barrier 
treatment (including bank filtration, artificial recharge, flocculation, ozonation, activated 
carbon filtration, and disinfection) (Scheurer et al., 2010), and constructed wetlands 
(Vymazal & Dvořáková Březinová, 2016). 
1.1.5 Occurrence, Fate, and Treatment Technologies of Emerging 
Contaminants, Perfluoroalkyl Substances 
Polyfluoroalkyl and perfluoroalkyl substances (PFASs) are a recent class of Persistent 
Organic Pollutants that have an aliphatic carbon backbone in which hydrogen atoms are 
partially (poly-) or completely (per-) replaced by fluorine (F) (Rahman et al., 2014). Due 
to the unique structure of C-F bond, PFASs present high surface activity, and high 
thermal and chemical stability. Therefore, they have been widely used in numerous 
industrial and consumer products such as firefighting foams, food packing, waterproof 
breathable fabrics, non-stick cookware, semiconductors, and photographic films. The 
perfluoroalkyl acids (PFAAs) are one class of PFASs which have received the most 
attention to date. The two important sub-classes of PFAAs are perfluoroalkyl carboxylic 
acids (PFCAs) and perfluoroalkyl sulfonic acids (PFSAs). The most commonly used and 
frequently detected PFCAs and PFSAs are perfluorooctanoic acid (PFOA) and 
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perfluorooctane sulfonic acid (PFOS), respectively. Both PFOA and PFOS have eight C 
atoms in their structure; PFOA consists of a hydrophobic perfluorinated carbon (C7F15 ̶) 
tail and a hydrophilic carboxylic (̶ COOH) ionic head, PFOS consists of a hydrophobic 
perfluorinated carbon (C8F17 ̶ )  tail and a hydrophilic sulfonic (̶ SO3H) ionic head (Table 
1.3). The target PFCAs and PFSAs in this study are summarized in Table 1.3. As the C 
chain length increases, the water solubility and vapour pressure of PFCAs and PFSAs 
decrease; however, the soil organic carbon-water partitioning coefficient (log Koc) and 
acid dissociation constant (pKa) increase with increasing carbon chain length (Rahman et 
al., 2014; Rayne & Forest, 2009).  
Table 1.3 Selected properties for target perfluoroalkyl carboxylic acids (PFCAs) and 
perfluoroalkyl sulfonic acids (PFSAs). 
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The high stability of PFASs results in their environmental persistence and 
widespread occurrences. The PFASs are detected in numerous worldwide jurisdictions in 
wastewater (D'Eon et al., 2009; Rayne & Forest, 2009), surface water (Müller et al., 2011; 
Scott et al., 2009), groundwater (Lin et al., 2015b; Schaider et al., 2014), drinking water 
(Pan et al., 2016; Post et al., 2013) at reported concentrations that range from pg L-1 to μg 
L−1 levels and in soils at reported concentrations that range from 29 to 14,300 pg g-1 
(Rankin et al., 2016), and even human serum and milk at reported concentrations ranging 
from 0.07 to 27 µg L-1 (Von Ehrenstein et al., 2009). PFASs can have adverse effects on 
human reproductive and development systems (Goudarzi et al., 2016; Lopez-Espinosa et 
al., 2011). PFOA is reported to be associated with human kidney and testicular cancer 
near a PFAS chemical manufacturing plant (Barry et al., 2013). In addition, PFASs are 
endocrine disrupters; the longer chain PFASs (> C8) are bioaccumulative in wild life and 
humans, the shorter chains are less bioaccumulative (Conder et al., 2008; Martin et al., 
2003). US EPA recommends drinking water advisory levels for PFOA and PFOS of 400 
and 200 ng L-1 (US EPA, 2009a).  
Treatment technologies for removing PFASs from water have been extensively 
investigated, and include advanced oxidation (electrochemical oxidation, photolysis, and 
photocatalysis) (Cho, 2011; Liu et al., 2015c), advanced reduction (by nanoscale ZVI, 
iodide, dithionite) (Arvaniti et al., 2015; Park et al., 2011; Vellanki et al., 2013), sorption 
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(by activated carbon, resins and other sorbents) (Deng et al., 2012; Zhang et al., 2016), 
and microbial treatment (Liu & Liu, 2016; Ochoa-Herrera et al., 2016). During advanced 
oxidation processes, strong oxidizing and non-selective radicals (·OH, SO4·
-, and O2·
-) are 
generated to attack and cleave the contaminant. However, F is the most electronegative 
element; C-F bond is one of the strongest bonds, and the bond becomes stronger with an 
increased number of C-F. This unique saturated C-F structure makes PFASs resistant to 
oxidation, even using O3 and ·OH (Rahman et al., 2014).  
The extreme laboratory conditions such as high temperature, low pH, and high 
pressure greatly enhance the oxidative degradation of PFASs. Zhang et al. (2015) report 
the removal (24 ̶ 52%) of eleven PFASs using an electrochemical oxidation reactor within 
30 min. Yin et al. (2016) report effective degradation (90%) and defluorination (24%) of 
PFOA (initial concentration: 20 µM) using activated persulfate oxidation at pH of 2.0 and 
a temperature of 50 oC. Ochiai et al. (2011) report efficient decomposition of PFCAs in 
aqueous suspensions using a TiO2 photocatalyst.  
During the advanced reduction of PFASs, the highly reactive, non-selective 
reducing hydrated electrons are the main nucleophiles attributed to the reductive 
defluorination of PFASs. Song et al. (2013) demonstrate reductive defluorination of 
PFOA (88.5%) after 24 h by hydrated electrons generated from a sulfite-mediated UV 
photochemical system. Park et al. (2011) report reductive degradation of six PFASs, 
PFCAs, and PFSAs using hydrated electrons generated from photolysis of iodide at 254 
nm. Sorption of PFASs by different sorbents and environmental matrices occur mainly 
through hydrophobic interaction and electrostatic forces (Merino et al., 2016). Effective 
sorption of PFOA, PFOS, and PFHpA has been reported using granular activated carbon 
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(GAC) (Zhang et al., 2016). Due to the high stability of C-F bond, the microbial 
degradation of PFASs is only likely for polyfluoroalkyl substances (containing C-H), but 
less likely for perfluoroalkyl substances (containing C-F) (Liu & Mejia Avendaño, 2013; 
Merino et al., 2016). Liu and Liu (2016) observe the microbial transformation of 
polyfluoroalkyl phosphate esters (PAPs) into PFCAs in activated sludge and soil.  
1.1.6 Why Use Zero-valent Iron, Biochar, Magnetically Recoverable 
Nano-TiO2 Nanoparticles, and Passive Treatment Systems?  
Permeable reactive barriers (PRBs), efficient , cost-effective, long-term stable passive 
treatment technologies, have been extensively used to remediate contaminated 
groundwater and soil (Blowes et al., 2000). Zero valent iron (ZVI) is a strong reducing 
agent extensively used in permeable reactive barriers (PRBs) to remove a large number of 
inorganic contaminants, including As, Cd, Cr, Cu, Hg, U, V, NO3, and SO4 (Blowes et al., 
2000; Blowes et al., 1997; Robertson et al., 2000), and organic contaminants, such as 
halogenated compounds (TCE, DCE, PCE), nitroaromatics, dyes, and phenolic 
compounds from contaminated wastewater, groundwater and soil (Bell et al., 2003; 
Cundy et al., 2008; Gillham & O'Hannesin, 1994; Jeen et al., 2006; Orth & Gillham, 
1996; Scherer et al., 2000). ZVI is abundant in the environment and easy to access. As a 
remediation tool, ZVI can act as a reductant, sorbent, and coagulant to treat a wide range 
of contaminants (Crawford et al., 1993; Matheson & Tratnyek, 1994; Odziemkowski & 
Simpraga, 2004). The high reductive capacity, environmental sustainability, and non-
toxic iron by-products after treatment make ZVI a promising technology for treating a 
range of pollutants in wastewater and groundwater (Sun et al., 2016).      
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Biochar is a carbon rich material produced from the pyrolysis of biomass, such as 
wood, manure or leaves under low oxygen conditions (Lehmann & Joseph, 2009). Its 
high porosity, low density, large surface area and cation exchange capacity, and cost-
effectiveness make biochar practical and effective for stabilizing organic and inorganic 
contaminants in soils (Beesley et al., 2011), and removing various contaminants, such as 
organic compounds, heavy metals from water (Chen et al., 2011a; Xu et al., 2012). 
Inyang and Dickenson (2015) report a review of the use of biochar for removal of a wide 
range of organic contaminants include volatile organic compounds (VOCs), natural 
organic matter (NOM), disinfection by-products (DBPs), perfluoroalkyl acids (PFAAs), 
pesticides, pharmaceutical and personal care products (PPCPs) as well as the associated 
removal mechanisms. Ahmad et al. (2012) report equivalent or stronger sorption capacity 
of BC compared to AC for removing TCE from water. In addition, it has been reported 
that the estimated break-even price for biochar is $246/ton, but $1500/ton for activated 
carbon (Lehmann & Joseph, 2009). Biochar can be a potential substitute sorbent to AC 
due to its competitive or enhanced sorption efficiency and lower production costs 
compared to AC.   
Ultraviolet light (UV) photodegradation catalyzed by nanoTiO2 particles has been 
studied as an effective advanced oxidation process for removing a wide range of 
emerging contaminants from water such as pharmaceuticals (Choina et al., 2010), 
artificial sweeteners (Calza et al., 2013), perchlorate (Ye et al., 2013), and perfluoroalkyl 
substances (Cho, 2011). TiO2 is the most widely studied heterogeneous photocatalyst due 
to its cost effectiveness, inert nature and photo-stability (Gaya & Abdullah, 2008). 
However, nano-TiO2 particles themselves are also emerging contaminants which can 
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cause adverse toxic effects to various aquatic organisms and even humans (Hund-Rinke 
& Simon, 2006; Sharifi et al., 2012); they tend to enter the environment after use if they 
are not properly recovered. Magnetically recoverable nano-TiO2 particles can be a 
substitute for commercial nano-TiO2 particles used in photocatalytic treatment to 
minimize the risk of releasing nano-TiO2 into the environment (Makovec et al., 2011). 
Linley et al. (2014) demonstrate enhanced removal of pharmaceuticals carbamazepine 
and caffeine using a recyclable graphene oxide-supported TiO2 photocatalyst compared to 
commercial P25 TiO2. Similarly, comparable catalytic activity of synthesized magnetic 
TiO2 to P25 TiO2 nanoparticles has been reported in the removal of acetaminophen and 
four PPCPs (Álvarez et al., 2010).  
Passive treatment systems were proposed and used to remove metals and 
neutralize pH of acid mine drainage (Blowes et al., 1995; Blowes et al., 1991; Kleinmann 
& Hedin, 1993). Passive treatment systems are different from active systems (such as 
water treatment plants) which commonly use power and hazardous chemicals (such as 
hydrated lime and ammonia). Successful passive treatment systems can achieve 
competitive treatment results compared to active treatment systems, but are often less 
expensive than active treatment systems because of lower use of resources and 
maintenance. Active treatment systems require continuous inputs of resources and 
maintenance (Ford, 2003). Passive treatment systems include wetlands, bioreactors, and 
permeable reactive barriers (Benner et al., 1997; Blowes et al., 1995; Blowes et al., 1994; 
Johnson & Hallberg, 2005).  
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1.2 Research Hypotheses and Objectives 
1.2.1 Research Hypotheses 
Five main research hypotheses are proposed in this thesis; each hypothesis corresponds to 
the research study from Chapters 2 to 6: 
Hypothesis One (for Chapter 2): 
Passive treatment systems containing ZVI and wood chips are an effective approach for 
simultaneously removing nitrate, sulfate, and perchlorate from water under dynamic flow 
conditions.  
 Nitrate is removed by zero-valent iron through reduction and removed by wood 
chips (organic carbon, OC) through denitrification.  
 Sulfate and perchlorate are removed by OC through biological reduction of sulfate 
to sulfide and of perchlorate to chloride.   
Hypothesis Two (for Chapter 3): 
Effluents from WWTPs are the primary sources of the emerging contaminants (ECs) in 
the study area. The ECs are correlated with each other and can be used as potential co-
tracers of municipal wastewater in a receiving river. 
Hypothesis Three (for Chapter 4): 
UV photocatalysis using laboratory-synthesized magnetically recoverable TiO2 and 
commercial P25 TiO2 nanoparticles are effective for removing artificial sweetener 
acesulfame-K and pharmaceuticals from water.  
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 Target ECs are removed to varying extents during UV photocatalysis due to their 
different chemical structures (functional groups).  
 Magnetically recoverable TiO2 can be removed from water through magnetic 
separation.  
Hypothesis Four (for Chapter 5): 
Passive treatment systems containing ZVI, biochar, and a mixture of ZVI and biochar are 
an effective approach for simultaneously removing pharmaceuticals, artificial sweeteners, 
and perfluoroalkyl substances from water under dynamic flow conditions. 
 Target ECs are removed to differing degrees and removal mechanisms are likely 
related to their different physiochemical properties (pKa and log Kow) and 
chemical structures (functional groups).  
 Target ECs with redox sensitive and halogen functional groups are removed by 
ZVI through reduction and dehalogenation.  
 Target ECs are more effectively removed by the combination of ZVI and biochar 
(through both reduction and sorption) than by ZVI alone or biochar alone.   
Hypothesis Five (for Chapter 6): 
Removal of perfluoroalkyl substances PFOA and PFOS by ZVI is through reductive 
defluorination. The hydrophobicity of C-F bonds in PFOA and PFOS might result in 
efficient removal of PFOA and PFOS by biochar through hydrophobic interaction.   
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1.2.2 Research Objectives 
The primary objectives of this research are to evaluate the effectiveness of passive 
treatment systems using ZVI and organic carbon (wood chips and biochar) and UV 
photocatalytic treatment technology for removing emerging contaminants, perchlorate, 
pharmaceutical compounds, artificial sweeteners, and perfluoroalkyl substances (PFASs) 
from water. In addition, the use of artificial sweeteners and pharmaceutical compounds as 
co-tracers of municipal wastewater was investigated in a receiving river. The target 
pharmaceutical compounds include carbamazepine (CBZ), caffeine (CAF), 
sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA), ibuprofen (IBU), gemfibrozil (GEM), and 
naproxen (NAP). The target artificial sweeteners include acesulfame-K (ACE-K), 
cyclamate (CYC), saccharin (SAC), and sucralose (SCL). The target PFASs include 
PFCAs perfluorooctanoic acid (PFOA, C8-PFCA), perfluoroheptanoic acid (PFHpA, C7-
PFCA), perfluorohexanoic acid (PFHxA, C6-PFCA) and PFSAs perfluorooctane sulfonic 
acid (PFOS, C8-PFSA), perfluoroheptane sulfonic acid (PFHpS, C7-PFSA), 
perfluorohexane sulfonic acid (PFHxS, C6-PFSA), and perfluorobutane sulfonic acid 
(PFBS, C4-PFSA). These emerging contaminants were selected because of their 
widespread occurrence and persistence in the environment and limited information is 
available regarding their treatability. These compounds were also selected to represent 
different types of emerging contaminants due to their varying physiochemical properties 




● Evaluate the effectiveness of a passive treatment system composed of ZVI and 
wood chips for removing perchlorate, nitrate, and sulfate under dynamic flow 
conditions.  
● Track the emerging contaminants artificial sweetener acesulfame-K and a suite of 
pharmaceutical compounds downstream from two WWTPs and assess the 
potential use of these compounds as co-tracers of municipal wastewater in a 
receiving river.  
● Evaluate the effectiveness of UV photocatalytic treatment using recoverable TiO2 
nanoparticles for removing artificial sweetener acesulfame-K and a suite of 
pharmaceutical compounds from water compared to commercial P25 TiO2 
nanoparticles.  
● Evaluate the effectiveness of a passive treatment system composed of ZVI and 
biochar for removing pharmaceutical compounds, artificial sweeteners, and 
perfluoroalkyl substances from water under dynamic flow conditions.  
● Investigate the removal mechanisms of perfluoroalkyl substances PFOA and 
PFOS by reactive media ZVI and BC.  
1.3 Thesis Organization 
This thesis is composed of seven chapters. Chapter 1 presents an overall research 
introduction and objectives. Chapters 2, 3, 4, 5 and 6 are five main research papers for 
publication in international peer-reviewed journals that are related to the objectives 
outlined in the previous section. Chapter 2 describes four column experiments conducted 
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to evaluate the effectiveness of ZVI, organic C (OC), and a mixture of (ZVI + OC) for 
removing perchlorate, nitrate, and sulfate from water. Chapter 3 investigates the transport 
of emerging contaminants artificial sweetener acesulfame-K and pharmaceutical 
compounds downstream from two WWTPs effluents and assesses the potential use of 
these compounds as co-tracers of municipal wastewater in a receiving river. Chapter 4 
describes a series of laboratory batch experiments conducted to evaluate the UV 
photocatalytic treatment using recoverable TiO2 nanoparticles (MST and GO TiO2 
nanoparticles) for removing artificial sweetener acesulfame-K and pharmaceutical 
compounds from water compared to commercial P25 TiO2 nanoparticles. Chapter 5 
describes four column experiments conducted to evaluate the potential of ZVI, biochar 
(BC), and a mixture of (ZVI + OC) for simultaneous removal of pharmaceutical 
compounds, artificial sweeteners, and perfluoroalkyl substances from water. Chapter 6 
describes a series of batch experiments conducted to investigate the removal mechanisms 
of perfluoroalkyl substances PFOA and PFOS by ZVI and BC. Chapter 7 summarizes the 
main findings and scientific contributions of the above five research papers and gives 
recommendations for future work. Supplementary information related to Chapter 2, 3, 4, 




Chapter 2: Treatment of Dissolved 
Perchlorate, Nitrate, and Sulfate Using 













2.1 Executive Summary 
Waters containing ClO4
- and dissolved NO3
-, derived from detonated explosives and solid 
propellants, often also contain elevated concentrations of other dissolved constituents, 
including SO4
2-. Four column experiments, containing mixtures of silica sand, zero-valent 




-. Initially, the flow rate was maintained at 0.5 pore 
volume (PV) d-1, and then decreased to 0.1 PV d-1 after 100 PV of flow. Nitrate 
concentrations decreased from 10.8 mg L-1 (NO3-N) to trace levels through NO3
- 
reduction to NH4
+ using ZVI alone, and through denitrification using OC. Observations 
from the mixture of ZVI and OC suggest a combination of nitrate reduction and 
denitrification. Up to 71% of input SO4
2- (24.5 ± 3.5 mg L-1) was removed in the column 
containing OC and more than 99.7% of the input perchlorate (857 ± 63 μg L-1) was 
removed by the OC- and (ZVI + OC)-containing columns as the flow rate was maintained 
at 0.1 PV d-1. Nitrate and ClO4
- removal followed first-order and zero-order rates, 
respectively. Nitrate > 2 mg L-1 NO3-N inhibited ClO4
- removal in the OC-containing 
column but not in the (ZVI + OC)-containing column. Sulfate did not inhibit ClO4
-





Perchlorate (ClO4‐) is a common contaminant in groundwater and surface water. 
Approximately 90% of perchlorate salts are manufactured as NH4ClO4, which is widely 
used in large volumes of solid propellants for rockets, missiles, explosives, and 
pyrotechnics. A variety of non-military sources, such as the use and manufacture of road 
flares, HClO4 and HClO3, fireworks displays, and blasting agents used in mining and 
construction, can also cause widespread, low concentration ClO4‐ contamination in water. 
In addition to these anthropogenic sources, naturally-occurring ClO4‐ generated via 
atmospheric processes and contained in NO3 fertilizers and some natural minerals also 
contributes low levels of ClO4‐ in some parts of the world (Ward, 2008). 
Perchlorate is highly soluble, mobile, and recalcitrant in the environment. It is 
potentially toxic to various forms of life, with low concentrations inhibiting iodide uptake 
in human thyroid and animal thyroid glands (Leung et al., 2010). Due to these health 
impacts, the US EPA adopted the National Research Council (NRC) recommended 
reference dose of 0.0007 mg kg‐1 per day for perchlorate as an interim health limit in 
2005, which translates to a drinking water equivalent level (DWEL) of 24.5 µg L‐1. 
Physical-chemical treatment technologies, such as ion exchange, C adsorption, and 
advanced oxidation are effective for treating a range of contaminants, but are less cost-
efficient and effective for removing ClO4‐ from water (Srinivasan & Sorial, 2009). Ion-
exchange, a widely accepted water treatment technology, can effectively remove ClO4‐
 
from water; however, the highly saline (7–12%) brine generated during the ion-exchange 
process requires costly management before disposal (Okeke et al., 2002). Microbial 
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reduction of perchlorate is an area of intense interest because this strategy is relatively 
cost effective, environmentally compatible, and has shown promise for large scale 
applications (Gal et al., 2008; Okeke & Frankenberger Jr., 2005). The hazardous ClO4‐ is 
converted into two innocuous compounds—Cl‐ and O2—catalyzed by at least two 
separate enzymes (Xu et al., 2003a).  
Perchlorate and nitrate are often found as co-contaminants in water, as a large 
number of propellants, blasting agents, and explosives contain perchlorate as well as 
nitrogen-containing compounds. Moreover, NO3–containing compounds, such as KNO3 
and NaNO3, are widely used in agriculture and ClO4‐–containing pyrotechnics. High 
concentrations of SO4
2‐, derived from S2‐ oxidation at some mining sites, also require 
management. Because ClO4‐– and NO3–containing blasting agents and explosives are 
used at mine sites, water containing co-mingled ClO4‐, NO3‐, and SO4
2‐ can develop 
(Bailey et al., 2013; Ward, 2008). Bioremediation of ClO4‐– and NO3‐–contaminated 
water has been widely studied using various electron donors, such as H2 or ethyl acetate 
gases (Evans & Trute, 2006), edible oil (Borden, 2007; Hunter, 2002), compost and 
mulch mixtures (Wang et al., 2013), and wood particle media (Robertson et al., 2007). 
The purpose of this study was to identify an effective, economical, and feasible 
technology to remediate ClO4‐–, NO3‐–, and SO4
2‐–contaminated waters associated with 
mining and blasting sites. A series of column experiments was conducted using mixtures 
of zero-valent Fe (ZVI) and wood chips (OC) as reactive media to remove co-mingled 
ClO4‐, NO3‐, and SO4
2‐ in simulated groundwater.  
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2.3 Material and Methods 
2.3.1 Column Design and Experimental Setup 
Four acrylic columns were used, each 30 cm in length with an internal diameter of 5 cm. 
Influent ports were located at the base of each column, and effluent ports were located at 
the top of each column for discharge of the effluent solution and for sample collection. In 
addition, 13 equally spaced sampling ports were installed at approximately 2.1-cm 
intervals along the length of the columns. Both the bottom and top layers of the four 
columns were packed with a 1.0 cm thick layer of silica sand as a non-reactive material to 
separate the reactive mixture from the influent and effluent end ports.    
Column 1 was packed with 100% silica sand (SS) as a control. Column packings 
were composed of 50% (v/v) granular ZVI with the balance as SS (Column 2), 50% (v/v) 
wood chips (OC) with the balance as SS (Column 3), and a mixture of 10%  (v/v) ZVI 
and 40% (v/v) OC adjusted with 50% (v/v) SS (Column 4). The granular ZVI (0.17–1.41 
mm) was obtained from Connelly-GPM, Inc. (Chicago, USA). The silica sand (0.6–0.8 
mm) was obtained from the Silica Company (Ottawa, USA). The wood chips (~1–9.5 
mm, deciduous hardwood) were obtained from a lumber producer in Waterloo, ON. 
Before initiating the experiments, all four columns were placed in an anaerobic glove box 
(COY, Ltd., Grass Lake, USA) that contained 5% H2 and 95% N2. The columns were 
flushed with CO2 (g), which is more soluble in water than N2 and O2, for 24 h to displace 
atmospheric gases from the void pore space of the column packing and enhance 
saturation of the packing material. The columns were then wet with simulated 
groundwater, composed of CaCO3 saturated water, over a 48-h period. 
A conservative tracer test was performed to determine the flow and transport 
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characteristics of each column. The computer code CXTFIT 2.0 (Toride et al., 1995), a 
series of analytical solutions to the one-dimensional advection-dispersion equation with 
non-linear, least-squares parameter optimization, was used to determine the average 
linear velocities and dispersion coefficients from the column effluent concentration data. 
The flow rates of the column experiments were approximately 0.5 pore volumes (PV) d-1 
during the conservative tracer test.    
The input solution was prepared by adding NO3‐, SO4
2‐, and ClO4‐ to the CaCO3 
saturated water as Na salts to obtain concentrations of 10.8 ± 0.3 mg L‐1 NO3-N, 24.5 ± 
3.5 mg L‐1 SO4
2‐, and 857 ± 63 µg L‐1 ClO4‐. The ratios of concentrations were based on 
measurements of effluent from test-scale waste-rock piles (Bailey et al., 2013). The 
purpose of using CaCO3 saturated water as the input solution is to simulate the presence 
of HCO3‐ and CO3
2‐, which are common in natural surface water and groundwater. Before 
introducing the input solution, Columns 3 (OC) and 4 (ZVI + OC) were saturated with a 
solution containing 5% (v/v) sodium lactate for 3 d to promote the growth of 
microorganisms (Lindsay et al., 2011). The input solution initially was displaced through 
the four columns from the bottom to the top at a flow rate of 0.5 PV d‐1 during the first 
stage of the experiment. During the second stage of the experiment, the flow rates were 
decreased to 0.1 PV d‐1 (after 99 PV in Column 2, 112 PV in Column 3, and 110 PV in 
Column 4) to evaluate the effect of residence time on contaminant removal. The selected 
flow rates resulted in a range of average groundwater velocities that are typical of 
shallow aquifers. Three profiles were collected along the columns during the course of 
the experiments: after 95.4, 115, and 129 PV of flow passed through Column 2 (ZVI); 
after 108, 132, and 151 PV of flow through Column 3 (OC); and after 106, 128, and 144 
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PV of flow through Column 4 (ZVI + OC). During the experiment, there were no obvious 
signs of clogging or changes in hydraulic conductivity. 
2.3.2 Sample Collection and Analytical Methods 
Water samples were collected using 30-mL glass syringes attached directly to the ports 
along the length of the columns and to the effluent ports so that the syringes were filled at 
the same rate as the input solution being introduced to the columns. Except where noted, 
all samples were passed through 0.45-µm cellulose acetate filters prior to measurement. 
The pH, Eh, and alkalinity were determined immediately after sampling. All other 
samples were kept chilled (< 4°C) until analysis within 1 mo of collection.  
Values of pH and Eh were measured on unfiltered samples in sealed cells to 
minimize O2 exposure. The pH measurements were made using a Ross combination glass 
electrode (Orion 815600) calibrated using standard pH 4.0 and 7.0 buffers and then 
checked against a pH 10.0 buffer. The Eh measurements were made using a Pt-billeted 
Ag/AgCl combination electrode (Orion 9678BNWP). The performance of the electrode 
was checked using Zobell’s (Nordstrom, 1977) and Light’s (Light, 1972) solutions before 
and after each measurement. Measurements were corrected to the standard H2 electrode 
(SHE). Alkalinity was determined using a Hach digital titrator with bromcresol 
green/methyl red indicator and 0.08 mol L-1 H2SO4.  
The concentrations of major anions (Br‐, NO3‐, NO2‐, Cl‐ and SO4
2‐) were determined 
by ion chromatography (IC; DX600, Dionex, Sunnyvale, USA). Ammonia (NH3-N) 
concentrations were determined using a Hach spectrophotometer DR/8400 following the 
salicylate method (APHA, 2005a). Dissolved H2S was determined using the methylene 
blue spectrophotometric method (Lindsay & Baedecker, 1988).  
34 
 
Filtered 20-mL samples were collected separately in 30-mL polyethylene bottles for 
ClO4‐ analysis. A headspace was maintained in these sample bottles to minimize the 
possibility of anaerobic conditions developing during storage. Perchlorate was analyzed 
following the method described by Snyder et al. (2005) with the addition of equal 
aliquots of isotopically enriched sodium perchlorate (NaCl18O4, Cambridge Isotope 
Laboratories, Andover, USA) to all the samples and calibration standards as an internal 
standard (IS). All water samples were prepared by elution through one OnGuard-II Ba 
cartridge and one OnGuard-II H cartridge (Dionex, Sunnyvale, USA) in series to remove 
SO4
2‐ and CO3
2‐, respectively. Perchlorate was analyzed by high performance liquid 
chromatography (Agilent 1100, Agilent Technologies) followed by electrospray tandem 
mass spectrometry (4000 Q TRAP, Applied Biosystems) and detected by negative 
electrospray ionization mass spectrometry using multiple reaction monitoring detection. 
The instrument and practical detection limits were 0.02 and 0.05 μg L‐1, respectively. 
Quality assurance/quality control results showed that relative method recovery over the 
entire standard curve (0.5 ̶ 100 μg L‐1) fell into the range of 98 to 110%, and the relative 
internal standard recovery for unknown samples was 71 to 118%.     
2.4 Results and Discussion  
2.4.1 Conservative Tracer Test and Control Column Results 
The transport model CXTFIT 2.0 was used to determine the velocity and dispersion 
coefficient for each column during the first stage of the experiments. The fitted velocities 
estimated by CXTFIT using the Br‐ breakthrough curve data ranged from 40.3 to 54.3 m 
yr‐1 for the four columns. These values were in agreement with the average linear 
velocities calculated from porosity and flow volume measurements, which ranged from 
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49.1 to 59.6 m yr‐1, with the exception of Column 2 (ZVI). The dispersion coefficients 
ranged from 0.1 to 1.2 m2 yr‐1 for the four columns (Table 2.1). Measurements made on 
the control column indicated that transport of ClO4‐, NO3‐ and SO4
2‐ was conservative 
(Figure 2.1)   
2.4.2 Geochemistry Conditions of Columns 
The three pH profiles within Columns 2-4 measured at different times almost overlapped, 
exhibiting similar values with distance (Figure 2.2). The influent water pH value was 8.3 
throughout the experiments. The average pH value within Column 2 (ZVI) was 9.7. The 
increase in pH was due to the reduction of water by ZVI. The average pH in Column 4 
(ZVI + OC) was slightly lower at 8.6. The pH of Column 3 (OC), which did not contain 
ZVI, was much lower at pH 7.4. Similarly, the average pH of the column effluent was 9.7 
in Column 2 and 7.2 in Column 3, remaining within 0.5 pH units throughout the entire 
experiment (Figure 2.3). The effluent pH of Column 4 increased quickly from below 7 to 
about 9.5 during the first 10 PVs and then decreased to about 8.6 for the remainder of the 
first stage of the experiment.  
The three alkalinity profiles for each of Columns 2, 3, and 4 indicated similar 
average values and changing trends, with slight increases as the input solution advanced 
through the columns (Figure 2.2). Total alkalinities with an average value of 96 mg L‐1 
(as CaCO3) were generated in Column 2 (ZVI) effluent; in the effluent of the columns 
containing OC, slightly higher alkalinity values of 119 mg L‐1 (as CaCO3) in Column 3 
(OC) and 113 mg L‐1 (as CaCO3) in Column 4 (ZVI + OC) were observed (Figure 2.3). 
The values of Eh in Columns 2, 3, and 4 ranged from moderately oxidizing to 
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moderately reducing conditions over the course of the experiments, with lower values 
observed during the second stage of the experiments when the flow rates were lower 
(Figure 2.2). Higher average Eh values of ~ 300 mV were observed within Column 3 (OC) 
relative to the values observed in the middle distances in Columns 2 (ZVI, -200 mV) and 
4 (ZVI + OC, -400 mV). Addition of the lactate solution to Columns 3 and 4 likely 
resulted in the relatively low Eh and high alkalinity values in the column effluent at the 
beginning of the first stage of the experiment compared to Column 2 (Figure 2.3). In the 
effluent of Columns 2 and 4 (Figure 2.3), the Eh values were relatively constant 
throughout the experiment. The Eh values in the effluent of Column 3 gradually increased 
from approximately 40 mV at the 35 PV to 460 mV at 110 PV in the first stage of the 
experiment, and then decreased to the average value of 200 mV in the second stage of the 
experiment. These decreases in Eh values were likely due to the decrease in flow rate 
from 0.5 PV d‐1 in the first stage of the experiment to 0.1 PV d‐1 in the second stage of the 
experiment.  
2.4.3 Removal of Nitrate, Sulfate, and Perchlorate in Columns      
Reduction of NO3‐ by ZVI has been observed to proceed rapidly through NO2‐ to NH4
+. 
The proposed pathway for the overall reaction is (Rahman & Agrawal, 1997):  
                   NO3
- + 4Fe0 + 10H+ → 4Fe2+ + NH4
+ + 3H2O                                   (2.1) 
Nitrate was almost completely removed in the column containing ZVI (Column 2) 
from the average input concentration of 10.8 mg L‐1 (NO3-N) to a trace concentration. 
Nitrite concentrations remained < 0.02 mg L‐1 (NO2-N) and the average NH4
+ 
concentration was 10.7 mg L‐1 (NH3–N) indicating that NH4
+ was the principal byproduct 
throughout the course of the experiment (Figure 2.1). The concentrations of total N (sum 
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of NO3-N, NO2-N, and NH3-N) in Column 2 (ZVI) effluent were consistent with the 
input NO3
− concentrations, indicating complete conversion of NO3‐ to NH4
+.  
Bacterially mediated denitrification by OC such as wood waste as a C source is 
thermodynamically favored and leads to the stepwise reduction of NO3‐ to form N2 gas: 




 (aq) → NO(enzyme complex) → N2O(gas) → N2(gas)                        (2.2) 
The overall reaction can be expressed as (Appelo & Postma, 2005):   
            5CH2O + 4NO3
− → 2N2 + 5HCO3
− + H+ + 2H2O                                 (2.3) 
The removal of NO3‐ in Column 3 containing OC was variable (Figure 2.1). In the first 
stage of the experiment (108 PV) at a flow rate of 0.5 PV d‐1, up to 2.6 mg L‐1 NO3-N 
remained in the effluent. In addition, up to 2.4 mg L‐1 NO2-N, an intermediate reaction 
product, was observed in the effluent in the first stage of the experiment. However, NO3‐ 
was more completely removed in the second stage of the experiment when the flow rate 
decreased to 0.1 PV d‐1, from an average input concentration of 10.8 to < 0.02 mg L‐1 
(NO3-N) without measurable NO2‐ observed. A trace of NH3 (average value 0.1 mg L‐
1 
NH3-N) was observed in Column 3 effluent samples, perhaps due to the decomposition of 
OC. In the first stage of the experiment, the total N concentrations in the Column 3 (OC) 
effluent progressively rose from 0.1 to 5.2 mg L‐1. The increase in total N concentrations 
is predominantly due to an increase in the concentrations of NO3‐ and NO2‐, indicating 
that the increase in total N was due to incomplete denitrification, possibly due to a 
depletion of labile OC. In the second stage of the experiment the total N concentration 
decreased to as low as 0.7 mg L‐1 N, suggesting that the rate of OC consumption was 
sufficient to result in complete denitrification during this stage.  
The mixture of ZVI + OC in Column 4 resulted in extensive removal of NO3‐, no 
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detectable release of NO2‐, and the release of 9.5 mg L‐
1 of NH3-N at the beginning of the 
experiment that gradually decreased to 6.6 mg L‐1 at 100 PV (Figure 2.1). This decreasing 
trend suggests that NO3‐ reduction by ZVI predominated early in the experiment and that 
denitrification became established, resulting in partial conversion of NO3‐ to N2(g). In 
stage 2 the average total N concentration was 5.5 mg L‐1, almost exclusively as NH4
+, 
indicating an increase in the extent of denitrification as the residence time increased, 
resulting in approximately equal removal by NO3‐ reduction and denitrification. Less 
NH4
+ is observed when ZVI was used in conjunction with a microbial consortia to reduce 
NO3‐ (Till et al., 1998).  
Effluent SO4
2‐ concentrations did not decrease in the columns containing ZVI 
(Column 2) or the mixture of ZVI + OC (Column 4) during the experiment (Figure 2.1). 
Sulfate was observed to break through Column 3 (OC) in the first stage of the experiment; 
however, effluent SO4
2‐ concentrations in Column 3 decreased from 24.7 mg L‐1 after 108 
PV in the first stage of the experiment to 7.1 mg L‐1 after 132 PV in the second stage of 
the experiment (when the flow rate slowed), with approximately 71% of the input SO4
2‐ 
(24.5 mg L‐1) removed. The effluent SO4
2‐ concentration then increased to 15.0 mg L‐1 
after 151 PV in the second stage of the experiment. This SO4
2‐ removal is attributed to the 
onset of biologically mediated SO4
2‐ reduction coupled to OC oxidation (Blowes et al., 
2000):  
                                  2CH2O + SO4
2- → 2HCO3
-+ H2S                                     (2.4) 
The decrease in the rate of SO4
2‐ removal over time was probably due to depletion of 
labile OC (C, N, and P source for microbial growth) over the long-term operation of the 
experiment. The inhibition of SO4
2‐ reduction observed in Column 4 (ZVI + OC) might 
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be attributed to the higher pH conditions developed in this column compared to Column 3 
(OC) (Figures 2.2 and 2.3). 
Although reduction of ClO4‐ by ZVI is thermodynamically favored, with ∆G°= -
596.27 kcal mol‐1, ClO4‐ was not removed by ZVI in Column 2 throughout the experiment; 
this is likely due to the high activation energy required for ClO4‐ reduction (Yu et al., 
2006). The effluent ClO4‐ concentration was 857 ± 63 μg L‐
1, similar to the input 
concentration (Figure 2.1). The total effluent Cl concentrations (sum of ClO4‐ and Cl in 
μmol L‐1) in Column 2 (ZVI) were much higher than the input ClO4‐ concentrations, this 
difference may be due to the release of Cl initially present on the ZVI (Figure 2.4). The 
presence of Cl in the first pore volumes of flow likely represented residual from the ZVI 
manufacturing processes. 
The effluent concentrations of ClO4‐ in Column 3 decreased from 547 μg L‐
1 after 
108 PV in the first stage of the experiment to 28 μg L‐1 after 151 PV in the second stage 
of the experiment (Figure 2.1). Similarly, in the second stage of the experiment when the 
flow rate was lowered, OC combined with ZVI exhibited more uniform removal of ClO4‐ 
in Column 4 than Column 3. The concentration of ClO4‐ in the effluent of Column 4 
decreased from 679 μg L‐1 after 106 PV in the first stage of the experiment to 1.37 μg L‐1 
after 144 PV in the second stage of the experiment. Previous studies have suggested the 
pathway for biological degradation of ClO4‐ (Rikken et al., 1996) as shown in Figure 2.5.  
 The first two reactions are catalyzed by (per)chlorate reductase. Chlorite 
dismutase catalyzes the disproportionation of ClO2‐ into Cl‐ and O2 (Okeke & 
Frankenberger Jr., 2003). The OC probably provided sufficient C and N for microbial 
degradation of ClO4‐ in Columns 3 (OC) and 4 (ZVI + OC); however, complete removal 
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of ClO4‐ was not consistently observed until the second stage of the experiment (Figure 
2.1). Extensive removal of ClO4‐ initially was observed in Column 3, but the rate of ClO4‐ 
removal declined after 30 PVs. After the flow rate decreased, complete removal of ClO4‐ 
was observed. Initially, little ClO4‐ removal was observed in Column 4. More extensive 
removal was observed after 10 PVs, suggesting a period of acclimation was required 
before ClO4‐ reduction was established. After 60 PVs, the rate of ClO4‐ removal declined, 
suggesting depletion of labile OC. During stage 2 of the experiment, complete removal of 
ClO4‐ was observed, suggesting that the rate of OC fermentation was sufficient to provide 
labile OC (C, N, and P source for microbial growth) for sustained biological ClO4‐ 
reduction.  
Chloride, the final potential product of ClO4‐ biological degradation, should be 
released at an amount equivalent to the moles of ClO4‐ removed. In contrast to Column 2 
(ZVI), the concentrations of Cl in the first 2 PVs effluents of Columns 3 (OC) and 4 (ZVI 
+ OC) were below the detection limit (0.01 mg L‐1), likely due to the flushing and 
saturation of the columns prior to the experiment and the small fraction (10% v/v) of ZVI 
in Column 4 (ZVI + OC) compared to that of ZVI (50% v/v) in Column 2 (ZVI). The 
changes in Cl‐ concentrations in both Columns 3 (OC) and 4 (ZVI + OC) effluent were 
inversely correlated to ClO4‐ concentrations. Very consistent concentrations of total 
effluent Cl (sum of ClO4
- and Cl‐ in μmol L‐1) relative to the input ClO4‐ concentrations 
for these columns indicated that the expected mass of Cl was accounted for in both 
Columns 3 and 4 (Figure 2.4). 
2.4.4 Removal Rates of Nitrate and Perchlorate within Columns 
The two NO3‐ and ClO4‐ profiles collected for each of Columns 2, 3, and 4 in the second 
41 
 
stage of the experiment were similar (Figure 2.6). Therefore, only the profiles measured 
in the first stage of the experiment (95.4 PV for Column 2; 108 PV for Column 3, and 
106 PV for Column 4) and one of the profiles measured in the second stage of the 
experiment (115 PV for Column 2; 132 PV for Column 3; and 128 PV for Column 4) 
were used for calculation of removal rate parameters.  
Nitrate removal rates within Columns 2, 3, and 4 were consistent with a first-order 
rate model (Figure 2.7) as reported in other studies (Appelo & Postma, 2005; Tan et al., 
2004):  
                                                            C = C0 exp(-k1 t)                                                  (2.5) 
                                                          RN = k1 C                                                          (2.6) 
where C is the NO3‐ concentration (mg L‐
1), C0 is the initial NO3‐ concentration (mg L‐
1 or 
mmol L‐1), k1 is a first-order rate constant (d‐
1), t is the residence time (d), and RN is the 
reaction rate (removal rate) of nitrate (mg L‐1 d‐1 or mmol L‐1 d‐1). The best-fit NO3‐
 
degradation equation based on calculated residuals for each column (SigmaPlot, SPSS 
Inc.) was selected from the two first-order expressions derived from the two stages of the 
experiment.  
Nitrate removal by ZVI within Column 2 (ZVI) followed a first order removal model, 
with removal rates of RN,2 = 0.015C mmol L‐
1 d‐1 in the first stage of the experiment and 
RN,2 = 0.011C mmol L‐
1 d‐1 in the second stage of the experiment (Table 2.2; Figure 2.7); 
however, neither of these equations could adequately describe the degradation curves in 
both experimental stages. An average first-order removal rate of RN,2 = 0.013C mmol L‐
1 
d‐1, which fell between the first and second stage data sets, is recommended to best 
describe the NO3‐ removal within Column 2 (ZVI).  
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The denitrification rate within Column 3 (OC) can be described by: RN,3 = 0.010C 
mmol L‐1 d‐1 (Table 2.2; Figure 2.7). Both zero-order and first-order rate expressions have 
been observed to provide reasonable descriptions of the rate of denitrification (R2 > 0.86) 
(Tan et al., 2004). Similar findings were observed in this study: NO3‐ removal by ZVI and 
OC in Column 4 in both first and second stages of the experiment were consistent with 
both the first-order and zero-order rate equations in terms of R2 (> 0.94) (Table 2.2 and 
Figure 2.7). However, to maintain consistency between the NO3‐ removal rates for 
Column 4 (ZVI + OC) and those for Column 2 (ZVI) and Column 3 (OC), RN,4 = 0.025C 
mmol L‐1 d‐1 was used to describe the rates of NO3‐ removal in Column 4 throughout the 
experiment. Given the same initial concentration, NO3‐ was removed much more rapidly 
in Column 4 than in Columns 2 or 3 (Figure 2.6).   
Perchlorate removal in some bioreactors has been observed to follow first-order 
reaction rates with respect to ClO4‐ concentration (Min et al., 2004). However, in this 
study, ClO4‐ removal in Columns 3 (OC) and 4 (ZVI + OC) followed zero-order rate 
equations (Figure 2.8):  
                                                                  0C k t                                                     (2.7) 
where C is the ClO4‐ concentration (µg L‐
1 or µmol L‐1), t is the residence time (d), and k0 
is a zero-order rate constant for ClO4‐ removal (µg L‐
1 d‐1 or µmol L‐1 d‐1). The best fit 
equation for ClO4‐ removal, based on least squares regression, was also obtained using a 
zero-order rate expression derived from the two stages of the experiment. The ClO4‐ 
removal rate within Column 3 (OC) was RP,3 = 0.61 µmol L‐
1 d‐1 for 0 < x < 2.9 d (derived 
from the distance between the column input and the sampling point) and NO3‐ 




in the first stage of the experiment and RP,3 = 1.84 µmol L‐
1 d‐1 in the second stage of the 
experiment, where 2.9 < t < 6.7 d (for a NO3‐ concentration < 2 mg L‐
1 NO3–N). Neither 
of these removal rates adequately described the observations from both experimental 
stages. An average zeroth-order removal rate of RP,3 = 1.89 µmol L‐
1 d‐1 was selected to 
describe the ClO4‐ removal rate within Column 3 (OC) for 2.9 < t < 6.7 d and NO3‐ < 2 
mg L‐1 NO3-N. The overall ClO4‐ removal rate within Column 4 (ZVI + OC) was RP,4 = 
1.14 µmol L‐1 d‐1 (Table 2.2; Figures 2.6 and 2.8). The ClO4‐ removal rate for the second 
stage of the Column 4 experiment was RP,4 = 0.94 µmol L‐
1 d‐1 for 0 < t < 2.0 d and NO3‐ 
concentration > 2 mg L‐1 NO3-N. A statistical comparison of the ClO4‐ removal rates for 
Columns 3 (OC) and 4 (ZVI + OC) indicated that ClO4‐ was removed more rapidly in 
Column 4 (ZVI + OC) than in Column 3 (OC) for NO3‐ > 2 mg L‐
1 (NO3-N) in the second 
stage of the experiment (Figures 2.6 and 2.8), but more rapidly in Column 3 for NO3‐ < 2 
mg L‐1 NO3-N.  
2.4.5 Effect of Nitrate and Sulfate on Perchlorate Removal Rate 
The impact of NO3‐
 on ClO4‐ reduction is important because NO3‐ is a common co-
contaminant in ClO4‐-contaminated water (Xu et al., 2003a). Most ClO4‐ reducing bacteria 
(PRB) are also denitrifiers, and the simultaneous removal of NO3‐ and ClO4‐ from 
contaminated waters has been observed (Logan & LaPoint, 2002; Min et al., 2004). 
Likewise, the NO3‐ and ClO4‐ within Columns 3 (OC) and 4 (ZVI + OC) were removed 
simultaneously. However, the overall NO3‐ removal within both Columns 3 and 4 
occurred at a more rapid rate than ClO4‐ removal (Figure 2.6), which may have been due 
to competition for common electron donors (organic matter) between the two removal 
processes (Chung et al., 2010). The selection of electron acceptors by microorganisms is 
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competitive to maximize the energy yield in a redox reaction. Nitrate reduction was found 
more thermodynamically favored over ClO4‐ reduction due to the lower electron transfer 
requirement for NO3‐ reduction compared to that for ClO4‐ reduction (Chung et al., 2010). 
The ClO4‐ reducing bacteria in preference of O2 or NO3‐ over ClO4‐ was also reported 
(Roldan et al., 1994). Moreover, if the same enzyme in a microorganism was used for 
both NO3‐ and ClO4‐ reductions, NO3‐ were likely to inhibit ClO4‐ reduction and ClO4‐ 
also likely to inhibit NO3‐ reduction, depending on the initial concentrations of NO3‐ and 
ClO4‐ (Giblin & Frankenberger W.T, 2001). Complete NO3‐ removal within Columns 3 
and 4 was observed prior to complete ClO4‐ removal (Figure 2.6), which is similar to 
other studies (Min et al., 2004).  
 Nitrate has different effects on ClO4‐ removal rates. Nitrate was found to inhibit 
the ClO4‐ reduction rate in some studies (Brown et al., 2002; Xu et al., 2003a) but not 
others (Giblin et al., 2000). In this study, the inhibition of ClO4‐ removal by NO3‐ was 
observed within Column 3 (OC) but not Column 4 (ZVI + OC). The inhibiting effects of 
NO3‐ on ClO4‐ removal occurred at NO3‐ concentrations > 2 mg L‐
1 NO3-N within Column 
3 (OC) during the second stage of the experiment when flow rate was maintained at 0.1 
PV d‐1. Moreover, rapid ClO4‐ degradation did not proceed until NO3‐ concentrations were 
reduced to relatively low levels (normally < 2 mg L‐1 NO3-N), which is consistent with 
previous findings (Tan et al., 2004). However, the presence of NO3‐ within Column 4 
(ZVI + OC) did not inhibit ClO4‐ removal (Figure 2.6), which followed similar linear 
rates in the presence and absence of NO3‐. These results suggest that adding ZVI to wood 
chips can potentially reduce the inhibition of NO3‐ (> 2 mg L‐
1 NO3-N) on ClO4‐ removal 
when flow rate was maintained at 0.1 PV d‐1. The presence of SO4
2‐ did not inhibit ClO4‐ 
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removal in Column 3 (OC) or 4 (ZVI + OC) (Figure 2.6), as is consistent with previous 
reports (Chung et al., 2010).  
2.5 Conclusions 
Reactive media containing OC or a mixture of ZVI + OC were found effective for 
removing NO3‐ and ClO4‐ from water. The removal of NO3‐ and ClO4‐ followed first-order 
and zero-order rates in these column experiments, respectively. Nitrate and ClO4‐ were 
removed simultaneously within the columns; however, complete NO3‐ removal occurred 
prior to complete ClO4‐ removal. Addition of ZVI to wood chips reduced the inhibition of 
NO3‐ (> 2 mg L‐
1 NO3-N) on ClO4‐ degradation when flow rate was maintained at 0.1 PV 
d‐1. Decreasing the flow rate from 0.5 to 0.1 PV d‐1 resulted in more complete removal of 
NO3‐, SO4
2‐, and ClO4‐. These results suggest that permeable reactive barriers and 
bioreactors containing OC or mixtures of OC and ZVI may be suitable for treating NO3‐, 
ClO4‐ and SO4
















Table 2.1 Physical characteristics of the columns used in this study, including a control 
and columns containing zero-valent Fe (ZVI), organic C (OC) or both. 







ZVI + OC 
Bulk density (g cm-3) 1.73 2.27 1.34 1.59 
Porosity 0.35 0.40 0.45 0.41 
Pore volume (cm3) 219 248 273 246 
Average linear velocity (m yr-1) 59.6 51.7 50.8 49.1 
Fitted velocity (m yr-1) 54.3 40.3 49.1 46.4 
Dispersion coefficient (m2 yr-1) 0.07 1.16 0.94 0.46 
R2  0.999 0.989 0.995 0.997 
















Table 2.2 Nitrate and ClO4
- removal rates calculated using least-squares regression during 
two experimental stages. 
Contaminant Column Stage† 
Removal rate‡, 
mmol L-1 d-1 
(NO3–N) 









1 0.015×C   0.7 0.983 
2 0.011×C   1.0 0.999 
avg. 0.013×C  § 0.8 —¶ 
3 
1 0.010×C  § 1.1 0.993 
2  0.010×C   1.1 0.997 
4 
1 0.025×C   § 0.4 0.947 
2 0.017×C   0.7 0.985 
ClO4‐ 
3 
1 1.41   3.1 0.890 
2  1.36  § 3.2 0.950 
1  1.21 (0–12.9cm)  3.6 0.833 
2 0.61 (0–12.9cm) § 7.0 0.999 
1  1.95 (12.9–30cm)  2.2 0.882 
2 1.84 (12.9–30cm)  2.3 0.991 
avg. 1.89 (12.9–30cm) § 2.3 — 
4 
1 0.93   4.6 0.945 
2  1.14  § 3.8 0.968 
† Removal rates were calculated for either Stage 1 or 2 of the experiment or the average 
of the stages, where indicated.   
‡ C is the input NO3‐N concentrations; the reported rates were calculated for the entire 
length of the columns, except where the column distance range is provided. The distance 
0–12.9 cm corresponds to NO3‐N concentrations > 2 mg L
-1 and the distance 12.9–30 cm    
corresponds to NO3‐N concentrations < 2 mg L
-1. 
§ Recommended rates that provide the best fits for both stages of the experiments.   








Figure 2.1 Concentrations of NO2-N, NH3-N, NO3-N, SO4
2-, and ClO4
- as a function of 
pore volumes in effluent from columns containing zero-valent Fe (ZVI), organic C (OC), 
or both; the dashed lines indicate a change in flow rate in each column, dividing the 
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Figure 2.2 Values of pH, Eh, and concentrations of alkalinity as a function of distance 
along flow direction within the columns containing zero-valent Fe (ZVI), organic C (OC), 
or both. Blue circle symbols represent data collected during the first stage of the 
experiment, while orange square and green triangle symbols represent data collected 
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Figure 2.3 Values of pH, Eh, and concentrations of alkalinity as a function of pore 
volumes in effluent from columns containing zero-valent Fe (ZVI), organic C (OC), or 
both; the dashed lines indicate a change in flow rate in each column, dividing the 
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Figure 2.4 Concentrations of Cl-, ClO4
-, and total Cl- (sum of Cl- and ClO4
-) as a function 
of pore volumes in effluent from columns containing zero-valent Fe (ZVI), organic C 
(OC), or both; the dashed lines indicate a change in flow rate in each column, dividing 
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Figure 2.5 Suggested pathway for biological degradation of ClO4
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Figure 2.6 Concentrations of NO3-N, NH3-N, NO2-N, SO4
2-, H2S, ClO4
-, and Cl- as a 
function of distance along flow direction within the columns containing zero-valent Fe 
(ZVI), organic C (OC), or both. Blue circle symbols represent data collected during the 
first stage of the experiment, while orange square and green triangle symbols represent 


























Figure 2.7 Regression fits of NO3-N removal as a function of residence time in columns 
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Figure 2.8 Regression fits of ClO4
- removal as a function of residence time in columns 
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Chapter 3: Artificial Sweeteners and 
Pharmaceuticals as Co-tracers of Municipal 



















3.1 Executive Summary 
Wastewater treatment plant (WWTP) effluents are important sources of emerging 
contaminants at environmentally-relevant concentrations. In this study, water samples 
were collected from a river downstream of two WWTPs to identify practical tracers for 
tracking wastewater. The results of the study indicate elevated concentrations of Cl-, 
nutrients (NH3-N and NO2
-), the artificial sweetener acesulfame-K (ACE-K), and the 
pharmaceuticals carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), 
ibuprofen (IBU), gemfibrozil (GEM), and naproxen (NAP) in the river close to the 
WWTPs that decreased with distance downstream. A correlation analysis using the 
Spearman Rank method showed that ACE-K, CBZ, GEM, NAP, and Cl- were strongly 
correlated with each other over a 31 km stretch of the river in the study area. The strong 
correlations of these target compounds indicate that the artificial sweetener ACE-K and 






Domestic sewage is collected and treated in wastewater treatment plants (WWTPs) 
where contaminant removal occurs through a series of physical, chemical, and 
biological processes. However, due to the persistence of some emerging 
contaminants (ECs) and their metabolites, they cannot be completely removed in 
WWTPs and become widely distributed in environmental waters (Bueno et al., 
2012). Emerging contaminants and their metabolites accumulated in the aquatic 
environment may cause adverse effects on aquatic ecosystems, such as interference 
with reproduction and development systems of biota in the environment and 
development of bacterial resistance (Fent et al., 2006; Morley, 2009; Santos et al., 
2010). It is important to track the transport, and monitor the widespread 
occurrence, of ECs in the aquatic environment using proper tracers. 
 Chemical tracers for wastewater contamination should be conservative and 
present in most wastewaters, and ideally be derived only from wastewater. In 
addition, the concentrations of tracers should be well above analytical detection 
limits and not vary greatly over time (Kasprzyk-Hordern et al., 2009; Van 
Stempvoort et al., 2013). Chloride and nutrients have been used as conventional 
tracers of wastewater contamination; however, other anthropogenic sources, such 
as road salts and fertilizer, can contribute to loadings in surface and ground waters 
thus making these constituents potentially less reliable as tracers.  
 Artificial sweeteners such as acesulfame-K (ACE-K) and sucralose are 
particularly widespread and persistent in surface water and groundwater, and 
therefore have been suggested as ideal tracers of domestic wastewater in the 
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environment (Buerge et al., 2009; Lubick, 2009; Scheurer et al., 2009). In addition, 
some pharmaceuticals, such as carbamazepine (CBZ) and caffeine (CAF), have 
been proposed as indicators of wastewater contamination in the environment 
(Andreozzi et al., 2002; Clara et al., 2004; Kurissery et al., 2012). However, CBZ 
and naproxen (NAP) can adsorb to sediment (Chefetz et al., 2008; Durán-álvarez et 
al., 2012) and CAF tends to biodegrade (Buerge et al., 2003). These natural 
attenuation processes make these pharmaceuticals less ideal as wastewater tracers. 
Therefore, the use of multiple tracers would greatly increase the confidence of 
identifying wastewater in aquatic environments (Van Stempvoort et al., 2013; 
Williams et al., 2013). The purpose of this study is to evaluate the potential use of 
ECs as co-tracers to track wastewater in receiving water bodies.  
 In this study, samples of river water were collected and analyzed for several 
potential tracers to track wastewater from two WWTPs in the Grand River 
watershed. The Grand River is the largest watershed in southwestern Ontario, 
Canada, flowing 300 km through a number of municipalities before discharging to 
Lake Erie. The persistence of several target compounds—ACE-K, CBZ, CAF, 
NAP, sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA), ibuprofen (IBU), and gemfibrozil 
(GEM)—was compared to conventional wastewater parameters to determine the 
potential use of these compounds as tracers.  
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3.3 Materials and Methods 
3.3.1 Water Sampling and Field Analyses 
Samples of river water were collected at 10 locations over a distance of 32.1 km 
along the Grand River near the cities of Waterloo and Kitchener (southwestern 
Ontario, Canada) in August 2012 and July 2013. Winter samples were collected in 
December 2014; sampling results are updated in Appendix B (Table B.1 and 
Figures B.1-B.3). The 10 sampling locations are labeled GR 1 to GR 10 (Figure 
3.1). GR 8 and GR 1 are upstream of GR 2 (the location of the first WWTP; 
WWTP-1), then GR 3, 9, 10, 4, 5, 6, 7 are located sequentially downstream. GR 5 
is located at the intake of a Water Treatment Plant-1 (WTP-1) where Grand River 
water is treated to provide a drinking water supply, and GR 6 is located 0.1 km 
downstream of the effluent of WWTP-2. The average discharge of the Grand River 
measured at a gauge station near GR 6 (Grand River near DOON, station number 
02GA048) (Environment Canada, 2013) was 9.8 m3 s-1 for the sampling dates in 
2012 (August 9 ̶ 10) and 56.7 m3 s-1 for the sampling dates in 2013 (July 8 ̶ 9, 
during a rain event).  
All river water samples were collected in a consistent manner 5 m away from the 
river bank on the side of the river into which WWTP-1 and WWTP-2 effluents are 
discharged. Additional samples were collected directly from the effluent discharge pipe 
from the wastewater treatment plant (WWTP-1), and from the water treatment plant 
(WTP-1) influent reservoir. Duplicate samples were collected at the two WWTPs.  These 
locations were selected to provide samples most representative of the WWTP-1 effluent 
and of the intake of WTP-1. Samples were obtained using Teflon tubing (6.5 m in length) 
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connected to a peristaltic pump (MasterFlex, Cole-Parmer Instrument Company, CA). All 
samples, except those for pH, Eh, and electrical conductivity (EC) measurements, were 
filtered through 0.45 µm Thermopor membrane filters to determine alkalinity and 
concentrations of Cl-, SO4
2-, NO3
-, NO2
-, NH3-N, PO4-P, and the target pharmaceuticals 
and artificial sweetener. Determination of pH, Eh, alkalinity, and EC was performed on 
site immediately after sample collection. The sampling program included: collection of  2 
L river water in two 1 L amber glass bottles for pharmaceutical and ACE-K analysis; 30 
mL river water in a 35 mL polypropylene bottle for NH3-N and PO4-P analysis; and 10 
mL river water in a 15 mL polypropylene bottle for anion analysis. The samples for NH3-
N, PO4-P, pharmaceuticals, and artificial sweetener were acidified on site with H2SO4 to 
pH < 2 while samples for anions (Cl-, SO4
2-, NO3
-, NO2
-) were not. All samples were 
stored at 4 °C and analyzed within one month of collection, except for pharmaceuticals 
and ACE-K samples which were analyzed within three days after collection. 
3.3.2 Analysis of Water Samples 
3.3.2.1 Primary Wastewater Parameters 
Values of pH were determined using a pH electrode (Ross combination, Orion 
815600) calibrated with standard pH 7.0 and pH 10.0 buffers prior to each 
measurement, and checked with a pH 7.0 buffer after each measurement. Values of 
Eh were determined using an Eh electrode (Pt-billeted Ag/AgCl combination, 
Orion 9678BNWP) checked using Zobell’s (Nordstrom, 1977) solution before and 
after each measurement. Electrical conductivity was measured using an Orion 
013005MD conductivity cell. The performance of the electrical conductivity cell 
was checked with a 0.01M KCI solution prior to each measurement. Alkalinity 
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values were determined using standardized H2SO4 and a Hach digital titrator 
following Titration Method 2320 B (APHA, 1992). 
 Anion (Cl-, SO4
2-, NO3
-, NO2
-) concentrations were determined by ion 
chromatography (Dionex ICS-5000+, Mississauga, CA). Ammonia (NH3-N) and 
ortho-phosphate (PO4-P) concentrations were determined using a Hach 
spectrophotometer DR/8400 following the salicylate method (4500-NH3)(APHA, 
2005a) and ascorbic acid method (4500-P: E) (APHA, 2005b), respectively.  
3.3.2.2 Trace Wastewater Parameters 
ACE-K and the eight pharmaceutical compounds were analyzed using solid-phase 
extraction and high-performance liquid chromatography (HPLC) followed by 
tandem mass spectrometry using previously published methods (Scheurer et al., 
2009; Stafiej et al., 2007; Vanderford & Snyder, 2006), with slight modifications 
such as inclusion of isotope dilution techniques for each study compound and 
optimization of instrument operating conditions. Native compounds were supplied 
by Sigma-Aldrich (Oakville, Canada) with the exception of ACE-K obtained from 
Toronto Research Chemicals Inc. (Toronto, Canada). Isotope-labeled standards, 
including ACE-K-d4 and SMX-d4 (Toronto Research Chemicals Inc., Toronto, 
Canada), MDA-d5 and MDMA-d5 (Cerilliant Inc., Texas, USA), and CBZ-d10, 
CAF-d3, IBU-d3, GEM-d6, and [13C]-NAP (Cambridge Isotope Laboratory Inc., 
Cambridge, USA) were obtained as dry powders. Standard stock solutions of 
~1000 µg L-1 were prepared by dissolving each compound in methanol. Working 
standard solutions containing all analytes were prepared by serial dilution in 
methanol:water 50:50 vol:vol. HPLC-grade ammonium acetate  and formic acid 
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were obtained from Sigma-Aldrich (Oakville, Canada). Ultrapure (Type 1) water 
was generated using a MilliQ A10 water system (18.2 MΩ.cm @ 25 oC).  
 Prior to analysis, 600 mL aliquots of aqueous samples were spiked with a 
consistent amount of internal standard mixture. These samples were passed 
through solid-phase extraction (SPE) cartridges (Oasis HLB 6 mL glass cartridges; 
Waters Corp., Mississauga, Canada) pre-conditioned with 3 × 2 mL methanol and 
then equilibrated with 3 × 2 mL ultrapure water. After loading the 600 mL 
samples, the cartridges were washed using 3 × 2 mL 5 vol. % methanol then eluted 
with 3 × 2 mL methanol. The eluate was collected in an amber glass vial and 
stored at 4 °C until analysis.  
 The extracts were analyzed using an Agilent 1100 HPLC (Agilent 
Technologies, Mississauga, Canada) followed by electrospray tandem mass 
spectrometry (MS/MS; 4000 Q TRAP, Applied Biosystems, Foster City, USA). 
Caffeine, SMX, CBZ, MDA, and MDMA were analyzed in electrospray ionization 
positive (ESI+) mode, while IBU, GEM, NAP, and ACE-K were analyzed in ESI 
negative (ESI-) mode. The gradient and mobile phases were changed from 
previous methods based on the HPLC analytical columns and mass spectrometer 
(MS) requirements. The compound and source-dependent parameters of the MS 
were modified to obtain an optimum signal response. The mobile phases for 
analysis in ESI+ mode consisted of 0.1% formic acid and 5 mM ammonium 
acetate in water (phase A) and 99.9% MeOH with 0.1% formic acid (phase B). A 
gradient elution started at 10% B for 3 min, increased to 90% B in 10 min, and 
then held at 90% B min for 10 min. The flow rate was 1000 µL min-1 and the 
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injection volume was 15 µL. The mobile phases for analysis in ESI- mode 
consisted of 6.9 mM acetic acid in 300 mL acetonitrile and 700 mL water (phase 
A) and 100% acetonitrile (phase B). A gradient elution started at 12% B, then 
increased linearly to 40% in 10 min and held at 40% for 10 min. The injection 
volume was 10 µL and the flow rate was 1000 µL min-1. For ACE-K analyzed in 
ESI- mode, the mobile phases consisted of 20 mM ammonium acetate in water 
(phase A) and 20 mM ammonium acetate in methanol (phase B). The gradient 
elution started at 2% B, then increased linearly to 75% in 8 min and held at 75% 
for 8 min. The injection volume was 10 µL and the flow rate was 1000 µL min-1. 
 A mixed standard containing ACE-K, CBZ, CAF, SMX, IBU, NAP, and GEM 
was used for method calibration. The same amount of isotope-labeled compounds 
was added to the calibration standards, method standards, and unknown samples. 
The recovery of the isotope-labeled compounds was used to correct the response of 
the instrument to each compound. Nine-point calibration curves from 5 to 10,000 
ng L-1 were established by analysis of standard mixtures prepared in 50% 
methanol: 50% water. Tap water samples spiked with the analyte mixtures and 
internal standards and extracted following the same procedure as the unknown 
samples were used to evaluate the addition of the SPE step to the method. The 
limits of detection (LOD) and quantification (LOQ) were calculated at three and 10 
times the signal-to-noise values, respectively. The method detection limits (MDL) 
were determined by extracting 14 deionized water samples fortified with labeled 
analytes at concentrations three to five times the LOD, depending on the expected 
MDL and internal standard at the same concentration level used in the method. The 
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MDL was calculated by multiplying the standard deviation of the replicate 
measurements by the Student’s t value for n-1 degrees of freedom. The MDLs 
determined were 41.9 ng L-1 for ACE-K, 99 ng L-1 for CAF, 10.4 ng L-1 for SMX, 
17.1 ng L-1 for CBZ, 38.8 ng L-1 for MDA, 3.9 ng L-1 for MDMA, 29.6 ng L-1 for 
IBU, 3.1 ng L-1 for GEM, and 9.7 ng L-1 for NAP. The LOQs determined were 
four to 230 times lower than MDL values. 
 Methanol:water samples (continuous calibration verification samples) were 
analyzed at initial instrument calibration and after every 10 unknown samples. 
Quality assurance/quality control results showed that the concentrations of all 
target compounds in the calibration standard blanks and method standard blanks 
were consistently below detection limits. The absolute analyte and internal 
standard recovery for continuous calibration verification samples ranged from 84 
to 116%. Relative method recovery for ACE-K ranged from 94 to 118% across the 
standard curve from 0.1 to 100 µg L-1. The relative internal standard recovery of 
ACE-K for unknown samples ranged from 71 to 95%. Relative method recovery 
for CAF, SMX, CBZ, MDA, and MDMA ranged from 84 to 120% across the 
standard curve (0.01 ̶ 10 µg L-1 for SMX and MDMA, 0.05 ̶ 10 µg L-1 for CBZ and 
MDA, 1 ̶ 10 µg L-1 for CAF). Relative internal standard recovery of CAF, SMX, 
CBZ, MDA, and MDMA for unknown samples ranged from 70 to 109%; CBZ had 
the best absolute internal standard recovery (84 ̶ 97%) for unknown samples. 
Relative method recovery for IBU, GEM, and NAP ranged from 91 to 110% 
across the standard curve (0.02 ̶ 10 µg L-1); the corresponding relative internal 
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standard recovery for unknown samples was 94 ̶ 119%. The recovery of 
duplicated, spiked, and repeated samples was 75 ̶ 121%.  
3.4 Results and Discussion 
3.4.1 Grand River Sampling Results 
The average pH of the river water samples was ~7.9 during the 2012 and 2013 
sampling events, with lower values of 7.6 ̶ 7.8 observed near the effluent of 
WWTP-1. Eh varied over the sampling distance of the river in 2012, with lower 
values observed near the effluents of both WWTP-1 and WWTP-2; however, 
values were relatively constant (~350 mV) in 2013 likely due to the larger 
discharge of the river at the time of sampling. The highest alkalinity and electrical 
conductivity values over the sampling distance in both 2012 and 2013 were 
observed near the effluent of WWTP-1, and higher values were observed in 2013 
(alkalinity, ~330 as CaCO3 mg L
-1; EC, ~870 µS cm-1) than in 2012 (Figure 3.2).  
 Chloride (Cl-) reached its highest concentration of ~150 mg L-1 near the effluent 
of WWTP-1 in both 2012 and 2013, and reached a second peak concentration (~87 
mg L-1) near the effluent of WWTP-2 in 2012. Elevated concentrations of SO4
2- 
and PO4-P were observed near the effluents of both WWTPs in 2012, but the 
concentrations of SO4
2- and PO4-P were less variable in 2013 compared to 2012 
likely due to the much larger river discharge in 2013. Incomplete removal of 
nitrogen (nitrification and denitrification) by WWTP-1 likely resulted in the 
generally low observed concentrations of NO3
- and higher concentrations of NO2
- 
and NH3-N in the effluent. Concentrations of NO3
- decreased from a background 




- (4.6 mg L-1) and NH3-N (3.0 mg L
-1) were observed in July 
2013 (Figure 3.2). In addition, small increases in the concentrations of NO2
- and 
NH3-N were observed near the effluent of WWTP-2. Elevated concentrations of 
NH3-N near WWTPs have also been observed in other studies (Sonthiphand et al., 
2013).   
 The concentrations of ACE-K and the target pharmaceuticals were observed to 
follow a similar trend over the sampling distance, with the highest concentrations 
observed near the effluent of WWTP-1 in both 2012 and 2013; this is consistent 
with other studies of pharmaceutical compounds in southwestern Ontario rivers 
(Spoelstra et al., 2013). The concentrations of the target compounds downstream of 
WWTP-1 deceased gradually with distance and, when discharge from WWTP-2 
entered the river, a secondary concentration peak of target compounds was noted, 
especially in 2012 (Figure 3.3). The concentrations of target compounds 10 km 
downstream of WWTP-1 were at least one order of magnitude lower than those 
observed at the effluent of WWTP-1, likely as a result of dilution and dispersion 
and other natural attenuation processes such as biodegradation and photolysis 
(Carrara et al., 2008; Fono et al., 2006).  
 Concentrations of ACE-K (~6500 ng L-1 in 2012 and ~4000 ng L-1 in 2013) 
were consistent with those observed at the effluent of WWTP-1 in 2007 ̶ 2009 
(Spoelstra et al., 2013). ACE-K is particularly conservative and recalcitrant, and 
has been proposed as an ideal marker for wastewater in the environment (Buerge et 
al., 2009; Robertson et al., 2013). Furthermore, observed ACE-K concentrations 
were well above the MDL (~40 ng L-1), and were one or two orders of magnitude 
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higher in concentration than other target pharmaceuticals (Figure 3.3). Its 
conservative behavior and high detectable concentrations suggest that ACE-K may 
be a suitable tracer of wastewater in river systems.  
 Concentrations of CAF at the effluent of WWTP-1 in 2012 were ~3300 ng L-1, 
which is one order of magnitude larger than observed in 2013 (~280 ng L-1). 
Caffeine is extensively ingested in food, beverage, and drugs, and has been 
reported as a stable compound under variable environmental conditions. Caffeine 
has been widely used as an anthropogenic indicator of domestic wastewater 
contamination (Buerge et al., 2003; Kurissery et al., 2012; Seiler et al., 1999). 
Metcalfe et al. (2003b) report that CAF is detectable in most sewage treatment 
plants and surface waters in Lake Ontario and Lake Erie in Canada. Buerge et al. 
(2003) observe CAF concentrations of up to 9.5 µg L-1 in WWTP effluents in 
Switzerland, and up to 250 ng L-1 in downstream lakes and rivers.  
  Illicit amphetamine compounds, including MDA and MDMA, are used as 
recreational and empathogenic drugs. The concentrations of MDA and MDMA in 
the study area over the entire sampling distance were below the MDLs in both 
2012 and 2013. However, these compounds have been widely detected in 
wastewaters at ng L-1 levels, with MDMA observed to exhibit relatively higher 
detectable concentrations and frequencies than MDA (Lai et al., 2013; Nefau et al., 
2013; Van Nuijs et al., 2011). In addition, Metcalfe et al. (2010a) report MDMA at 
concentrations up to 35 ng L-1, but MDA at concentrations below the detection 
limit in treated and untreated wastewaters from three Canadian cities.  
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 Sulfamethoxazole (SMX), a sulfonamide antibiotic, has been widely used in 
human and veterinary medicine. The highest concentration of SMX (~37 ng L-1) 
was observed near WWTP-1 in 2012 with a somewhat lower concentration (~20 
ng L-1) observed in 2013. Sulfamethoxazole has been frequently detected in 
environmental water samples (Karthikeyan & Meyer, 2006; Miao et al., 2004; 
Milić et al., 2013; Watts et al., 1983). Yargeau et al. (2007) report up to 578 ng L-1 
of SMX downstream of a WWTP in the Yamaska River, Quebec, Canada.  
 Carbamazepine (CBZ), an antiepileptic drug, was observed near WWTP-1 in the 
Grand River at a concentration of ~146 ng L-1; this is similar to concentrations 
observed in another Canadian river (Yargeau et al., 2007). Carbamazepine has 
been found to be recalcitrant in conventional and biological WWTPs (Clara et al., 
2005; Joss et al., 2005) and is widespread in the environment. Miao et al. (2005) 
report the ubiquitous and persistent nature of CBZ and its five metabolites through 
different stages of treatment in a Canadian WWTP.   
 Ibuprofen (IBU) and naproxen (NAP) are two common non-steroidal anti-
inflammatory drugs, and gemfibrozil (GEM) is widely used as a lipid regulator. 
The highest concentrations of IBU (160 ng L-1), GEM (29 ng L-1), and NAP (506 
ng L-1) were observed near the effluent of WWTP-1 in 2012; lower concentrations 
were observed in 2013. Widespread distribution of IBU, GEM, and NAP in 
wastewater and downstream river water at ng L-1 concentrations has been reported 
since 1998 and attributed to their variable removal (IBU, > 90%; NAP, ~80%; 
GEM, ~55%) by conventional WWTPs (Huang et al., 2011; Lishman et al., 2006; 
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Ternes, 1998). IBU, GEM, and NAP have also been observed to persist in a 
subsurface receiving aquifer (Carrara et al., 2008).  
 Concentrations of ACE-K and most of the target pharmaceuticals were lower in 
2013 than in 2012. Secondary concentration peaks of ACE-K, SMX, CBZ, IBU, 
GEM, and NAP observed near the effluent of WWTP-2 in 2012 were also not as 
apparent in 2013. This is likely due to either the larger discharge when sampling 
was conducted in 2013 vs. 2012 and/or implementation of a new ultraviolet (UV) 
facility at WWTP-2 in 2013 that enhanced effluent disinfection but also likely 
removed some target contaminants through UV photolysis (Coiffard et al., 1999; 
De la Cruz et al., 2012; Gagnon et al., 2008; Ngouyap Mouamfon et al., 2010).  
3.4.2 Mechanisms Affecting the Transport of the Target Compounds 
Natural attenuation processes account for a significant decrease in concentrations 
of wastewater-derived contaminants in surface water bodies (Fono et al., 2006) and 
groundwater (Carrara et al., 2008). During transport from WWTPs to downstream 
areas, the concentrations of the seven target compounds considered in this study 
can be affected by physical processes, primarily dilution and dispersion. Other 
chemical and biological natural attenuation processes, such as sorption, hydrolysis, 
biotransformation, and photolysis (Schwarzenbach et al., 2002) also may affect the 
transport of target compounds, but likely have a limited influence due to the 
relatively short travel time of target compounds in the study area. However, it 
remains important to determine the relative influence of these processes on 
contaminant transport in the Grand River and other rivers.  
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 ACE-K has been reported to undergo photo-degradation in aqueous systems, 
following first-order rates of removal (Coiffard et al., 1999). Benotti and 
Brownawell (2009) report that CAF is biodegradable in estuarine and coastal 
waters, with an average half-life of 5.4 days. The antibiotic SMX has been reported 
to undergo biotransformation (Larcher & Yargeau, 2012) and direct photolysis 
(Periša et al., 2013) in aqueous systems. In addition, direct photolysis is an 
important process for removing SMX from surface water (Lam & Mabury, 2005). 
CBZ is reported to be resistant to biodegradation but may undergo indirect photo-
degradation (Matamoros et al., 2009) and adsorption reactions (Williams & 
Adamsen, 2006). The indirect photo-degradation rate of CBZ is limited (t1/2 = 8 ̶ 39 
h), however, and strongly dependent on the dissolved organic carbon (DOC) 
concentration in solution (Matamoros et al., 2009).  
 Removal of NAP through natural attenuation processes is more variable. 
Approximately 40% of NAP present in surface water during daylight hours has 
been reported to be removed through photolysis (t1/2 = 1.7 h), with the remainder 
most likely removed via sorption (Lin et al., 2006). Strong sorption of NAP to soils 
also has been observed (Lin & Gan, 2011). Biotransformation reactions can be an 
important attenuating process for IBU and GEM in river water, with half lives of 
5.4 h and 2.7 h respectively (Fono et al., 2006; Lin et al., 2006). IBU and GEM 
exhibit relatively longer photodegradation half-lives of ~15 h (Lin & Reinhard, 
2005).      
73 
 
3.4.3 Acesulfame-K and Pharmaceuticals as Co-tracers in the Grand 
River 
The concentrations of the target compounds exhibited similar changes over the 
sampling distance, with a primary peak in concentrations observed at the effluent 
of WWTP-1 and a secondary peak near WWTP-2 (Figure 3.3). Correlation 
analysis using Spearman Rank correlation coefficients (ρ) of the target compounds 
and Cl- indicated that ACE-K and CBZ were very strongly correlated with Cl- over 
the sampling distance downstream of WWTP-1, with ρ values ranging from 0.95 
to 1.00 in both 2012 and 2013; GEM and NAP were strongly correlated with ACE-
K, CBZ, and Cl- with ρ values ranging from 0.69 to 0.89 in both 2012 and 2013; 
and CAF, SMX, and IBU were moderately correlated with ACE-K, CBZ, and Cl- 
(Tables 3.1 and 3.2, Figure 3.4). Concentrations of MDA and MDMA were below 
the MDLs in both 2012 and 2013, therefore no correlations could be determined. 
Similarly, the Spearman Rank correlation for SMX in 2012 was not calculated due 
to the low concentrations (< MDL) observed.  
 The artificial sweetener ACE-K and pharmaceuticals CBZ, IBU, GEM, and 
NAP exhibited strong correlations over the sampling distance downstream of 
WWTP-1 in 2013, but weaker correlations in 2012. The pharmaceuticals CAF and 
SMX exhibited moderate correlations with other target compounds (Tables 3.1 and 
3.2). This analysis indicates that ACE-K, CBZ, GEM, and NAP can potentially be 
used as co-tracers of the wastewater over the sampling distance considered. The 
very strong correlation between ACE-K, CBZ and Cl-, however, suggests that Cl- 
may also be used as a waste-water indicator. However, previous studies have 
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indicated that Cl- may be affected by other sources, including road salt application 
(Cooke, 2006). Alkalinity and electrical conductivity were weakly or moderately 
correlated with target contaminants in 2012, and moderately or strongly correlated 
with target contaminants in 2013. Due to this inconsistency, alkalinity and 
electrical conductivity are not considered to be effective co-tracers of wastewater.     
3.5 Conclusions 
This study indicates that the decline in concentrations of bulk wastewater 
constituents, ACE-K, and a suite of pharmaceutical compounds downstream from 
two WWTPs is due to dilution and, for some compounds, other attenuation 
mechanisms. Of the compounds studied, the artificial sweetener ACE-K and three 
pharmaceutical compounds (CBZ, GEM, and NAP) had the greatest persistence. 
These compounds dissipated at the same rate as the conservative anion Cl-, 
indicating that declines in concentration were primarily controlled by dilution 
alone. The use of multiple tracers, such as artificial sweeteners combined with 
pharmaceutical compounds, would greatly increase confidence when tracking 
wastewater in aquatic environments throughout the year.  
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Table 3.1 Spearman rank correlation coefficients (ρ)† of the target compounds and Cl- 
over the sampling distance in the Grand River in August 2012. 
 
 CAF CBZ IBU GEM NAP Cl- 
ACE 0.36 0.98 0.45 0.69 0.69 0.98 
CAF  0.40 0.93 0.64 0.64 0.40 
CBZ   0.52 0.71 0.71 1.00 
IBU    0.79 0.79 0.52 
GEM     1.00 0.71 
NAP      0.71 
Note: † Positive values were interpreted as follows: 0.8-1.0 = very strong; 0.6-0.8 = 














































Table 3.2 Spearman rank correlation coefficients (ρ)† of the target compounds and Cl- 
over the sampling distance in the Grand River in July 2013. 
 CAF SMX CBZ IBU GEM NAP Cl- 
ACE 0.71 0.59 0.90 0.71 0.89 0.74 0.98 
CAF  0.84 0.62 0.71 0.85 0.64 0.62 
SMX   0.54 0.64 0.73 0.59 0.56 
CBZ    0.90 0.92 0.93 0.95 
IBU     0.92 0.98 0.76 
GEM      0.92 0.89 
NAP       0.81 
Note: † Positive values were interpreted as follows: 0.8-1.0 = very strong; 0.6-0.8 = 




































































































































































Data collected in Aug 2012
Data collected in July 2013
Note: 
0 km: WWTP-1





Figure 3.3 Concentrations of acesulfame-K (ACE-K), caffeine (CAF), sulfamethoxazole 
(SMX), carbamazepine (CBZ), ibuprofen (IBU), gemfibrozil (GEM), and naproxen (NAP) 
as a function of sampling distance. The method detection limits of ACE-K and CAF were 




























































































Data collected in Aug 2012
Data collected in July 2013
Note:
0 km: WWTP-1
17 km: Intake for WTP-1
22km:  WWTP-2
CAF data on right y axis in red 





Figure 3.4 Concentrations of acesulfame-K (ACE-K), caffeine (CAF), sulfamethoxazole 
(SMX), carbamazepine (CBZ), ibuprofen (IBU), gemfibrozil (GEM), and naproxen (NAP) 
as a function of Cl- concentration. The method detection limits of ACE-K and CAF were 
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CAF data on right y axis in red 

















Chapter 4: Ultraviolet Light 
Photo(catalytic) Treatment of Acesulfame-K 
and Pharmaceuticals Using Magnetically 















4.1 Executive Summary 
Ultraviolet light (UV) photocatalysis by TiO2 nanoparticles is an effective process for 
removing contaminants from drinking water and wastewater; however, non-recoverable 
TiO2 nanoparticles also may become contaminants when released to the environment. In 
this study, two types of catalysts—magnetically separable TiO2 (MST) recoverable 
nanoparticles (γ-Fe2O3/SiO2/TiO2 colloidal nanospheres) and graphene oxide-supported 
TiO2 (GO TiO2) recoverable nanoparticles (GO/TiO2/CSA nanocomposites)—were 
evaluated for their effectiveness relative to commercial P25 TiO2 for photocatalysis of an 
artificial sweetener and a suite of pharmaceutical compounds at environmental 
concentrations. The results show that over 99% of the artificial sweetener (acesulfame-K) 
and over 92% of the pharmaceuticals (sulfamethoxazole, 3,4-
methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, ibuprofen, 
gemfibrozil, naproxen, caffeine and carbamazepine were removed within 60 min of UV 
(wavelength: 254 nm) photocatalysis using both P25 and GO TiO2 nanoparticles. The UV 
photocatalysis of target contaminants followed a pseudo-first-order rate. The synthesized 
GO TiO2 exhibited comparable or greater catalytic ability in assisting photocatalytic 
treatment of the target compounds by factors of up to 4.1 when comparing their intrinsic 
reaction rate constants. The MST particles were less effective in photocatalysis of 
contaminants compared to P25 and GO TiO2 particles. The greater catalytic ability and 
high magnetic recovery makes the GO TiO2 nanoparticles a potential alternative for 




Emerging contaminants, including food additives such as artificial sweeteners, 
pharmaceuticals and personal care products, nanomaterials, steroids and hormones, 
surfactants, and microorganisms have been found to be widely distributed in the 
environment. Artificial sweeteners, including acesulfame-K (potassium), cyclamate, 
saccharin, sucralose, and aspartame, have been used worldwide for decades in 
considerable quantities as sugar substitutes in foods, diet beverages, pharmaceuticals, and 
some personal care products (Kroger et al., 2006). Artificial sweeteners pass through the 
digestive system with little metabolic breakdown and are excreted, therefore ending up in 
wastewater virtually unchanged. Acesulfame-K and sucralose are particularly widespread 
and persistent in the aquatic environment, making them ideal markers for tracing 
pollution from domestic wastewater into natural waters, particularly groundwater (Buerge 
et al., 2009; Scheurer et al., 2009). Pharmaceutical compounds also pass through the 
digestive system and are widely detected in the environment (Kolpin et al., 2002; Ternes, 
1998).  
Sewage effluents are considered to be the major source of pharmaceutical compounds 
in surface water (Bendz et al., 2005; Focazio et al., 2008), groundwater (Barnes et al., 
2008; Carrara et al., 2008), and drinking water (Jones et al., 2005; Kleywegt et al., 2011) 
where they may cause toxicological effects (Fent et al., 2006) and, in the case of 
antibiotics, bacterial resistance (Richardson & Ternes, 2011). Adverse impacts of 
pharmaceuticals on ecosystem health have been generally acknowledged; however, 
ingestion of pharmaceuticals in drinking-water (ng L-1) is not considered to result in 
appreciable adverse risks to human health (the WHO information sheet: Pharmaceuticals 
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in drinking-water). The concentrations of pharmaceuticals detected in drinking-water are 
typically several orders of magnitude lower than minimum therapeutic doses. The issue 
of health impacts of artificial sweeteners on humans is still controversial (Safe, 2000; 
Sharpe & Irvine, 2004; Sumpter, 2005). 
Remedial technologies for removing artificial sweeteners from water supplies, 
including soil aquifer treatment (Scheurer et al., 2009) and chemical oxidation (Sharma et 
al., 2012), have recently been evaluated. Due to the ecotoxicity of pharmaceutical 
compounds, more extensive studies have been performed on the elimination of these 
compounds from environmental waters, including advanced oxidation, such as 
photo(catalytic) degradation using ultraviolet light (UV) and TiO2 (Achilleos et al., 2010), 
UV/H2O2 (Rosario-Ortiz et al., 2010), (catalytic)ozonation (Beltrán et al., 2009), 
ultrasonic irradiation (Naddeo et al., 2009), and gamma irradiation (Zheng et al., 2011). 
Other methods studied include adsorption by activated carbon (Grover et al., 2011), 
biological activated carbon filtration (Reungoat et al., 2012), and constructed wetlands 
(Conkle et al., 2008). 
Photocatalysis by means of illuminated TiO2 is a promising technology for the 
degradation and removal of a wide range of emerging contaminants (Doll & Frimmel, 
2005; Sturini et al., 2012). As a catalyst, TiO2 can theoretically be reused indefinitely for 
continuous water purification. The high surface area afforded by nanostructuring 
enhances the catalytic efficiency (Ismail & Bahnemann, 2011; Xiang et al., 2012); 
however, fine TiO2 nanoparticles are impractical to deploy in water treatment 
applications due to the difficulty of their recovery from the treated water after the 
photocatalytic decontamination process and the concern that residual TiO2 nanocrystals 
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may be released to the environment (Chong et al., 2010; Malato et al., 2009). The 
presence of nano-TiO2 particles can have adverse toxic effects on various organisms in 
environmental waters and soils (Klaine et al., 2008) and humans (Hsiao & Huang, 2011); 
however, the use of magnetically recoverable TiO2 nanoparticles in water treatment 
would minimize the risk of releasing nano-TiO2 into the environment.   
Magnetic separation technology is widely used in industry, and is being explored for 
water treatment (Ambashta & Sillanpää, 2010; Yavuz et al., 2009). Extensive studies are 
being performed on the synthesis of different types of magnetically recoverable 
nanoparticles. The photocatalytic ability of these synthesized nanoparticles was usually 
tested in the decolouration of common model organic compounds, such as methylene 
blue dyes (Harraz et al., 2014), phenol (Feng et al., 2014; Mu et al., 2010), and formic 
acid (Makovec et al., 2011) under UV light. However, it is more impactful and attractive 
to test the synthesized recoverable nanoparticles in photodegradation of environmentally 
relevant contaminants, such as emerging contaminants under UV light. Álvarez et al. 
(2010) reported comparable ability of TiO2/SiO2/Fe3O4 nanoparticles in photodegradation 
of five pharmaceutical and personal care products (PPCPs) compared to Degussa P25 
TiO2. Linley et al. (2014) reported the enhanced photocatalytic ability of recyclable 
graphene oxide-supported TiO2 nanoparticles in photodegradation of the pharmaceutical 
compounds caffeine and carbamazepine.  
The photocatalytic ability of two types of laboratory-synthesized catalysts in 
removing emerging contaminants under UV light was evaluated through a series of batch 
experiments. The two types of laboratory-synthesized magnetically recoverable 
catalysts— magnetically separable TiO2 (MST particles, γ-Fe2O3/SiO2/TiO2 colloidal 
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nanospheres and reduced graphene oxide-supported TiO2 nanoparticles (GO TiO2 
particles, GO/TiO2/CSA (Controlled SPION, Superparamagnetic Iron Oxide Nanoparticle, 
Aggregates) nanocomposites)—were compared with respect to photocatalytic efficiency 
relative to commercial P25 TiO2 nanoparticles. Target pollutants for photocatalytic 
treatment included acesulfame-potassium (ACE-K) and eight pharmaceutical compounds: 
sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA), ibuprofen (IBU), gemfibrozil (GEM), 
naproxen (NAP), caffeine (CAF), and carbamazepine (CBZ). These compounds were 
selected because they are frequently detected in the environment due to their recalcitrance 
or they are emerging compounds with little available data on potential treatability. The 
concentrations of target contaminants were set at environmental levels (10 µg L-1 of 
ACE-K and 1 µg L-1 of pharmaceuticals) according to their reported occurrences in 
natural waters (Lapworth et al., 2012; Liu et al., 2014b; Metcalfe et al., 2010b; Yargeau 
et al., 2007).   
4.3 Material and Methods 
4.3.1 Nanoparticle Synthesis 
Mesoporous, superparamagnetic, core-shell γ-Fe2O3/SiO2/TiO2 colloidal nanospheres 
(MST particles) were prepared using a stepwise synthesis method (Leshuk et al., 2013). 
The inner core maghemite spheres were prepared using a one-pot hydrothermal reaction 
(Cheng et al., 2010; Wang et al., 2012). These were then coated with silica following a 
modified Stöber process (Stöber et al., 1968) to preserve the photocatalytic activity of the 
TiO2 by minimizing electrical contact with the inner core iron oxide (Watson et al., 2005). 
An outer titania coating was added using a sol-gel reaction employing titanium (IV) 
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butoxide as a precursor and hydroxypropyl cellulose as a surfactant (Lee et al., 2007; 
Linley et al., 2013). The resulting particles were hydrothermally treated in a 
polytetrafluoroethylene (PTFE)-lined stainless steel pressure vessel (Parr, Moline, IL, 
USA) at 100 °C for 2 h, followed by drying and calcination at 500 °C for 2 h.  
The GO/TiO2/CSA (1:12.5 GO/TiO2, 1:1 TiO2/CSAs as weight ratio) 
nanocomposites used in this study were prepared following a modular synthesis process 
allowing for tuning the ratio of GO and TiO2 loading on GO to achieve efficient 
photocatalytic ability and magnetic separability (Linley et al., 2014). The synthesized 
magnetic CSA (Controlled SPION Aggregates) cores were first coated with a silicon 
dioxide shell to form silica-coated CASs (SiO2/CSAs). The SiO2/CSAs and P25 
underwent amine functionalization to be positively charged, and then were mixed with 
GO in solution and electrostatically attached to the surface of GO sheets. The composites 
were hydrothermally treated to reduce GO and bind the SiO2/CSAs and P25 to the 
reduced GO. P25 TiO2 Aeroxide powder was obtained from Acros Organics (New Jersey, 
US). 
4.3.2 Characterization of Particles 
The size and surface morphology of the catalyst particles were analyzed with 
transmission electron microscopy (TEM, Philips CM-10, 60 keV). The hydrodynamic 
diameters of the particles suspended in deionized water were measured with dynamic 
light scattering (DLS, Brookhaven 90Plus Particle Size Analyzer, MSD number-weighted 
mean diameter). The crystallinity of the powdered samples was analyzed through X-ray 
diffraction (XRD, Bruker D8 Focus, 1.542 Å Cu Kα radiation). The surface area of the 
particles (pre-dried at 300 °C in N2) was calculated from the Brunauer-Emmett-Teller 
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(BET) equation with data from N2 adsorption isotherms obtained at 77 K (Micrometrics 
Gemini VII 2390 Surface Area Analyzer).  
4.3.3 Batch Experimental Procedures 
A concentrated stock solution was prepared by adding the target compounds in aqueous 
solutions containing a trace amount (< 0.01%) of methanol, resulting in about 1000 µg L-
1 ACE-K (Toronto Research Chemicals Inc., Toronto, Canada) and 100 µg L-1 of the 
pharmaceuticals SMX, IBU, GEM, NAP, CAF, and CBZ (Sigma-Aldrich, Oakville, 
Canada), and MDA and MDMA (Cerilliant Inc., Texas, USA). A second, more dilute 
stock solution was prepared by adding 10 mL of the concentrated stock solution to 490 
mL Nanopure water to obtain approximately 20 µg L-1 ACE-K and 2 µg L-1 of the 
pharmaceuticals.  
 The reaction solutions for the UV photolytic treatment (no catalysts) and control 
samples were prepared by adding 25 mL of the second stock solution and 25 mL 
Nanopure water into reaction bottles, yielding approximately 10 µg L-1 ACE-K and 1 µg 
L-1 of the pharmaceuticals. The reaction solutions for UV photocatalytic treatment and 
dark adsorption test samples were prepared by mixing 25 mL of the second stock solution, 
24 mL Nanopure water, and 1 mL of 5 g L-1 photocatalyst suspended solutions into 
reaction bottles with the catalysts at concentrations of 0.1 g L-1. The concentrations of 
ACE-K and pharmaceuticals in the reaction solutions for the photo(catalytic) treatment 
experiments, control samples, and dark adsorption samples were about 10 and 1 µg L-1. 
The reaction bottles used for the photo(catalytic) treatment experiments were transparent, 
clear glass bottles (9 cm in height, 7 cm inner diameter). Reaction bottles for the control 
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and dark adsorption test samples were wrapped with aluminum foil and placed in the dark 
during the experiments.   
 For the UV treatment experiments, reaction bottles with solutions were placed in a 
UV reactor (UVP CL-1000 Ultravoilet Crosslinker at 254 nm wavelength, energy: x100 
µJ/cm2; UV intensity: 66.7 W/m2 = 6.7 mW/cm2 or 24,012 mj/cm2) (UVP, Upland, CA, 
USA) and sampled at 0, 10, 30, and 60 min. During the 60 min UV irradiation, three 
control and three dark adsorption test samples were collected at 0, 30, and 60 min 
intervals. All samples were mixed manually every 10 min to avoid aggregation of the 
photocatalysts during UV irradiation, and then centrifuged at 10,000 rpm for 30 min to 
remove the catalysts from solution. The supernatants were transferred to amber glass 
bottles, acidified with H2SO4 to pH < 2, and stored at 4 °C until analysis. The 
experiments were performed at room temperature (23 °C) and the initial pH of the 
solutions was around 6.3. 
4.3.4 Analytical Procedures 
The target compounds were separated from the aqueous phase using solid-phase 
extraction (SPE). Prior to the extraction step, 10 mL samples were spiked with a mixture 
of isotope-labeled internal standards containing ACE-K-d4 and SMX-d4 (Toronto 
Research Chemicals Inc., Toronto, Canada), MDA-d5 and MDMA-d5 (Cerilliant Inc., 
Texas, USA), GEM-d6, IBU-d3, CAF-d3 and CBZ-d10 (CDN isotopes Inc., Quebec, 
Canada), and [13C]-NAP (Cambridge Isotope Laboratory Inc., Cambridge, USA). The 
concentration of ACE-K-d4 and isotope labeled pharmaceuticals were 10 and 1 µg L-1 in 
10 mL samples. SPE was performed using Oasis HLB 3 mL glass cartridges (Waters 
Corp., Mississauga, Canada). The cartridges were conditioned with 2 × 1 mL of HPLC 
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grade methanol and then equilibrated with 2 × 1 mL Nanopure water. After loading with 
10 mL samples, the cartridges were washed using 2 × 1 mL 5 vol. % methanol, and then 
eluted with 2 × 1 mL methanol. The eluate was collected in an amber glass vial and 
stored at 4 °C until analysis.   
 The extracts were analyzed using an Agilent 1100 (Palo Alto, CA) high 
performance liquid chromatography system (HPLC) and detected by an API triple 
quadrupole tandem mass spectrometer with a turbo electrospray ion source (ESI) (4000 Q 
Trap; Applied Biosystems, Concord, Canada). The pharmaceuticals SMX, MDA, MDMA, 
CAF, and CBZ were analyzed in electrospray ionization positive (ESI+) mode, while 
ACE-K, IBU, GEM, and NAP were analyzed in electrospray ionization negative (ESI-) 
mode. A mixture of standards containing each of the non-labeled target compounds was 
used for instrument calibration and the response corrected by comparison to the recovery 
of the isotope-labeled internal standards. 
Analytical procedures were modified slightly from published methods to optimize for 
separation and detector response (Stafiej et al., 2007; Vanderford et al., 2003). For 
pharmaceuticals analyzed in ESI+ mode, the mobile phase consisted of 0.1% formic acid 
and 5 mM ammonium acetate in Nanopure water (phase A) and 100% MeOH with 0.1% 
formic acid (phase B). The chromatographic separation used a gradient elution that 
started at 10 % B for 3 min, increased to 90% B over 10 min, and then held at 90% B min 
for 10 min. The flow rate was 1000 µL min-1 and the injection volume was 15 µL. For 
pharmaceuticals analyzed in ESI- mode, the mobile phase consisted of 6.9 mM acetic 
acid in 300 mL acetonitrile and 700 mL water (phase A) and 100% acetonitrile (phase B). 
A binary gradient was used: B increased linearly from 12% to 40% over 10 min and held 
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at 40% for 10 min. The injection volume was 10 µL and the flow rate was 1000 µL min-1. 
For ACE-K analyzed in ESI- mode, the mobile phase consisted of 20 mM ammonium 
acetate in water (phase A) and 20 mM ammonium acetate in methanol (phase B). The 
gradient used for ACE-K was as follows: B increased linearly from 2% to 75% over 8 
min and held at 75% for 8 min. The injection volume was 10 µL and the flow rate was 
1000 µL min-1. The relative internal standard (IS) recovery of ACE-K was between 72% 
and 118%. The absolute IS recovery of pharmaceuticals was between 85% and 118%. 
The method detection limits (MDLs) were 60 ng L-1 for ACE-K, 10 ng L-1 for SMX, 30 
ng L-1 for MDA, 5 ng L-1 for MDMA, 30 ng L-1 for IBU, 5 ng L-1 for GEM, 20 ng L-1 for 
NAP, 100 ng L-1 for CAF, and 20 ng L-1 for CBZ. 
4.3.5 Magnetic Separation 
Magnetic separation tests to evaluate the MST particles recovery were performed by 
placing a glass vial containing 20 mL of MST nanoparticles suspended in solution on a 
permanent magnet for 15 min. Prior to magnetic separation, 2 mL of MST suspended 
solution was collected from the glass vial as a control. After 15 min magnetic separation, 
15 mL of supernatant were extracted using a syringe and 15 mL of Nanopure water were 
added back to the glass vial. The MST solution was then re-suspended for further 
sampling as another control. Samples were acidified with HNO3 to pH < 2 and stored at 
4 °C for Fe and Ti analysis. The concentrations of total Fe and Ti, including dissolved 
and fine particulate fractions, were determined by inductively coupled plasma optical 




4.4 Results and Discussion 
4.4.1 Particle Characterization 
The synthesized MST particles were spherical and relatively monodispersed, with 
minimal interparticle aggregation (Figure 4.1). The MST particles were ~640 nm in 
diameter, with a ~50 nm thick nanocrystalline TiO2 outer shell (measured by TEM). The 
observable rough surface texture of the MST particles results from the mesoporosity of 
the TiO2 coating, indicating controllable uniform MST particles were successfully 
prepared as intended. The MST particles (in a powder form or dispersed in water) were 
strongly attracted towards a permanent magnet placed nearby. The TEM of 
GO/TiO2/CSA nanoparticles were reported previously (Linley et al., 2014) (Figure C.1; 
Appendix C).   
The hydrodynamic diameters of the MST particles in aqueous suspension, measured 
by DLS, were similar to diameters obtained using TEM (Table 4.1), indicating minimal 
aggregation of the particles in deionized (DI) water. This result was indicative of 
superparamagnetic behavior, as extensive solution phase aggregation would be observed 
if the particles possessed permanent magnetic moments. The colloidal stability of the 
synthesized particles differed from P25, a benchmark photocatalyst, which is well known 
to form extensive micron-scale aggregates in aqueous suspension (Table 4.1) that 
partially diminish the advantages of using nanocrystals. Aggregation is undesirable, 
because it reduces the accessible catalytic surface area available for reaction. The mean 
diameter of silica coated CSAs used for synthesizing GO TiO2 particles is ~477 nm 
(Linley et al., 2014), which is relatively smaller than the MST particles. 
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XRD results indicate the TiO2 in MST particles was present as well-crystallized 
anatase, which is one of the most photocatalytically active phases of TiO2 (Figure 4.2). 
As expected, the MST sample also exhibited peaks corresponding to maghemite in its 
pattern, indicating that the iron oxide core did not transform to another iron oxide phase 
during synthesis; this is also consistent with the strong magnetic response. P25 is well 
known to consist of mixed anatase- and rutile-phase TiO2 (Figure 4.2), with a primary 
nanocrystal size of ~20 nm (Table 4.1). The TiO2 crystal sizes of the MST samples were 
notably smaller than P25 and much smaller than the composite spheres as a whole. The 
XRD analysis shows the presence of anatase, rutile, and magnetite in GO TiO2 particles 
(Figure C.2), indicating both P25 and magnetite are preserved through hydrothermal 
treatment (Linley et al., 2014). 
The specific surface area of the MST particles was double that of P25 (Table 4.1), 
likely due to the finer crystallite sizes in the synthesized MST samples as compared to 
P25. In addition, the hydrothermal processing employed during MST synthesis allows for 
the formation of a disordered mesoporous TiO2 shell, comprised of small interaggregated 
nanocrystallites, and resulting in very high specific surface areas despite the relatively 
large dimensions of the composite spheres as a whole.  
4.4.2 Control and Dark Adsorption Samples 
The concentrations of ACE-K and pharmaceuticals in the control samples remained 
constant or decreased slightly relative to initial concentrations of 11000 ng L-1 for ACE-K 
and 1200 ng L-1 for pharmaceuticals. A small fraction of initial ACE-K (< 3%), SMX (< 
4%), MDA (< 5%), MDMA (< 9%), IBU (< 5%), GEM (< 4%), NAP (< 10%), CAF (< 
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7%), and CBZ (< 10%) were lost in the control samples during 60 min of dark storage 
(Figures 4.3 and 4.4).    
During 60 min dark adsorption, a portion of the target compounds was lost compared 
to the control samples. Less than 3.8% of input ACE-K, < 7.5% of input SMX, < 9.8% of 
input IBU, < 11.1% of input GEM, < 11.1% of input NAP, < 8.9% of input CAF, and < 
11.4% of input CBZ were lost in the input solution with P25 and MST nanoparticles 
(Figure C.3). The differences in concentration of target compounds between the control 
and dark adsorption samples were likely due to the adsorption of contaminants onto the 
nanoparticles. Greater loss associated with the MST nanoparticles compared to P25 was 
likely due to their larger surface area (Table 4.1). Adsorption of a pharmaceutical 
(ibuprofen) on photocatalyst TiO2 nanoparticles (< 5%) has been reported for pH > 5 
solutions (Tungudomwongsa et al., 2006). The adsorption of target contaminants on GO 
TiO2 particles was not tested in this study; however, GO TiO2 particle exhibit enhanced 
adsorption of methylene blue compared to P25 (Linley et al., 2014).   
4.4.3 UV Photo(catalytic) Treatment Results and Rate Calculations 
The artificial sweetener ACE-K and pharmaceutical SMX were almost completely 
removed during a 60 min UV irradiation alone and during photocatalysis using P25, MST, 
and GO TiO2 nanoparticles. Pharmaceuticals MDA, MDMA, IBU, GEM, NAP, CAF, 
and CBZ were either not removed or partially removed during 60 min UV irradiation 
alone; however, more rapid and complete removals of these compounds were observed 
during photocatalysis using P25 and GO TiO2 particles. The MST particles were less 
effective in photocatalysis of the contaminants compared to P25 and GO TiO2.  
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Common degradation pathways for drugs during direct UV photolysis include 
decarboxylation, isomerization, aromatization, dehalogenation, cyclization, elimination, 
dimerization, and polymerization (Min, 2012). Heterogeneous photocatalysis by TiO2 is 
initiated by the excitation of the semiconductor (TiO2) by UV irradiation to generate a 
positive hole-electron pair. Hydroxyl radicals are generated through a series of oxidation 
and reduction reactions on the surface of TiO2. These hydroxyl radicals are highly 
reactive, non-selective, and very efficient oxidizers of adsorbed pollutants (Khetan & 
Collins, 2007).  
Langmuir-Hinshelwood (L-H) kinetics is the most common kinetic expression used 
to represent the rate of heterogeneous photocatalysis of organic compounds by 
illuminated TiO2 particles. L-H kinetic model can be described as -dC/dt = kKC/(1+KC), 
where dC/dt is the rate of degradation; k is the apparent reaction rate constant; K is the 
adsorption coefficient of the substance to be degraded; and C is the concentration of the 
substance. The L-H model is surface-area dependent; the reaction rate is proportional to 
the fraction of surface covered by the organic compounds. The L-H kinetic model is valid 
for the four possible situations: (i) reaction occurs between the adsorbed radicals and 
organic compounds; (ii) reaction occurs between the radicals in water and adsorbed 
organic compounds; (iii) reaction occurs between the radicals on the surface and organic 
compounds in water; and (iv) reaction occurs with both radicals and organic compounds 
in water (Chong et al., 2010; Konstantinou & Albanis, 2004).  
When the extent of adsorption and/or substance concentration is low (i.e., KC<<1), 
the L-H equation can be simplified to a pseudo-first-order kinetic equation: -dc/dt = kC or 
Ct = C0 e
-kt, where k is the pseudo-first-order rate constant (Dimitrakopoulou et al., 2012; 
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Doll & Frimmel, 2004). In this study, the concentrations of target contaminant 
concentrations were very low (at environmental levels) and their adsorption onto the 
photocatalysts was relatively weak. Therefore, a simplified pseudo-first-order kinetic 
approach was used to represent the photocatalytic removal of ACE-K, SMX, MDA, 
MDMA, IBU, GEM, NAP, CAF and CBZ. The first-order rate constant (k) of each 
contaminant was calculated by SigmaPlot (SPSS Inc.) based on least squares regression 
(R2 > 0.989 for all contaminants). To explore the intrinsic photoreactivity of the catalysts, 
k was normalized to the mass and specific surface area of TiO2. The mass normalized rate 
constant (kM) was calculated following kM = k/ρ and the surface area normalized rate 
constant (kSA, intrinsic rate constant) was calculated as kSA = k/(ρAS), where kM is the mass 
normalized rate constant (L g-1 min-1), k is the first order rate constant (min-1), ρ is the 
mass concentration (g L-1), and AS is the surface area of the particle (m
2 g-1). The 
calculated values of k, kM, and kSA for each contaminant during the photo(catalytic) 
treatment are provided in Tables 4.2 and 4.3. The target contaminants were divided into 
four groups based on the extent of their removability during 60 min photo- and 
photocatalytic treatment.  
4.4.3.1 Group 1: Easily Photo- and Photocatalytically Degradable Compounds ACE 
and SMX 
Containing the same functional group sulfonamide, artificial sweetener ACE-K and 
pharmaceutical SMX were almost completely removed under both UV alone and UV 
with catalysts (Figure 4.3).    
The concentration of ACE-K decreased from approximately 11000 ng L-1 to < MDL 
(60 ng L-1) during 60 min UV irradiation without catalysts, representing a removal > 
97 
 
99.7%. Relatively faster and complete removals of ACE-K were observed during UV 
photolysis than UV photocatalysis (Figure 4.3 and Table 4.2), likely due to the shielding 
effect of the catalysts with respect to the UV penetrating light. The removal rate constant 
(k, 2.3 × 10-1 min-1) of ACE-K under UV photolysis was similar to the rate constants (pH 
independent between 5 and10) reported by Scheurer et al. (2014), but was one order of 
magnitude larger than a previously reported rate constant (pH dependent at 3, 9 and 12) 
which was likely due to the higher UV intensity used in this study (Coiffard et al., 1999). 
The concentrations of ACE-K decreased from 11000 ng L-1 to 146 ng L-1 after a 60 min 
photocatalysis using P25 nanoparticles (98.7% removed), decreased to 65 ng L-1 (99.4% 
removal) using MST nanoparticles, and decreased to < MDL (60 ng L-1) (> 99.7% 
removal) using GO TiO2 nanoparticles.  
The pharmaceutical SMX was almost completely removed, falling from initial 
concentrations of 1200 ng L-1 to < MDL (< 10 ng L-1) during a 60 min UV 
photo(catalytic) treatment (up to 99.9% removal). However, SMX was removed much 
more rapidly during the first 10 min of UV photolysis without catalyst (Figure 4.3 and 
Table 4.2). The rate constant (k) of UV photolysis of SMX in Table 4.2 was three times 
to one order of magnitude larger than previously reported (Fukahori et al., 2012; 
Ngouyap Mouamfon et al., 2011). The greater rate constant observed was likely due to 
the higher UV intensity used in this study. The synthesized GO TiO2 nanoparticles 
exhibited a greater ability in the photocatalysis of SMX than P25 by a factor of 1.6 and 
MST nanoparticles by a factor of 6.1 in terms of the intrinsic rate constant (kSA) (Table 
4.2). The slightly larger k value observed during P25 catalyzed photocatalysis than UV 
photolysis is consistent with other studies (Prieto-Rodriguez et al., 2012). Fukahori et al. 
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(2012) report that the reaction rate constants of photocatalysis of SMX using TiO2 
nanoparticles decrease with increasing pH (pH: 6.5 ̶ 9.0) due to the repulsive force 
between TiO2 particles and anionic SMX. 
The photo(catalytic) degradations of ACE-K and SMX were reported to follow 
various pathways (Gan et al., 2014; Hu et al., 2007; Li et al., 2016; Ngouyap Mouamfon 
et al., 2011; Scheurer et al., 2014); however, similar degradation pathways involving ring 
breakage or hydroxyl radicals cleavage on sulfonamide bond likely occur during 
photo(catalytic) degradation (Abellán et al., 2007; Sang et al., 2014b). The presence of 
sulfonamide likely accounted for the easy degradation of ACE and SMX during UV 
photolysis and photocatalysis.  
4.4.3.2 Group 2: Easily Photocatalytically Degradable Compounds MDA and 
MDMA 
As methylenedioxyphenyl compounds, MDA and MDMA followed similar removal 
trends during the course of a 60 min UV photolysis and photocatalysis using P25, MST 
and GO TiO2 nanoparticles.  
The concentrations of MDA and MDMA decreased slightly from input 
concentrations of 1280 and 1322 ng L-1 to 1058 and 1052 ng L-1, respectively, after a 60 
min UV irradiation; this represents removal of 18% of the MDA and 20% of the MDMA. 
However, up to 99.9% of input MDA and MDMA were removed (from approximately 
1200 ng L-1 to undetectable concentrations) within the first 10 min of the photocatalysis 
by P25, MST, and GO TiO2 nanoparticles (Figure 4.3), with k values three orders of 
magnitude larger than for UV photolysis (Table 4.2). The intrinsic rate constant (kSA) of 
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photocatalysis of MDA and MDMA using GO TiO2 were 1.1 ̶ 1.4 times larger than that 
using P25 particle, indicating exceeding catalytic ability of GO TiO2 compared to P25 
(Table 4.2). The MST particles were less efficient in photocatalysis of MDA and MDMA 
compared to commercial P25 and GO TiO2 particles.  
UV photolysis of MDA and MDMA has not been studied previously. The 
photocatalysis of MDA and MDMA assisted by TiO2 were likely to follow similar 
degradation pathway through hydroxyl radical cleavage of methylenedioxy group with 
catechol and formate as metabolites (Kumagai et al., 1991). This similar photocatalytic 
degradation pathway likely accounted for the similar photo(catalytic) characteristic of 
MDA and MDMA.    
4.4.3.3 Group 3: Moderately Photo- and Photocatalytically Degradable Compounds 
IBU, GEM, and NAP 
Pharmaceuticals IBU, GEM, and NAP were not effectively removed during UV 
photolysis with removals of up to 65%. Faster (observed k) and almost complete 
removals (> 98%) of these compounds were observed during photocatalysis using P25. 
Extensive removal of NAP by P25-assisted photocatalysis relative to photolysis has been 
reported during 180 min of UV irradiation (Méndez-Arriaga et al., 2008b). During 
photocatalysis using GO TiO2, concentrations of IBU and NAP decreased from ~1200 ng 
L-1 to up to 96 ng L-1 and undetectable concentrations with removals of 99% and 92%, 
respectively. The nanoparticle GO TiO2 exhibited comparable ability in photocatalysis of 
IBU and NAP with relatively smaller intrinsic rate constants (kSA) observed (Table 4.3). 
The first order rate constant k of photocatalysis of IBU and NAP were one or two orders 
of magnitude larger than previous study (Méndez-Arriaga et al., 2008a). The 
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concentration of GEM decreased from 1100 ng L-1 to undetectable concentrations during 
the photocatalysis using P25 and GO TiO2. The intrinsic rate constant (kSA= 8.3 × 10
-2 L 
m-2 min-1) during photocatalysis of GEM using GO TiO2 was larger than that (kSA= 6.3 × 
10-2 L m-2 min-1) using P25, indicating advanced photocatalytic ability of GO TiO2 in 
removing GEM compared to P25 by a factor of 1.3. The complete mineralization of GEM 
were observed during photodegradation using commercial P25 with a first-order rate 
constant of 1.5 x10-5 s-1, which is two orders of magnitude lower than the rate constant 
observed in this study (Yurdakal et al., 2007). 
The MST particles were less effective in photocatalysis of IBU, GEM, and NAP with 
kSA values one order of magnitude small than that using P25 and GO TiO2 particles 
(Figure 4.4 and Table 4.3). P25 and GO nanoparticles contain both anatase and rutile 
forms of TiO2, whereas MST nanoparticles contain anatase alone. The enhanced 
photocatalytic ability of P25 and GO TiO2 particles compared to MST particles is likely 
due to a synergy effect of electron transfer in the mixed anatase and rutile phases in P25 
and GO TiO2 nanoparticles. When anatase and rutile are in direct interfacial contact, the 
electron transfer from rutile to anatase stabilizes the charge separation and prevents rapid 
recombination. This electron transfer is enhanced by the small size of rutile crystallites, 
making the rutile/anatase interface a hot spot for photocatalysis (Hurum et al., 2003; 
Scanlon et al., 2013).  
The pharmaceuticals IBU, GEM, and NAP have aromatic and carboxyl groups in 
their structures. One pathway of the photo(catalytic) degradation of IBU and NAP likely 
follow decarboxylation in common (Boscá et al., 2001; Méndez-Arriaga et al., 2008a; 
Méndez-Arriaga et al., 2008b; Yan & Song, 2014), but not for GEM. The photocatalysis 
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of GEM by TiO2 likely occur through the breakage of ethereal bond besides the aromatic 
group (Yurdakal et al., 2007). The aromatic group in the structure of IBU, GEM, and 
NAP likely make them less vulnerable to UV photolysis and photocatalysis by the 
anatase-phase TiO2 in MST particles. 
4.4.3.4 Group 4: Recalcitrant Photo- and Photocatalytically Degradable Compounds 
CAF and CBZ 
Caffeine and CBZ are the most recalcitrant compounds during photo(catalytic) treatment 
in this study, and cannot be removed during UV photolysis, which is consistent with 
previous study (Jelic et al., 2013); however, rapid and complete removals of CAF and 
CBZ were observed during photocatalysis using GO TiO2 and P25 particles (Linley et al., 
2014). The GO TiO2 particles exhibited greater ability in photocatalysis of CAF and CBZ 
by a factor of 4.1 and 2.7 in terms of intrinsic rate constants (kSA) (Table 4.3). The first 
order rate constant k for photocatalysis of CAF and CBZ using P25 and GO TiO2 
particles were ~3 ̶ 9 times larger than published value using P25 and other synthesized 
TiO2 particles (Barndõk et al., 2013; Jelic et al., 2013; Marques et al., 2013). The MST 
particles were less photocatalyticly effective compared to P25 and GO TiO2 particles in 
photocatalysis of CAF and CBZ. Results showed of ~12% of input CAF and ~27% of 
input CBZ were removed during photocatalysis using MST particles, with kSA values 
~two orders of magnitude smaller than that using P25 and GO TiO2 particles (Figure 4.4 
and Table 4.3). The relatively stable multi-rings structure in CAF and CBZ likely make 
them more recalcitrant to UV photolysis and photocatalysis, resulting in slower removal 
rates for CAF and CBZ compared to other target contaminants (Tables 4.2 and 4.3). . The 
photocatalytic degradation of CAF is likely initiated through hydroxylation of the C4=C8 
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double bond and demethylation (Dalmázio et al., 2005). Doll and Frimmel (2005) and 
Jelic et al. (2013) report the multi-step and interconnected pathways of photocatalytic 
degradation of CBZ with nine intermediates identified.    
4.4.4 Magnetic Separation Results 
The initial concentrations of Fe and Ti in the MST suspended solution for the control 
sample were 2.80 and 6.72 mg L-1 before magnetic separation. The concentrations of Fe 
and Ti in the MST suspended solution decreased slightly to 2.76 and 6.62 mg L-1 after 
placing the control sample on a permanent magnet for 15 min and replacing the 
supernatant with the same volume of water. This slight decrease in Fe and Ti 
concentrations shows that more than 98.5% of MST nanoparticles were magnetically 
recovered through a 15 min magnetic separation process.  
Magnetic separation efficiency of GO TiO2 particles was previously evaluated by 
exposing the GO TiO2 particle solution to a permanent magnet and reported by the UV-
vis adsorption as a function of time. Results showed that more than 90% of the GO TiO2 
particles were separated from solution in 75 s (Linley et al., 2014). 
The UV photocatalytic treatment results show that the GO TiO2 nanoparticles are 
comparable as commercial P25 TiO2 in inducing photocatalysis of IBU and NAP within 
60 min UV irradiation; more efficient in catalyzing the photodegradation of MDA, 
MDMA, GEM, CAF and CBZ in terms of intrinsic rate constants (Tables 4.2 and 4.3). 
However, MST nanoparticles seem much less effective compared to P25 and GO TiO2 
particles, likely due the absence of rutile-phase TiO2. The commercial P25 TiO2 (80% 
anatase and 20% rutile) is more photocatalytically efficient than laboratory synthesized 
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MST nanoparticles (pure form anatase); this is attributed to the morphology of crystallites, 
efficient photogenerated charge carrier separation due to the junction between its anatase 
and rutile phases, and increasing photocatalytic quantum yield by limiting recombination 
(Kaniou et al., 2005). In addition, the activation energy with smaller band-gap enhanced 
the use of visible light by rutile phase TiO2. The rutile phase TiO2 has been reported to 
exhibit advanced catalytic ability in photodegradation of phenol compared to anatase 
phase TiO2 (Andersson et al., 2002). The enhanced photocatalytic ability of GO TiO2 
relatively to P25 is likely attributed to improved adsorption by the π-π stacking 
interaction, extended light absorption range, efficient charge separation and transportation 
of GO TiO2 compared to P25 (Zhang et al., 2010). GO has a large π-π bonding network 
acting as a sorbent for contaminants with a similar aromatic structure (i.e. compounds 
such as SMX, MDA, MDMA, IBU, GEM, NAP, and CBZ) through π-π interaction. GO 
as an electron sink accepts photogenerated electrons from TiO2, slowing down electron-
hole recombination and improving the quantum efficiency and activity of the catalyst (Du 
et al., 2011). In addition, P25 nanoparticles tend to aggregate, which likely reduces the 
accessible surface area involved in photocatalytic treatment. By attaching the TiO2 
nanoparticles to GO, aggregation is restricted and TiO2 surface area remains accessible 
throughout treatment. Therefore, application of recoverable GO TiO2 photocatalysts in 
the water treatment industry is expected to provide environmental benefits over the use of 





The laboratory synthesized recoverable magnetic graphene oxide supported TiO2 (GO 
TiO2) nanoparticles exhibit catalytic ability comparable or greater to commercial P25 
TiO2 by an average factor of 1.8 when comparing their intrinsic reaction rate constants 
during UV photocatalytic treatment of target contaminants at environmental levels. Up to 
99% of the artificial sweetener acesulfame-K (~10 µg L-1) and pharmaceuticals (~1 µg L-
1) sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA), ibuprofen (IBU), gemfibrozil (GEM), 
naproxen (NAP), caffeine (CAF) and carbamazepine (CBZ) were removed during 60 min 
UV photocatalysis with 0.1 g L-1 of P25 and GO TiO2 nanoparticles. The synthesized 
pure anatase phased MST (γ-Fe2O3@SiO2@TiO2 colloidal nanospheres) nanoparticles 
were less photocatalytically efficient compared to the P25 and GO TiO2 nanoparticles. 
Due to its high photocatalytic efficiency and recovery, the GO TiO2 nanoparticles could 
serve as an alternative to commercial P25 in the water treatment industry in terms of 
environmental benefits. The results reported herein contribute to existing literature by 
presenting results of UV photocatalytic treatment of emerging contaminants (ACE-K, 
SMX, MDA, MDMA, IBU, GEM, NAP, CAF, and CBZ) using magnetically recoverable 






Table 4.1 Nanocrystal size, BET surface area, and hydrodynamic (DLS) diameter of the 











P25 27[c]  57.4[c]  >3000[b] n/a 
MST 8.5 115.4 592.2 0.023 
Note: Similar data in this table for GO TiO2 nanoparticles are not available. 
[a] As calculated from the anatase (101) peak using the Scherrer formula. 
[b] Aggregate sizes were above the operating range of the instrument. 



















Table 4.2 Selected properties of acesulfame-K (ACE-K), sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), and 
3,4-methylenedioxymethamphetamine (MDMA), first order rate constants (k), correlation coefficient (R2), mass normalized rate 
constants (kM), and surface-area normalized rate constants (kSA) during (photo)catalytic treatment. 
 







R2 k, min-1 












































(55589-62-3), artificial sweetener, 










UV — 0.999 2.3E-01 — — 
P25 0.1 0.999 1.8E-01 1.8 3.1E-02 
MST 0.1 0.999 1.1E-01 1.1 9.7E-03 
GO TiO2 0.05 0.999 1.6E-01 3.2 7.0E-02 
Sulfamethoxazole (SMX)              
(723-46-6), antibiotic, pKa1=1.7, 









UV — 1.000 3.1E-01 — — 
P25 0.1 0.999 4.5E-01 4.5 7.9E-02 
MST 0.1 0.999 2.5E-01 2.5 2.1E-02 





































(MDA) (4764-17-4), psychedelic and 







UV — 0.499 4.0E-03 — — 
P25 0.1 0.999 5.3E-01 5.3 9.2E-02 
MST 0.1 1.000 4.9E-01 4.9 4.3E-02 
GO TiO2 0.05 0.999 2.9E-01 6.0 1.3E-01 
3,4-methylenedioxymethamphetamine 
(MDMA) (42542-10-9), ecstasy, 







UV — 0.892 3.0E-03 — — 
P25 0.1 1.000 6.8E-01 6.8 1.2E-01 
MST 0.1 1.000 4.5E-01 4.5 3.9E-02 
GO TiO2 0.05 0.999 3.0E-01 6.1 1.3E-01 
[a] The catalyst concentration of GO TiO2 was normalized as TiO2 concentration in solution based on the weight ratio of TiO2 in GO 
TiO2 (1:12.5 GO/TiO2, 1:1 TiO2/CSAs). The catalyst concentration of MST TiO2 was not normalized to TiO2 mass concentration. 
[b] The surface area of GO TiO2 used for calculating kSA was assumed to be 80% of TiO2 surface area. The TiO2 particles are 





Table 4.3 Selected properties of ibuprofen (IBU), gemfibrozil (GEM), naproxen (NAP), caffeine (CAF), and carbamazepine (CBZ), 
first order rate constants (k), correlation coefficient (R2), mass normalized rate constants (kM), and surface-area normalized rate 
constants (kSA) during (photo)catalytic treatment. 
 
Compound (CAS#),  use, pKa, 
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Ibuprofen (IBU) (15687-27-1),  
nonsteroidal anti-inflammatory drug, 







UV — 0.899 6.0E-03 — — 
P25 0.1 0.998 1.7E-01 1.7 2.9E-02 
MST 0.1 0.999 1.5E-02 1.5E-01 1.3E-03 
GO TiO2 0.05 0.994 5.2E-02 1.1 2.4E-02 
Gemfibrozil (GEM) (25812-30-0), 








UV — 0.943 1.0E-02 — — 
P25 0.1 1.000 3.6E-01 3.6 6.3E-02 
MST 0.1 0.985 1.4E-02 1.4E-01 1.2E-03 
GO TiO2 0.05 1.000 1.8E-01 3.8 8.3E-02 
Naproxen (NAP) (22204-53-1), 







UV — 0.992 1.8E-02 — — 
P25 0.1 0.999 3.9E-01 3.9 6.8E-02 
MST 0.1 0.992 9.3E-02 9.3E-01 8.1E-03 











































Caffeine (CAF) (58-08-2),stimulant, 










UV — 0.348 1.0E-03 — — 
P25 0.1 0.992 8.9E-02 8.9E-01 1.6E-02 
MST 0.1 0.836 2.0E-03 2.0E-02 1.7E-04 
GO TiO2 0.05 0.999 1.4E-01
[c] 2.9 6.3E-02 
Carbamazepine (CBZ) (298-46-4),  
anti-depressant, antiepileptic,     
pKa=-0.49[d], log Kow=2.3 
N
O NH2  
UV — — — — — 
P25 0.1 0.999 5.4E-02 5.4E-01 9.4E-03 
MST 0.1 0.954 5.0E-03 5.0E-02 4.3E-04 
GO TiO2 0.05 0.997 5.5E-02
 [c] 1.1 2.5E-02 
[a] The catalyst concentration of GO TiO2 was normalized as TiO2 concentration in solution based on the weight ratio of TiO2 in GO 
TiO2. The catalyst concentration of MST TiO2 was not normalized to TiO2 mass concentration. 
[b] The surface area of GO TiO2 used for calculating kSA was assumed to be 80% of TiO2 surface area. The TiO2 particles are 
associated on the GO sheet; the area of the TiO2 in contact with the GO sheet is not exposed to the solution.  
[c] Reference: Linley et al. (2014).   
















Figure 4.2 XRD patterns of the MST particles and P25 as indicated. Peaks labelled with A match 
anatase phase TiO2 (JCPDS No. 21-1272), R matches rutile phase TiO2 (JCPDS No.21-1276), 








Figure 4.3 Concentrations of acesulfame-K (ACE-K), sulfamethoxazole (SMX), 3,4-
methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) as a 
function of reaction time during UV photo(catalytic) treatment. Group 1: Easily photo- and 
photocatalytically degradable compounds ACE and SMX. Group 2: Easily photocatalytically 
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Figure 4.4 Concentrations of ibuprofen (IBU), gemfibrozil (GEM), naproxen (NAP), caffeine 
(CAF), and carbamazepine (CBZ) as a function of reaction time during UV photo(catalytic) 
treatment. Group 3: Moderately photo- and photocatalytically degradable compounds IBU, GEM, 
and NAP. Group 4: Recalcitrant photo- and photocatalytically degradable compounds CAF and 
CBZ. The data of UV photolysis and photocatalysis of CAF and CBZ using P25 and GO TiO2 
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Chapter 5: Removal of Pharmaceutical 
Compounds, Artificial Sweeteners, and 
Perfluoroalkyl Substances from Water Using 














5.1 Executive Summary 
Emerging contaminants such as pharmaceutical compounds, artificial sweeteners, and 
perfluoroalkyl substances (PFASs) are widely detected and persistent in environmental waters 
such as surface water, groundwater, and drinking water. Advanced oxidation processes are 
among the most effective and heavily studied methods for removing emerging contaminants 
from water; however, high energy consumption (such as ultraviolet light and ozone) greatly 
increases the operating costs and limits its large scale application. In this study, a passive 
treatment system consisting of four columns packed with mixtures of silica sand, zero-valent iron 
(ZVI), biochar (BC), and a mixture of (ZVI + BC) were evaluated for simultaneous removal of 
pharmaceuticals, artificial sweeteners, and PFASs from water. The experiment was divided into 
two stages; the flow rate was maintained at 0.3 pore volume (PV) d-1 in the first stage of the 
experiment, and then decreased to 0.1 PV d-1 in the second stage of the experiment. Almost 
complete removal (> 97%) of the pharmaceutical compounds carbamazepine (CBZ), caffeine 
(CAF), sulfamethoxazole (SMX), 3,4-methylenedioxyamphetamine (MDA), 3,4-
methylenedioxymethamphetamine (MDMA), ibuprofen (IBU), gemfibrozil (GEM) and naproxen 
(NAP) from an influent of ~9 µg L-1 to trace concentrations (< 0.25 µg L-1) was observed in 
Columns ZVI, BC, and (ZVI + BC) over the complete duration of the experiment. The removal 
of pharmaceuticals within the treatment columns followed the first-order rate model (R2 > 0.93). 
The artificial sweeteners acesulfame-K (ACE-K) and saccharin (SAC) (~110 µg L-1) were 
partially removed in the treatment columns. Removal of cyclamate (CYC) was not observed in 
any of the columns. However, more than 76% of input sucralose (SCL) (~110 µg L-1) was 
removed in three treatment columns. Input perfluorooctanoic acid (PFOA) (~45 µg L-1) was 
partially removed in the columns containing BC, but not in Column ZVI. Between 10% and 80% 
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of input perfluorooctane sulfonic acid (PFOS) (24.0 ̶ 89.6 µg L-1) was removed in Column ZVI; 
greater removals (57 ̶ 99%) of PFOS were observed in Columns BC and (ZVI + BC) compared 
to Column ZVI. The removal of the artificial sweeteners, PFOA, and PFOS followed the first-
order or zero-order rate models or followed the first-order rate in the early stage of the 
experiment followed by zero-order rate in the late stage of the experiment. The removal rates of 
target contaminants decreased over time. The decrease in flow rate did not lead to noticeable 









Pharmaceuticals and artificial sweeteners are heavily consumed in our daily life. These 
compounds pass through human bodies and finally end up in wastewater treatment plants 
(WWTPs) in the forms of their unchanged parent or degradation products. However, at many 
locations, conventional WWTPs cannot efficiently remove these emerging contaminants from 
water (Joss et al., 2005; Metcalfe et al., 2003a; Scheurer et al., 2009), resulting in the ubiquitous 
occurrences of pharmaceuticals (such as carbamazepine, caffeine, sulfamethoxazole, 3,4-
methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), 
ibuprofen, gemfibrozil, and naproxen) and artificial sweeteners (such as acesulfame-K, 
cyclamate, sucralose, and saccharin) in the environment (Carrara et al., 2008; González et al., 
2012; Liu et al., 2014b; Rodil et al., 2012).  
Pharmaceutical carbamazepine (CBZ) is an antiepileptic drug with a carboxamide 
functional group attached to a benzo[b][1]benzazepine structure. The persistent behaviors of 
CBZ (removal < 10%) and diclofenac (removal of 21–40%) in WWTPs have been reported by 
Zhang et al. (2008). Caffeine (CAF) is a psychoactive substance widely consumed in beverages 
and drugs; CAF has two carbonyl ( ̶ C=O ̶) functional groups and three methyl side chains 
attached to a purine structure. Sulfamethoxazole (SMX) is a sulfonamide class antibacterial drug 
widely used for treating bacterial infections in humans and domesticated animals; SMX contains 
an amino (NH2 ̶) and oxazole groups attached to the benzenesulfonamide. Bueno et al. (2012) 
report the occurrences and persistence of CBZ (160 ̶ 270 ng L-1), CAF (8 ̶ 59 µg L-1), SMX (0.5 ̶ 
1.3 µg L-1), ibuprofen (IBU) (5 ̶ 14 µg L-1), and gemfibrozil (GEM) (up to 1 µg L-1) in WWTPs 
with removals 50 ̶ 80%, except for CBZ (no removal with effluent concentration higher than 
118 
 
influent). MDA and MDMA are illicit psychedelic recreational drugs; they contain the same 
methylenedioxy (-O-CH2-O-) group attached to the aromatic ring of amphetamine (for MDA) 
and methamphetamine (for MDMA) molecules. MDA and MDMA are widely detected in 
untreated and treated wastewater, surface water and groundwater with observed concentrations 
up to 600 ng L-1 (Jurado et al., 2012; Metcalfe et al., 2010a; Pal et al., 2013) and reported 
persistent at different stages of treatment within municipal wastewater treatment plants (Nefau et 
al., 2013). Pharmaceuticals IBU and NAP are  nonsteroidal anti-inflammatory drugs (NSAID), 
which are used as pain killers. IBU contains an isobutylphenyl group attached to a propanoic 
acid; NAP contains a methoxynaphthalene structure attached to a propanoic acid. GEM is a lipid 
regulating drug which contains a dimethylphenoxy attached to a 2,2-dimethylpentanoic acid. 
Metcalfe et al. (2003a) report the occurrences of neutral drug CBZ (1.9 ̶ 2.3 µg L-1) and acidic 
drugs IBU (24.6 ̶ 75.8 µg L-1), NAP (33.9 ̶ 611 µg L-1), and GEM (1.3 ̶ 2.1 µg L-1) in influent and 
effluent samples collected in 14 Canadian sewage treatment plants (STP) with no removal for 
CBZ and removals of 51% for IBU, 94% for NAP, and 38% for GEM. The widespread 
occurrences of pharmaceuticals IBU and NAP in surface water, treated wastewater and drinking 
water  have also been reported previously (Boyd et al., 2003).   
Acesulfame-K (ACE-K) is an artificial sweetener, which is a potassium salt of 6-methyl-
1,2,3-oxathiazine-4(3H)-one 2,2-dioxide. Artificial sweetener cyclamate (CYC) is a sulfamic 
acid (NH2SO3H) with cyclohexane structure attached to the N atom. The artificial sweetener 
saccharin (SAC) is 300–400 times as sweet as sucrose or table sugar with an O-benzoic 
sulfimide structure. Artificial sweetener sucralose (SCL) has a disaccharide structure where three 
hydroxyl groups are replaced by chlorine. Due to the persistence of some pharmaceuticals and 
artificial sweeteners, they have been used to track anthropogenic contamination in aquatic 
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environments. Buerge et al. (2009) report the artificial sweeteners ACE-K and SCL are not 
routinely removed in WWTPs with activated sludge processes; however, SAC and CYC are 
biodegradable (Lange et al., 2012). Emerging contaminants such as artificial sweetener ACE-K, 
pharmaceuticals CAF, CBZ and IBU, and insect repellent DEET have been reported to be useful 
tracers of wastewater in surface water and groundwater (James et al., 2016; Liu et al., 2014b; 
Sorensen et al., 2015; Van Stempvoort et al., 2013). Mawhinney et al. (2011) use the artificial 
sweetener SCL as an indicator for the presence of other recalcitrant compounds in finished 
drinking water. ACE-K is also used as a population marker to assist identifying sources of 
perfluoroalkyl acids in surface waters (Müller et al., 2011). 
Perfluoroalkyl substances (PFASs) are aliphatic hydrocarbons consisting of a 
hydrophobic perfluoroalkyl carbon group (H atoms have been completely replaced by F atoms) 
attached to a hydrophilic ionic acid (such as carboxylic acid and sulfonic acid). They are 
primarily used as surfactants in industrial, military, and consumer products such as polymer 
additives, surface treatment agents and fire retardants because of their high thermal and chemical 
stability (Ahrens, 2011). High water solubility, hydrophobicity/hydrophilicity, and low volatility 
make PFASs ubiquitous contaminants in water, wildlife, and humans (Ahrens & Bundschuh, 
2014; Houde et al., 2011). These compounds are extremely persistent and resistant to physical, 
chemical, and biological degradation and have been reported to be transported globally (Paul et 
al., 2009; Rahman et al., 2014). Perfluorooctanoic acid (PFOA, C7F15COOH) and 
perfluorooctane sulfonic acid (PFOS, C8F17SO3
-) are the most studied PFASs because of their 
frequent detection and high observed concentrations (Ahrens, 2011; Schaider et al., 2014). These 
contaminants have been widely found in wastewater, surface water, groundwater, and drinking 
water (Ahrens, 2011; Ahrens & Bundschuh, 2014; Schaider et al., 2014). 
120 
 
Pharmaceutical compounds and PFASs have been reported to be reproductive and 
development toxicants, and endocrine disruptors; moreover, PFASs are bioaccumulative and 
even possible carcinogens (Ding & Peijnenburg, 2013; Sanchez et al., 2011; Santos et al., 2010). 
Because the municipal water and wastewater treatment systems cannot efficiently remove 
pharmaceuticals such as CBZ, CAF, and IBU,  artificial sweeteners such as ACE-K and SCL, 
and especially PFASs such as PFOA and PFOS from water (except for reverse osmosis and 
nanofiltration), different technologies such as advanced oxidation, microbial treatment, and 
granular activated carbon (GAC) adsorption have been extensively studied for removing these 
contaminants from water (Ahmed et al., 2016; Bo et al., 2015; Merino et al., 2016; Sotelo et al., 
2014).  
Advanced oxidation technologies such as UV photo-and photocatalytic degradation and 
UV/H2O2, ozonation have shown to effectively degrade many pharmaceuticals and artificial 
sweeteners (Sharma et al., 2014; Tong et al., 2012). The degradation or decomposition of PFASs 
is more challenging than other emerging contaminants, due to the highly stable saturated C-F 
bond. Efficient decomposition of PFOS has been reported using zero-valent iron (ZVI) in 
subcritical water (> 205 oC, high pressure at 23.3 MPa)  (Hori et al., 2006). Lee et al. (2009) 
demonstrate that 99.3% of PFOA (254 µM) can be decomposed with 74% defluorination 
efficiency using microwave-induced persulfate. Effective removals of perfluoroalkyl acids 
(PFAAs) is observed using nanofiltration (>93%) and GAC (>80%) (Appleman et al., 2013). 
However, these treatment methods either require strong oxidizing radicals (•OH and SO4•-) under 
extreme conditions such as low pH, high temperature and pressure or need to be frequently 
changed or renewed, which makes the treatment costly (Merino et al., 2016). In addition, the 
strong oxidants (such as persulfate and hydrogen peroxide) used in in-situ chemical oxidation 
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have been reported to be greatly decomposed by naturally occurring minerals [such as Fe(III)- 
and Mn(IV)-containing oxides] in groundwater and aquifer materials (Liu et al., 2014a), which 
also makes the advanced oxidation processes less effective in field applications.  
ZVI is a strong reductant (reduction potential of -0.44 V) and has the potential to degrade 
environmental contaminants, such as nitro-organic compounds and chlorinated hydrocarbons 
(Devlin et al., 1998; Gillham & O'Hannesin, 1994; Matheson & Tratnyek, 1994; Orth & Gillham, 
1996). In addition, some iron corrosion products formed on the surface of ZVI such as green rust 
and magnetite have been proposed as effective reductants for treating many contaminants 
(Agrawal et al., 2002; Elsner et al., 2004). Compared to granular ZVI, nanoscale ZVI has larger 
specific surface area and higher surface reactivity which results in more rapid and extensive 
removals of contaminants. Nanoscale and granular ZVI based advanced oxidation processes are 
widely studied for removing contaminants from water. Bautitz et al. (2012) report degradation 
(96%) and mineralization (60%) of pharmaceutical diazepam (~25 mg L-1) after 60 min in an 
enhanced Fenton (ZVI/EDTA/O2) system. Granular ZVI has also been used as a persulfate 
(S2O8
2-) activator to facilitate chemical oxidation of pharmaceutical SMX (Liu et al., 2016b). 
Limited studies have been reported on the use of ZVI alone as a reducing agent for removing 
pharmaceuticals and PFASs from water. König et al. (2016) demonstrate reductive 
biotransformation of the pharmaceutical CBZ using ZVI sponge material with 20% removal. 
Reductive degradation (38 ̶ 96% removed) of four PFASs (PFOA, PFNA, PFDA, and PFOS) has 
been reported using Mg-aminoclay coated nanoscale ZVI under low pH (pH = 3) conditions 
(Arvaniti et al., 2015).  
Biochar (BC) is a porous carbon-residue derived from waste organic materials pyrolyzed 
under limited oxygen or anaerobic conditions. BC has a large surface area and high porosity, and 
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contains various functional groups such as carboxylic, aliphatic, and phenolic groups, which 
provide exchange sites for adsorption of cations, heavy metals, and anions. In addition, the high 
carbon content makes biochar an effective sorbent for nonpolar organic compounds in 
wastewater treatment (Scherer et al., 2000). Biochar is widely used in immobilization of organic 
contaminants (Kim et al., 2016; Oleszczuk et al., 2012) and heavy metals (Liu et al., 2016a; Xu 
et al., 2012) from contaminated water and soil. Effective sorption of pharmaceuticals CBZ, SMX, 
IBU, and NAP by biochar has been reported (Jung et al., 2015a; Rajapaksha et al., 2015; 
Williams et al., 2015).  
ZVI and BC are non-toxic and cost-effective reactive materials and easy to obtain. The 
purpose of this study is to evaluate the potential of low-cost reactive materials for the 
simultaneous removal of three classes of emerging contaminants under dynamic flow conditions. 
Four column experiments were conducted to evaluate the removal of pharmaceuticals (~10 µg L-
1), artificial sweeteners (~100 µg L-1), and perfluoroalkyl substances (20 ̶  100 µg L-1) from 
simulated groundwater using ZVI, BC and a mixture of ZVI and BC. The target contaminants 
and their concentrations were selected and chosen according to their occurrences and 
concentrations found in wastewaters derived from domestic and municipal sources. Simulated 
groundwater (~100 mg L-1 CaCO3 saturated water) was used as the matrix for the influent 
solution to represent concentrations of dissolved Ca2+, HCO3
-, and CO3
2-, which are present in 
natural surface water and groundwater. 
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5.3 Material and Methods 
5.3.1 Column Design and Experimental Setup 
Four acrylic columns were used, each 30 cm in length and 5 cm internal diameter.  Influent and 
effluent ports were attached to the bottom and top of each column for introducing influent and 
discharging effluent solutions. Thirteen sampling ports were installed along the length of each 
column at 2.1 cm intervals. Column Control was packed with 100% silica sand (SS). Column 
ZVI was packed with 50% (v/v) granular ZVI and 50% (v/v) SS.  Column BC was packed with 
50% (v/v) BC and 50% (v/v) SS. Column (ZVI + BC) was packed with 10% (v/v) granular ZVI , 
40% (v/v) BC, and 50% (v/v) SS. A 1 cm-thick layer of 100% SS was packed on the top and 
bottom ends of the columns to separate the column packing from the influent and effluent ports. 
The physical characteristics of the columns are provided in Table 5.1. The SS (0.6–0.8 mm) was 
obtained from the Silica Company (Ottawa, IL, US). The granular ZVI (0.25–1.19 mm) was 
obtained from Connelly-GPM, and was washed using 1.2 M HCl acid, followed by ultrapure 
H2O (Type 1, 18.2 MΩ cm @ 25 
oC, generated from a MilliQ A10 water system) before use. The 
BC (oak hard wood; 0.5–2.36 mm) was obtained from Cowboy Charcoal Co., Brentwood, TN, 
USA. The carbon content of the BC is 99.9% and contains hydroxyl, aliphatic, quinone, sulfate, 
and carbonate functional groups (Liu et al., 2015b). After packing, the columns were wrapped 
with aluminum foil to minimize exposure to light. The columns were purged with CO2 (g) for 24 
hr to displace atmospheric gases in the void pore spaces of the column packing, except for the 
Column ZVI. The CO2 (g) is more soluble in water than N2 and O2, which enhances the saturation 
of the packing materials. The Column ZVI was not purged with CO2 (g) to avoid the formation of 
carbonate precipitates which can cause a decrease in reactivity of the iron (Jeen et al., 2006). The 
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columns were placed in an anaerobic glove box (COY Ltd.) that contained 5% H2 and 95% N2 
and were saturated with ultrapure H2O before introducing influent solution.   
 A concentrated stock solution was prepared that contained 10 mg L-1 of pharmaceutical 
compounds carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), 3,4-
methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), 
ibuprofen (IBU), gemfibrozil (GEM), and naproxen (NAP), 100 mg L-1 of artificial sweeteners 
acesulfame-K (ACE-K), cyclamate (CYC), saccharin (SAC), and sucralose (SCL), and 50 – 100 
mg L-1 of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in ultrapure 
water. About 9% (v/v) of methanol (HPLC grade, Sigma-Aldrich) was used in the concentrated 
stock solution to dissolve the dry powders in the aqueous solution. The influent solution was 
prepared by adding 4 mL of the concentrated stock solution to 4 L Ar-purged simulated 
groundwater (CaCO3 saturated water), resulting in < 0.01% methanol. The final influent solution 
contained approximately 10 µg L-1 of pharmaceuticals CBZ, CAF, SMX, MDA, MDMA, IBU, 
GEM, and NAP, 100 µg L-1 of artificial sweeteners ACE-K, CYC, SAC, and SCL, and 50 µg L-1 
of PFOA and 20 µg L-1 PFOS for the first 21 pore volumes (PV) of flow. After 21 PV of flow 
through the columns, the concentration of PFOS in the influent solution was increased to 50 – 
100 µg L-1 to match the influent PFOA concentration; the concentrations of the other target 
contaminants remained the same.  
 The experiments were divided into two stages. The influent solution was pumped through 
the columns from the bottom to the top at 0.3 pore volume (PV) d-1 during the first stage of the 
experiment, and pumped at a rate of 0.1 PV d-1 after 50 PV of flow during the second stage of the 
experiment to evaluate the effect of residence time on contaminant removals. The flow rate was 
set at 0.3 or 0.1 PV d-1 to be representative of average groundwater velocities reported at 
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subsurface-wastewater disposal sites (Benner et al., 1997; Carrara et al., 2008; Robertson et al., 
2000). Profile samples were collected during the experiments at four times (1, 13, 25, 53 PV of 
flow) along the length of the columns.  
5.3.2 Sample Collection and Analytical Methods 
Water samples were collected from the effluent and profile ports using 125 mL amber glass 
bottles except those for PFOA and PFOS analysis, which were collected using 30 mL 
polypropylene bottles. Samples for pH and Eh analysis were not filtered; alkalinity samples were 
filtered through 0.45-µm cellulose acetate membranes (Pall Corp., Canada) before measurement. 
Pharmaceutical samples were filtered through 0.45-µm nylon membranes (Pall Corp., Canada) 
and collected in 25 mL amber glass vials. Artificial sweetener samples were filtered through 0.2-
µm PVDF membranes (Chromatographic Specialties Inc., Canada) and collected in 8 mL 
polyethylene (HDPE) bottles. Samples for PFOA and PFOS analysis were filtered through 0.45-
µm polypropylene membranes (Pall Corp., Canada) and collected in 15 mL HDPE bottles before 
36 PV of flow through the columns, but not filtered afterwards. The measurements of pH, Eh and 
alkalinity were performed immediately after sampling; all other samples were stored at 4 oC until 
analysis within one month of collection.  
 The pH values were measured using a Ross combination glass electrode (Orion 815600) 
calibrated using standard pH 7, 4, and 10 buffers before use and checked against pH 7 and 10 
buffers between samples. The Eh values were measured using a Pt-billeted Ag-AgCl 
combination electrode (Orion 9678BNWP). The performance of the Eh probe was checked 
against A and B solutions (redox/ORP electrode user guide, Thermo Scientific, Canada) between 
samples. The alkalinity measurements were performed using a Hach digital titrator with 
bromocresol green/methyl red indicator and 0.08 mol L-1 H2SO4.   
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 The analysis of target compounds involved isotope dilution  of each compound to track 
the analyte recovery, instrument variability and matrix suppression during sample analysis. The 
native analyte compounds of CBZ, CAF, SMX, IBU, GEM, NAP, CYC, and SAC for calibration 
standards and input stock solution were obtained from Sigma-Aldrich (Oakville, Canada). The 
isotope labeled standards CBZ-d10, CAF-d3, IBU-d3, GEM-d6, and [13C]-NAP were obtained 
from Cambridge Isotope Laboratory Inc. (Cambridge, USA); the isotope labeled standards SMX-
d4, CYC-d11, and SAC-13C6 were obtained from Toronto Research Chemicals Inc. (Toronto, 
Canada). The native analytes ACE-K and SCL and isotope labeled ACE-K-d4 and SCL-d6 
standards were obtained from Toronto Research Chemicals Inc. (Toronto, Canada). The native 
analytes MDA and MDMA and isotope labeled MDA-d5 and MDMA-d5 were obtained from 
Cerilliant Inc. (Texas, USA). The native analytes PFOA and PFOS and their isotope labeled 
standards [13C]-PFOA and [13C]-PFOS for preparation of calibration standards were obtained 
from Wellington Laboratories Inc. (Guelph, Canada). The analytes PFOA and PFOS dry powder 
for preparation of the input stock solution were obtained from Sigma-Aldrich, Canada. 
 Prior to analysis, 1 mL aliquots of artificial sweetener samples, 10 mL aliquots of 
pharmaceutical samples, and 20 mL aliquots of diluted PFOA and PFOS samples were spiked 
with consistent amounts of internal standards (IS). The IS spiked pharmaceutical and PFOA and 
PFOS samples were passed through solid-phase extraction (SPE) cartridges (Oasis HLB 3 cc 
glass cartridges; Waters Corp., Mississauga, Canada) preconditioned with 2 x 1 mL methanol 
and then washed with 2 x 1 mL ultrapure H2O. For pharmaceutical SPE, the cartridges were 
loaded with 10 mL pharmaceutical sample, washed with 2 x 1 mL 5% (v/v) methanol, vacuum 
dried, and eluted with 2 x 1 mL methanol. The pharmaceutical extracts were collected in 7 mL 
amber glass vials. For PFOA and PFOS SPE, the cartridges were loaded with 20 mL PFOA and 
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PFOS sample, washed with 2 x 1 mL ultrapure H2O, vacuum dried, and eluted with 2 x 1 mL 
methanol.  The PFOA and PFOS extracts were collected in 5 mL polypropylene centrifuge tubes 
(Eppendorf Ltd., Canada). The extracts were kept chilled at 4 oC before analysis.  
 Pharmaceutical compound extracts were analyzed by high performance liquid 
chromatography (Agilent 1100, Agilent Technologies) followed by electrospray tandem mass 
spectrometry (4000 Q TRAP, Applied Biosystems, Foster City, USA) using  previously 
described methods (Stafiej et al., 2007; Vanderford & Snyder, 2006) with some modifications to 
optimize for instrument operating conditions. Caffeine, SMX, CBZ, MDA, and MDMA were 
analyzed in electrospray ionization positive (ESI+) mode, while IBU, GEM, and NAP were 
analyzed in ESI negative (ESI-) mode. The mobile phase composition and gradient setup 
followed previously described procedures (Liu et al., 2014b). Seven to eleven point calibration 
curves (MDMA: 0.005 ̶ 10 µg L-1, CAF and SMX: 0.01 ̶ 10 µg L-1, CBZ and MDA: 0.1 ̶ 10 µg L-
1, IBU, GEM and NAP: 0.05 ̶ 10 µg L-1) were used to quantify pharmaceutical concentrations 
with pharmaceutical IS mixture added to yield a concentration of 1 µg L-1. Tap water samples 
spiked with analyte and IS following the same procedures as unknown samples (quality control, 
QC samples) were used to evaluate the impact of the SPE step on the analytical method. 
Fortified samples were prepared which consisted of the unknown samples spiked with a known 
amount of analyte and IS. One duplicate and one fortified sample were prepared between every 
ten unknown pharmaceutical samples to check the accuracy of the SPE procedures. The 
accuracies of pharmaceutical calibration, calibration verification (CV), and continuous 
calibration verification (CCV) samples were in the range of 85 ̶ 120% with IS recoveries of 84 ̶ 
11%. The accuracies of the duplicate and fortified unknown pharmaceutical samples were 83 ̶ 
119%. The absolute IS recoveries of pharmaceutical quality control and unknown samples, 
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including duplicate and fortified samples, were in the range of 71 ̶ 124%. The method detection 
limits (MDLs) of pharmaceutical compounds were 20 ng L-1 for CBZ, 100 ng L-1 for CAF, 10 ng 
L-1 for SMX, 30 ng L-1 for MDA, 5 ng L-1 for MDMA, 30 ng L-1 for IBU, 5 ng L-1 for GEM and 
20 ng L-1 for NAP.   
 The artificial sweetener samples were analyzed by ion chromatography (Dionex ICS-
5000, Thermo Scientific, Sunnyvale, USA) followed by tandem mass spectrometry (6460 QQQ, 
Agilent Technologies, Mississauga, Canada) in ESI- mode using a previously described method 
(Van Stempvoort et al., 2011). Nine point calibration curves (0.05 ̶ 200 µg L-1) with the IS 
concentration of 1 µg L-1 of ACE-d4, 5 µg L-1 of CYC-d11 and SAC-13C6, and 100 µg L-1 of 
SCL-d6 were used for AS quantitation. The quality control samples and duplicate and fortified 
unknown samples were prepared followed the same procedure as for the calibration samples. The 
accuracies of the AS calibration, CV, and CCV samples were 82 ̶ 114%. The accuracies for 
duplicate and fortified unknown AS samples were 80 ̶ 119%. The absolute IS recoveries for CCV 
and unknown AS samples were in the range of 71 ̶ 121%. The MDL of ACE, CYC, SAC, and 
SCL were 0.1 µg L-1.  
 The PFOA and PFOS extracts were analyzed by high performance liquid 
chromatography (1290 HPLC, Agilent Technologies, Mississauga, Canada) followed by tandem 
mass spectrometry (6460 QQQ, Agilent Technologies, Mississauga, Canada) in ESI- mode using 
EPA Method 537 (Shoemaker, 2013) with recommended modifications (Application Note, 
Agilent Technology; Yamashita et al., 2004). The analytes were separated using an Agilent 
Zorbax Eclipse C18 4.6 × 150 mm, 5 μm i.d. (Agilent, Mississauga, Canada) at 55 oC. The 
mobile phase consisted of 2 mM ammonium acetate (HPLC grade, Sigma-Aldrich, Oakville, 
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Canada) in water (phase A) and 2 mM ammonium acetate in methanol (phase B). A gradient 
elution started at 6% B for 1 min, increased linearly to 95% within 7 min  and held at 95% for 8 
min, then decreased to 6% at 16.01 min and held at 6% until 20 min. The flow rate was 0.6 mL 
min-1 and the injection volume was 20 µL. Eight point calibration standards (0.1 ̶ 20 µg L-1) with 
1 µg L-1 of [13C]-PFOA and 2 µg L-1 of [13C]-PFOS were prepared in 96 : 4% (v/v) methanol : 
water for PFOA and PFOS quantitation. The accuracies of calibration, CV, and CCV sample 
were between 80% and 119%. One duplicate sample with two different dilution factors was 
prepared for every ten unknown PFOA and PFOS samples, yielding accuracies of 85 ̶ 126%. One 
third of the unknown PFOA and PFOS samples were analyzed in duplicate or triplicate to assess 
the instrument variability. Tap water samples (QC samples) spiked with analyte and IS were 
used to track the precision of the SPE procedures. The absolute IS recoveries of the CV, CCV, 
QC, and unknown samples were 73 ̶ 126%. The MDL of PFOA and PFOS were 45 and 110 ng 
L-1.  
5.4 Results and Discussion  
5.4.1 Column Geochemistry 
The four pH profiles measured at different times within the columns were highly consistent, 
exhibiting similar values with distance along the columns, except for those obtained within 
Column ZVI (Figure 5.1). The average pH values within Columns Control and BC effluents 
were about 8.3 during the first stage of the experiment, which was consistent with the influent 
pH values. During the second stage of the experiment, the pH values of the Column Control 
effluent gradually increased to 8.6 at 63 PV, while the pH values of the Column BC effluent 
gradually decreased to 6.9 at 68 PV (Figure 5.2).  The pH values of the Column ZVI effluent 
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gradually increased from 7.8 at 5 PV to 9.4 at 25 PV until the end of the first stage of the 
experiment (50 PV); this increase in pH is attributed to the reduction of water by ZVI (
2 	 ↔ 	2 ) (Wilson, 1923); however, the pH of the Column ZVI effluent 
then started to decrease to 8.6 at 63 PV in the second stage of the experiments as the flow rate 
was decreased from 0.3 to 0.1 PV d-1 (Figure 5.2). This changing trend in pH for the Column 
ZVI effluent was consistent with the profile results (Figure 5.1). The average pH within Column 
(ZVI + BC) and in its effluents was constant at 8.7 through the entire experiment despite the 
decrease in flow rate.  
 The four Eh profiles within the columns exhibited similar values of < ‐400 mV, 
indicating strong reducing conditions in these columns over the course of the experiment. The 
average Eh values within Columns Control, ZVI, BC, and (ZVI + BC) were about ‐410, ‐450, ‐
395 and -440 mV (Figure 5.1).  The Eh of the Column Control effluent was consistent with the 
influent Eh (~ -410 mV).  The lowest Eh values of ‐500 mV were observed within Column ZVI 
and in its effluent at around 25 PV likely due to the production of H2 associated with ZVI 
corrosion (Wilson, 1923). The Eh values within Column BC and in the effluents were similar to 
the influent Eh during the first stage of the experiment; however, the Eh values increased from -
384 mV at 53 PV to -338 mV at 69 PV during the second stage of the experiment. The Eh values 
of Column (ZVI + BC) were relatively constant at ‐440 mV throughout the entire experiment 
(Figures 5.1 and 5.2).     
  The four alkalinity profiles within each column indicated similar changing trends,  with 
constant concentrations observed in the influent within Columns Control and BC and decreasing 
values with distance along the flow direction within Columns ZVI and (ZVI + BC) (Figure 5.1). 
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The concentrations of alkalinity in Columns Control and BC effluents were consistent with the 
influent alkalinity (51 ̶ 94 mg L-1 as CaCO3) during the experiment. The average alkalinity 
concentration in Column ZVI effluent increased from 14 mg L-1 (as CaCO3) before 18 PV to 39 
mg L-1 (as CaCO3) at 47 PV during the first stage of the experiment, and then decreased slightly 
to 27 mg L-1 (as CaCO3) at 63 PV in the second stage of the experiment. The concentrations of 
alkalinity in Column (ZVI + BC) effluent were slightly lower than that of Column BC, but 
higher than that of Column ZVI likely as a result of the mixed composition of the two reactive 
media (Figure 5.2).  
5.4.2 Removal of Pharmaceutical Compounds in Columns  
5.4.2.1 Removal of Pharmaceutical Compounds from Column Effluent  
Pharmaceutical compounds CBZ, CAF, MDA, MDMA, IBU, GEM, and NAP were not 
removed in the Column Control with consistent concentrations between their effluent and 
influent, except for sulfamethoxazole (SMX). SMX was not removed in the Column Control in 
the early stage of the experiment; however, increasing removal of SMX in the Column Control 
was observed in the late stage of the experiment. In general, all eight pharmaceuticals were 
removed in the three treatment columns with removals ranging from 97 ̶ 99% (Figures 5.3 and 
5.4).   
The concentrations of SMX in the Column Control effluent were consistent with the 
influent concentration before 14 PV; however, a gradual decrease from 8.6 µg L-1 at 14 PV to 2.8 
µg L-1 at 47 PV was observed in the first stage of the experiment. The decrease in flow rate from 
0.3 PV d-1 in the first stage of the experiment to 0.1 PV d-1 in the second stage of the experiment 
led to enhanced removal of SMX in the Column Control; the concentration of SMX then 
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decreased to ~0.3 µg L-1 in the second stage of the experiment (Figure 5.4). As an antibiotic, 
SMX has been reported to inhibit bacterial growth at concentrations in the range of 1.3 ̶ 253 µg 
L-1 (Underwood et al., 2011). However, the removal of SMX in Column Control was likely due 
to biodegradation and sorption of SMX to the biofilms as a result of microbial growth during the 
extended operating period. Removal of SMX in sand and soil matrix systems has been reported 
previously (Bertelkamp et al., 2014; Martínez-Hernández et al., 2016; Wunder et al., 2011).  
The concentrations of pharmaceutical compounds in the Columns ZVI, BC and (ZVI + 
BC) effluents decreased from the average input concentration of ~9 µg L-1 to the concentrations 
< 0.25 µg L-1 throughout the experiment, indicating almost complete removals (> 97%) of the 
eight target pharmaceuticals (Figures 5.3 and 5.4). The decrease in flow rate did not affect the 
removals of pharmaceutical compounds in the Columns ZVI, BC and (ZVI + BC). 
5.4.2.2 Potential Removal Mechanisms of Pharmaceutical Compounds by ZVI and BC  
Removal of contaminants using ZVI has been reported involving direct and indirect 
reduction of contaminants by ZVI and iron oxides, or adsorption or coprecipitation of 
contaminants on corrosion products  (Blowes et al., 1997; Crawford et al., 1993; Lee & 
Batchelor, 2002; Matheson & Tratnyek, 1994; Odziemkowski & Simpraga, 2004). The corrosion 
of Fe0 in natural waters (pH 4 ̶ 9) produces hydrated iron oxide films on the metal surface 
(Wilson, 1923). The OH groups (H donors and acceptors) of iron hydroxide can interact with NH, 
NH2, and OH groups (H donors and acceptors) of target pharmaceuticals through H bonding 
which likely enhanced the removal of pharmaceuticals by ZVI. In this study, common products 
of Fe0 corrosion and precipitation in dissolved calcium carbonate water (simulated groundwater) 
are iron hydroxy carbonate [Fe2(OH)2CO3] and aragonite (CaCO3), which likely are negatively 
charged in the pH range of this study (pH 7.9 ̶ 9.5) (Guilbaud et al., 2013); the electrostatic 
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interaction between negatively charged ZVI and positively charged pharmaceuticals can also 
contribute to the removal of pharmaceuticals by ZVI.  
Removal of organic contaminants by BC is attributed to the strong sorption affinity 
between organic contaminants and BC, which likely involves hydrophobic interaction, π  ̶  π 
electron donor-acceptor (EDA) interaction, π  ̶  π electron coupling interaction between the 
graphite moieties of BC and π electron of contaminants, electrostatic interaction, and H-bonding 
(Inyang & Dickenson, 2015; Wang et al., 2016). The BC used in this study (pyrolyzed under 
high temperature ~700 oC ) is likely a π-donor due to a high content of graphitic carbon content 
(99.9%) (Liu et al., 2015b), which likely interact with electron withdrawing functional groups of 
target pharmaceuticals through π  ̶  π EDA interaction. The  ̶ OH functional groups on BC (Liu et 
al., 2015b) can serve as both H donors and acceptors which can interact with electronegative N 
and O bearing functional groups (H acceptors) through H bonding. The BC was likely negatively 
charged under pH 7.0 ̶ 9.5 (Mukherjee et al., 2011); positively charged pharmaceuticals can be 
adsorbed on negatively charged BC through electrostatic interaction. The potential removal 
mechanisms of target pharmaceuticals by ZVI and BC are summarized in Table 5.2.  
The hydrophobic interaction between target pharmaceuticals and BC can be affected by 
the pH of the treatment system and pKa and log Kow (Kow: octanol-water partition coefficient) of 
the pharmaceuticals. Log Kow is used to express the hydrophobicity of a compound. A compound 
is considered to be hydrophilic when its log Kow < 1, moderately hydrophobic (transphilic) when 
its 1 < log Kow < 3, and hydrophobic when its log Kow > 3 (Verliefde et al., 2008). The 
pharmaceuticals CBZ, MDA, MDMA, IBU, GEM, and NAP are moderately hydrophobic in 
their neutral forms (log Kow > 1). However, dissociation of these compounds (except for CBZ, a 
neutral compound) at pH=8.3 (average investigated pH) results in a decrease in hydrophobicity 
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compared to the neutral form. Log Dow (pH dependent log Kow) is used to express the relationship 
among log Kow, pH, and pKa, and was calculated using the following expression (Schwarzenbach 
et al., 2003).  
														 	 	 	 	 	 											For	organic	acids                  Equation 5.1  
	 	 	 	 	 											For	organic	bases																					Equation 5.2 
The calculated log Dow values of target pharmaceuticals (Table 5.2) indicate that all the target 
pharmaceuticals (except for CBZ, moderately hydrophobic with log Dow =2.25) were hydrophilic 
in this study; hydrophobic interaction between these hydrophilic pharmaceuticals and 
hydrophobic BC is expected to be limited.  
The eight target pharmaceuticals were divided into three groups (neutral pharmaceuticals, 
basic pharmaceuticals, and acidic pharmaceuticals) according to their acidic (deprotonated) / 
basic (protonated) character of functional groups in the investigated pH range (pH: 7.0 ̶ 9.5):  
5.4.2.2.1 Neutral Pharmaceutical CBZ 
CBZ is a basic compound due to the presence of –NH2 functional group in its structure. 
CBZ was primarily in its neutral form in the investigated pH range due to its low pKa value (pKa 
< pH, Figure 5.5). Shirazi et al. (2013) argue that reductive degradation of CBZ by ZVI and 
nanoscale ZVI is unlikely; however, König et al. (2016) report that CBZ can be reduced by ZVI 
through reductive catalytic hydrogenation (H2 was produced during anaerobic corrosion of ZVI 
by H2O) with nine hydrogenation products identified. In addition, the H bonding between  ̶ NH2 
(H donor and acceptor) and O (H acceptor) of =O functional groups in CBZ and  ̶ OH groups (H 
donor and acceptor) on the surface of ZVI likely contributes to the sorption of CBZ by ZVI.   
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Sorption of CBZ by BC likely occurs through hydrophobic interactions (between 
moderately hydrophobic CBZ, log Dow=2.25 and hydrophobic BC) (Inyang & Dickenson, 2015), 
π-π interaction (between the aromatic rings of CBZ and the graphene aromatic structure of BC), 
and H bonding (between  ̶ NH2 and =O in CBZ and  ̶ OH on BC). Effective stabilization of CBZ 
in contaminated soil and water has been reported using BC (Jung et al., 2013; Williams et al., 
2015). 
5.4.2.2.2 Basic (Cationic) Pharmaceuticals CAF, MDA, and MDMA 
CAF, MDA, and MDMA are basic compounds because the N bearing functional groups 
in these compounds are protonated in the investigated pH range and in their cationic forms (pH < 
pKa) (Table 5.2 and Figure 5.5). Electrostatic interactions between positively charged CAF, 
MDA, and MDMA and negatively charged ZVI and BC likely contribute to the removals of 
these compounds from water. In addition, the N, –NH–, –NH2, =O, and –O– functional groups 
(H donor or acceptor) in CAF, MDA, and MDMA likely interacted with  ̶ OH groups (H donor 
or acceptor) on the surfaces of ZVI and BC through H bonding (Table 5.2).  
Limited studies have reported the removal of CAF, MDA, and MDMA from water using 
ZVI and BC. Effective decolorization (92.6%) and total organic carbon removal (60.2%) of dark 
brown colored coffee effluent has been reported using ZVI, its core (ZVI)-shell structure (ion 
oxides and hydroxides) provides electrons for reducing coffee and sites for sorption and 
chemical complex formation (Tomizawa et al., 2016). Effective removal of MDMA (~30 ng L-1) 
to undetectable levels is achieved using a ZVI modified Fenton reaction (ZVI/H2O2/H2SO4) and 
ferrate (VI) (Mackuľak et al., 2016).  
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The sorption of CAF, MDA, and MDMA by BC was likely through π  ̶ π EDA interaction, 
electrostatic interaction, H bonding, and π  ̶  π stacking interaction (except for CAF). The π  ̶  π 
EDA interaction likely formed between the electron withdrawing N, –NH–, –NH2, =O, and –O– 
functional groups in CAF, MDA, and MDMA and the π-electron rich BC. The aromatic structure 
in MDA and MDMA also likely interacted with the graphene aromatic structure of BC through 
π  ̶  π stacking interaction (Table 5.2). Effective mitigation of CAF uptake in plants has been 
reported using a wood biochar (Hurtado et al., 2016). Sotelo et al. (2014) report the competitive 
adsorption of CAF and diclofenac by GAC with the sorption capacity of 190.9 mg g-1 for CAF 
and 233.9 mg g-1 for diclofenac; the relatively lower sorption capacity of CAF compared to 
diclofenac is  likely due to the relatively high water solubility, low molecular weight and low Kow 
value of CAF.  
5.4.2.2.3 Acidic (Anionic) Pharmaceuticals SMX, IBU, GEM, and NAP 
SMX is a zwitterion (with two pKas: 1.7 and 5.6) which contains both acidic ( ̶ NH ̶ ) and 
basic ( ̶ NH2) functional groups. Due to the presence of two strong electron withdrawing groups 
(heterocyclic ring and sulfonamide), the sulfonamide  ̶ NH ̶  group deprotonates at pH > 5.6. The 
aromatic amine –NH2 group protonates at pH < 1.7. SMX exists predominantly as an anionic 
species (negatively charged) at pH > 5.6, uncharged species (neutral) at pH between 1.7 and 5.6, 
and cationic species (positively charged) at pH < 1.7. IBU, GEM, and NAP are acidic 
compounds because carboxylic groups in IBU, GEM, and NAP are deprotonated at pH > their 
pKas (4.2 ̶ 4.5) (Figure 5.5). Therefore, SMX, IBU, GEM, and NAP were present as anionic 
(negatively charged) species in the pH range of this study (Table 5.2).  
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Removal of SMX, IBU, GEM, and NAP using ZVI alone has not been previously 
reported; however, rapid degradation of SMX has been reported within 0.5 h using a ZVI ̶ 
activated persulfate ̶ assisted mechanochemical method (a chemical oxidation process induced by 
mechanical forces, which accelerates the reaction due to enhanced mass transfer) (Liu et al., 
2016b). The reductive degradation of aqueous IBU (10 mg L-1) by ZVI nanoparticles alone has 
been reported by Machado et al. (2013) with removals of 54 ̶ 66% observed. Similar to this study, 
the degradation rates of IBU by ZVI greatly decrease with increased reaction time likely due to 
the passivation (oxidation) of the ZVI nanoparticles surface which limits the electron transfer 
from the core of the ZVI particles to its surface (Li et al., 2006). Effective removal of IBU by 
advanced oxidation processes using ZVI as a catalyst or activator has been reported by Ziylan 
and Ince (2015) and Rodriguez et al. (2016). In addition, the H bonding between  ̶ NH2,  ̶ NH ̶ , 
and N in heterocyclic ring of SMX, COOH group (H donor or acceptor) of IBU, GEM, and NAP 
and  ̶ OH groups (H donor or acceptor) on the ZVI surface also likely contributed to the removal 
of SMX, IBU, GEM, and NAP by ZVI.  
The sorption of SMX, IBU, GEM, and NAP by BC has been reported through mainly 
hydrophobic interactions (log Kow of these compounds ranged from 0.89 ̶ 4.3) and π  ̶  π EDA 
interaction (Jung et al., 2015a; Jung et al., 2013; Zheng et al., 2013). However, hydrophobic 
interactions between SMX, IBU, GEM, NAP and BC were likely limited due to the dissociation 
(deprotonation) of these compounds under the investigated pH. The dissociation of these 
compounds resulted in much lower hydrophobicity (lower log Dow values) (Table 5.2) compared 
to their neutral species. The π  ̶  π EDA interaction likely formed between electron withdrawing 
sulfonamide and heterocyclic ring groups in SMX, carboxyl groups in IBU, GEM, and NAP (π 
electron acceptors) and the π-electron rich BC (π electron donors). The π ̶ π stacking interaction 
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between the aromatic rings in SMX, IBU, GEM, and NAP molecule and graphene aromatic 
structure of BC likely enhanced the sorption of SMX, IBU, GEM, and NAP by BC.  In addition, 
H bonding and π-H bonding between the N, NH, or NH2 functional groups in SMX, =O and  ̶ 
OH in carboxyl groups of  IBU, GEM, NAP (H electron donor or acceptors) and  ̶ OH (H 
electron donor or acceptors), and aromatic π structure of BC also likely contributed to sorption of 
these compounds by BC.  
Effective sorption of SMX (0 ̶ 80 mg L-1) has been reported using BC (produced at 300 ̶ 
600 oC) with a sorption capacity of 1.9 ̶ 4.9 mg g-1 at pH=5. The competitive adsorption of IBU 
by BC has been observed in the presence of other adsorption competitors diclofenac and NAP, 
which causes a lower binding energy (Jung et al., 2015a). Jung et al. (2015b) demonstrate that 
about 97.7% of input NAP (10 μM) can be removed by 50 mg L-1 BC from an aqueous solution 
(pH 6.5). Powder activated carbon (PAC) is a similar carbonaceous sorbent to biochar; limited 
removals of IBU < 21%, NAP and GEM < 50% from the input concentration of 50 ̶ 80 ng L-1 by 
PAC were reported during a simulated drinking water treatment process following a 
conventional (coagulation plus chlorination) treatment system (Westerhoff et al., 2005). 
However, Margot et al. (2013) report more effective removals of NAP (78 ̶ 95% removed from 
input concentration of 0.5 ̶ 0.7 µg L-1) and IBU (38 ̶ 83% removed from input concentration of 
1.6 ̶ 6.6 µg L-1) from raw wastewater by PAC (10 ̶ 20 mg L-1).  
5.4.2.3 Removal Rates of Pharmaceutical Compounds within Columns 
The removal of pharmaceutical compounds within Columns ZVI, BC and (ZVI + BC) followed a 
first-order rate model (Figures 5.6 and 5.7) with R2 > 0.93. The removal rates were calculated 
using least-squares regression by dividing the data into two experimental stages. The removal 
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rates, first order removal rate constants (kobs, d
-1), mass normalized rate constants (kM, L g
-1 d-1), 
and surface area normalized rate constants (kSA, L m
-2 d-1) of target pharmaceuticals are 
summarized in Appendix D (Tables D.1 ̶ D.8). KM and KSA were calculated following the 
expressions (Johnson et al., 1996): 
                                                    KM = Kobs/ρm                                                            Equation 5.3  
                                                    KSA = Kobs/ρa = KM/as                                              Equation 5.4  
Where ρm is the mass concentrations of reactive media (g L
-1 of solution); ρa is the surface area 
concentrations of reactive media (m2 L-1 of solution); and as is the specific surface area of 
reactive media (m2 g-1). Specific surface areas of ZVI, BC, and (ZVI + BC) used in the 
experiments are 9.5, 64.5, and 33.6 m2 g-1 (Jamieson-Hanes, 2012; Liu, 2016).  
Overall, the pharmaceuticals were removed more rapidly in Columns ZVI and (ZVI + BC) 
than Column BC. The removal rates of pharmaceuticals within the treatment columns decreased 
by 67  ̶  99% over the experimental period. Decreases in the removal rates of pharmaceuticals by 
ZVI may be related to a declining reactivity of ZVI due to accumulation of secondary 
precipitates on the ZVI surfaces, such has been described for treatment of trichloroethylene (TCE) 
by ZVI (Jeen et al., 2006; Jeen et al., 2007). Decreasing removals of pharmaceuticals by BC may 
be due to in-filling of pores and decreasing sorption sites over time. The removal rates of 
pharmaceuticals within Columns ZVI and (ZVI+BC) followed the order: SMX > MDMA > 
MDA > CAF > CBZ > GEM > NAP > IBU (SMX > cationic compounds > neutral compound > 
anionic compounds or N functional group bearing compounds > carboxylic functional group 
bearing compounds). The removal rates of pharmaceuticals within Column BC followed the 
order: MDMA > MDA > CAF > CBZ > NAP > GEM > SMX > IBU (cationic compounds > 
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neutral compound > anionic compounds) (Appendix D, Tables D.1 ̶ D.8).  Overall, removal rates 
of cationic pharmaceuticals (positively charged) were greater than neutral and anionic 
pharmaceuticals within each treatment column independent of the hydrophobicity (log Dow), 
number of aromatic rings and number of H acceptors and donors of the compounds. CBZ is the 
most hydrophobic (high log Dow value) pharmaceutical in this study, but its removal rate was 
lower than for the cationic pharmaceuticals (MDMA, MDA, and CAF). Electrostatic interactions 
were likely more important than other removal mechanisms such as hydrophobic interactions 
(log Dow), π  ̶  π EDA and stacking interactions, and H bonding in removal of target 
pharmaceuticals.  
5.4.3 Removal of Artificial Sweeteners in Columns  
5.4.3.1 Removal of Artificial Sweeteners from Column Effluent  
Artificial sweeteners acesulfame-K (ACE-K), cyclamate (CYC), saccharin (SAC) and sucralose 
(SCL) (input concentration: 90 ̶ 120 µg L-1) were not removed in Column Control. ACE-K and 
SAC were partially removed by the three treatment columns. Artificial sweetener CYC was not 
removed in any treatment column throughout the experiment. More than 76% of input SCL was 
removed in the three treatment columns (Figure 5.8).  
A small fraction of input ACE-K (~100 µg L-1) was removed in Columns ZVI and (ZVI 
+ BC). The effluent ACE-K concentration was maintained at ~75 µg L-1 (~27% removed) in 
Column ZVI and ~85 µg L-1 (~14% removed) in Column (ZVI + BC) in the first stage of the 
experiment. The removals of ACE-K in Columns ZVI and (ZVI + BC) were enhanced by the 
decrease in flow rate from 0.3 to 0.1 PV d-1. The concentrations of ACE in the effluents of 
Columns ZVI and (ZVI + BC) decreased to ~40 and ~75 µg L-1. The removals increased to 61% 
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and 31% as the experiment proceeded to the second stage. No removal of ACE-K was observed 
in Column BC (Figure 5.8). Similarly, poor removal (~10%) of ACE-K is reported using PAC 
filtration (Mailler et al., 2015; Scheurer et al., 2010). CYC was not removed in this study (Figure 
5.8). Similarly, poor removal of CYC is observed using GAC; CYC is minimally retarded in a 
GAC filter with 80% breakthrough after 3 d (Scheurer et al., 2010). 
Partial removal of SAC was observed in the columns containing BC, but not Column ZVI. 
The removal of SAC in Column BC was slightly enhanced with the decrease in flow rate; 
however, the removal of SAC in Column (ZVI + BC) was not affected by the decreasing flow 
rate. The concentration of SAC in the Column BC effluent gradually increased from 1.1 µg L-1 at 
6 PV to 85.5 µg L-1 at 56 PV in the first stage of the experiment, then slightly decreased to 70.3 
µg L-1 at 65 PV in the second stage of the experiment when the flow rate was decreased. The 
concentration of SAC in the Column (ZVI + BC) effluent increased from 7.3 µg L-1 at 6 PV to 
87.3 µg L-1 at 38 PV in the first stage of the experiment, and consistent effluent concentrations of 
SAC were maintained during the remainder of the first stage of the experiment and the second 
stage of the experiment (Figure 5.8).  
More than 88%, 85%, and 76% of input SCL (~110 µg L-1) were removed in Column 
ZVI, Column BC, and Column (ZVI + BC). The concentrations of SCL in Column ZVI effluent 
increased from 2.6 µg L-1 at 11 PV to 9.3 µg L-1 at 50 PV in the first stage of the experiment, and 
then increased to 13.1 µg L-1 at 58 PV in the second stage of the experiment. The removal of 
SCL in Column ZVI was not affected by the decrease in flow rate from 0.3 to 0.1 PV d-1; 
however, the removal of SCL in Columns BC and (ZVI + BC) was slightly enhanced with the 
decreasing flow rate. The concentration of SCL in the effluents of Columns BC and (ZVI + BC) 
increased from 7.4 and 0.9 µg L-1 at 10 PV to 17.2 and 28.4 µg L-1 at 53 PV in the first stage of 
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the experiment, then slightly decreased to 12.8 and 24.3 µg L-1 at 63 PV in the second stage of 
the experiment (Figure 5.8).  
5.4.3.2 Potential Removal Mechanisms of Artificial Sweeteners by ZVI and BC  
Four artificial sweeteners were divided into two groups (acidic and neutral artificial sweeteners) 
according to their acidic (deprotonated) / basic (protonated) character of functional groups in the 
investigated pH range (pH: 7.0 ̶ 9.5). The potential removal mechanisms of artificial sweeteners 
by ZVI and BC are summarized in Table 5.3.   
5.4.3.2.1 Anionic Artificial Sweeteners ACE-K, CYC, and SAC  
ACE-K, CYC, and SAC were anionic (negatively charged) in the investigated pH range 
(7.0 ̶ 9.5) due to dissociation of these compounds at pH > pKas (pKas of ACE-K, CYC, and SAC: 
1.7 ̶ 2.0, Table 5.3 and Figure 5.5). The removal of ACE-K by ZVI has not been previously 
reported. The removal of ACE-K (30 ̶ 60%) by ZVI was likely due to reduction by ZVI and H 
bonding between =O and N bearing groups (H acceptors) of ACE-K and  ̶ OH groups (H donors) 
on the surface of ZVI.  
The sorption of SAC by BC was likely through π  ̶  π stacking interaction between the 
aromatic ring in SAC and graphene aromatic structure of BC. ACE-K, CYC, and SAC are 
hydrophilic compounds due to their very low negative log Dow values (calculated following 
Equation 5.1 and listed in Table 5.3); hydrophobic interactions between these artificial 
sweeteners and BC were likely limited. The π  ̶  π EDA interaction between electron withdrawing 
sulfonamide and carbonyl functional groups (π electron acceptors) in SAC and the π-electron 
rich BC (π electron donors) also likely contributed to the sorption of SAC by BC (Inyang & 
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Dickenson, 2015). In addition, the H bonding between the =O and N bearing groups (H acceptors) 
in SAC molecule and the ̶ OH (H donors) of BC could also contribute to sorption of SAC by BC. 
Similarly, Seo et al. (2016) report that the H bonding between the –NH2 group (H donor) on 
modified sorbent and =O (H acceptor) in SAC molecule contributes to the adsorption removal of 
SAC by urea modified metal-organic frameworks. As a similar carbonaceous sorbent to BC, 
GAC has been used to removed SAC from contaminated water with similar removals (47 ̶ 90%) 
compared to BC (Mailler et al., 2015; Scheurer et al., 2010).  
5.4.3.2.2 Neutral Artificial Sweeteners SCL  
Artificial sweetener SCL mainly exists in its neutral form at pH (7.0 ̶ 9.5) < its pKa (11.8) 
(Figure 5.5) in this study (Lange et al., 2012). The removal of SCL by ZVI was likely through 
the dechlorination of the chlorine atom in SCL molecule (Table 5.3) by ZVI. Reductive 
dehalogenation is a surface reaction involving three potential pathways: (1) direct electron 
transfer from Fe0 surface; (2) reduction by Fe2+ produced from Fe0 corrosion; and (3) reduction 
by H2 formed by H2O corrosion (Matheson & Tratnyek, 1994).  In addition, the H bonding 
between  ̶ OH groups (H donors and acceptors) of SCL and  ̶ OH groups (H donors and acceptors) 
on the surface of ZVI also likely contributed to removal of SCL by ZVI.   
The sorption of SCL by BC was likely through H bonding. Sucralose contains hydroxyl 
groups ( ̶ OH, H donor or acceptor) which might be attracted to the quinone groups (  ̶ CO  ̶  ,  H 
acceptor)  and hydroxyl groups (̶ OH, H donor and acceptor) in  BC through H bonding. Similar 
to ACE-K, CYC, and SAC, hydrophobic interaction between SCL and BC was likely limited due 
to its low log Dow (calculated following Equation 5.1 and listed in Table 5.3). In addition, the 
electrostatic interaction between neutral SCL and negatively charged BC (Mukherjee et al., 2011) 
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was likely limited. Compared to the removal of SCL (85 ̶ 99%) by BC in this study, greater 
removal (> 99%) of SCL by AC has been demonstrated by Minten et al. (2011); in addition, SCL 
is removed more efficiently by AC filtration than ozonation, advanced oxidation, and membrane 
bioreactors. 
5.4.3.3 Removal Rates of Artificial Sweeteners within Columns 
The removal rates of artificial sweeteners were calculated using least-squares regression for the 
two experimental stages. The removal of artificial sweeteners followed the first-order or zero-
order rate models or followed the first-order rate in the early stage of the experiment followed by 
zero-order rate in the late stage of the experiment (Figure 5.9). The first-order and zero-order 
removal rates, removal rate constants (kobs, d
-1 for first-order; µmol or µg contaminant L-1 d-1 for 
zero-order), mass normalized rate constants (kM, L g
-1 d-1 for first-order; µmol or µg contaminant 
d-1 g -1 for zero-order), and surface area normalized rate constants (kSA, L m
-2 d-1 for first-order; 
µmol or µg contaminant d-1 m-2 for zero-order) were calculated using Equations 5.3 and 5.4 and 
listed in Appendix D (Tables D.9 ̶ D.12).  
ACE-K was removed more rapidly within Column ZVI (first-order model) than Column 
(ZVI + BC) (zero-order removal model) (Figure 5.9 and Table D.9). The average removal rate of 
ACE by ZVI in this study was much greater than observed by direct photolysis of ACE-K at pH 
of 4 in deionized water with a rate constant of 0.036 d-1 (Gan et al., 2014). The half-life of ACE-
K within Column (ZVI + BC) during the first stage of the experiment was similar to the half-life 
(9 d) observed in surface water during summer (Gan et al., 2014).  
Removal rate of SAC within three treatment columns followed the order: Column BC > 
Column (ZVI + BC) > Column ZVI (Figure 5.9 and Table D.11). Removal rate of SCL within 
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three treatment columns followed:  Column ZVI > Column (ZVI + BC) > Column BC (before 
13PV) and followed: Column BC = Column (ZVI + BC) > Column ZVI (after 13PV) (Figure 5.9 
and Table D.12). This decrease in the removal rates of SCL by ZVI through dechlorination 
(discussed in section 5.4.3.2) is likely due to the declining reactivity of ZVI resulting from the 
formation of secondary precipitates on the ZVI surfaces. The input solution used in this study 
contained CaCO3 which likely accelerated the formation of secondary precipitates resulting in 
further declining reactivity of ZVI. Similar decreasing removal rates of TCE by ZVI through 
dechlorination has been reported (Jeen et al., 2006; Jeen et al., 2007). The removal rates of ACE-
K, SAC and SCL within treatment columns were lower than the rates observed using advanced 
oxidation technologies (Sharma et al., 2014; Toth et al., 2012).  
Overall, adding ZVI to BC did not enhance the removals of artificial sweeteners ACE-K, 
CYC, SAC, and SCL in Column (ZVI + BC); artificial sweeteners are less effectively removed 
in Column (ZVI + BC) than either Column ZVI or Column BC. The removal rate of four 
artificial sweeteners followed: SCL > ACE-K > SAC > CYC (no removal) within Column ZVI 
and SCL > SAC > ACE-K and CYC (no removals) within the column containing BC.  
5.4.4 Removal of PFOA and PFOS in Columns  
5.4.4.1 Removal of PFOA and PFOS from Column Effluent 
Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) were persistent and 
not removed in the Column Control. More than 89% of input PFOA (~45 µg L-1) was removed 
in Columns ZVI, BC and (ZVI + BC) at the early first stage of the experiment (< 10 PV), the 
removal efficiency of PFOA in three treatment columns greatly decreased during the remainder 
of the experiment. About 49 ̶ 98% of input PFOS (24.0 ̶ 89.6 µg L-1) was removed in the 
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columns containing BC over the experimental period, less was removed in Column ZVI (Figure 
5.10).   
The concentration of PFOA in the Column ZVI effluent was < 0.5 µg L-1 before 10 PV 
with removal of 99%; then rapidly jumped to 28.1 µg L-1 at 11 PV and continued to increase to 
51.4 µg L-1 (which was 10   ̶ 25 % higher than the input PFOA) at 18 PV until the end of the first 
stage of the experiment, the concentration of PFOA gradually decreased to the influent PFOA 
level during the second stage of the experiment. Partial removal of PFOA was observed in 
Column BC. The concentration of PFOA in the Column BC effluent was < 5 µg L-1 before 10 
PV with removal of > 89%, and then gradually increased to 39.3 µg L-1 at the end of the first 
stage of the experiment with removal of 13%. The removal of PFOA in Column BC was 
enhanced as a result of a decrease in flow rate. The concentration of PFOA in the effluent of 
Column BC slightly decreased from 39.3 at 53 PV to 34.3 µg L-1 at 65 PV at the beginning of the 
second stage of the experiment when the flow rate was first lowered; however, PFOA then 
rapidly broke through Column BC with the concentration of 50.7 µg L-1 at 69 PV at the end of 
the second stage of the experiment (Figure 5.10).  
Limited removal of PFOA was observed in Column (ZVI + BC). More than 97% of input 
PFOA was removed in Column (ZVI + BC) from the average input concentration of 44.6 µg L-1 
to 1.58 µg L-1 within the first 6 PV in the first stage of the experiment; however, the 
concentration of PFOA in the Column (ZVI + BC) effluent rapidly increased to 44.7 µg L-1 after 
25 PV and continued to increase until concentrations reached 55.4 µg L-1 at 55 PV in the first 
stage of the experiment. Like in Column BC, the removal of PFOA in Column (ZVI + BC) was 
slightly enhanced when the flow rate was decreased. The concentration of PFOA in the effluent 
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of Column (ZVI + BC) slightly decreased from 55.4 µg L-1 to the average influent PFOA value 
(45 µg L-1) during the second stage of the experiment (Figure 5.10).  
More than 81% of input PFOS (24.0 ̶ 82.6 µg L-1) was removed in Column ZVI before 37 
PV during the first stage of the experiment; however, as the average input PFOS concentration 
increased from 47.5 µg L-1 at 34 PV to 82.9 µg L-1 at 50 PV, the concentration of PFOS in 
Column ZVI effluent rapidly increased from 2.23 µg L-1 to 51.2 µg L-1 with removals of 25 ̶ 46% 
during the first stage of the experiment. The concentration of PFOS in Column ZVI effluent 
followed the same changing trend with the influent PFOS with relatively smaller removals of 11 ̶ 
49% during the second stage of the experiment (Figure 5.10).   
More than 82% of input PFOS (varied from 24.0 to 89.6 µg L-1) was removed in Column 
BC throughout the experiment with the effluent concentrations < 8.6 µg L-1 and removal of up to 
99%, except for 13 ̶ 21 PV with removals of 63 ̶ 94%. Relatively less removal of PFOS was 
observed in Column (ZVI + BC) compared to Column BC. Similarly, low concentrations of 
PFOS (< 6.07 µg L-1) were observed in the Column (ZVI + BC) effluent before 41 PV with 
removal > 88%, except for 15 ̶ 22 PV with the smaller removals of 57 ̶ 95%. As the average input 
PFOS concentration increased from 49.0 to 84.7 µg L-1 at ~40 PV, the effluent PFOS 
concentration in Column (ZVI + BC) then increased from 6.07 µg L-1 at 41 PV to 19.2 µg L-1 at 
45 PV and maintained consistent at ~20 µg L-1 with the relatively smaller removals of 56 ̶ 79% 
(Figure 5.10). Overall, PFOA (up to 89%) and PFOS (up to 99%) were removed more effectively 
by high carbon content (99%) BC in this study compared to a previously reported study; 
Kupryianchyk et al. (2016) report little or no removal of PFOA and PFOS from top 20 cm soils 
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of a fire fighting training sites contaminated with PFASs attributed to the low C content (19 ̶ 
53%) biochars.   
5.4.4.2 Potential Removal Mechanisms of PFOA and PFOS by ZVI and BC 
PFOA and PFOS are acidic compounds which deprotonate and exist primarily in their anionic 
forms (negatively charged) at the investigated pH range (pH: 7.0 ̶ 9.5 > pKas; Table 5.4 and 
Figure 5.5). Removal of PFOA and PFOS by ZVI during the early stage (before 18 PV) of the 
experiment was likely due to electrostatic interactions, and H bonding and ion-dipole interactions; 
however, electrostatic interactions were likely limited after 18 PV through Column ZVI. The pH 
of pore water in Column ZVI ranged from 7.1 to 8.2 before 18 PV (Figure 5.2); the oxides and 
hydroxides were likely positively charged at pH < 8.3 (Parks, 1965), which may have promoted 
sorption of negatively charged PFOA and PFOS through electrostatic interactions. Similarly, the 
sorption of PFOA and PFOS by ZVI oxidation products (iron oxides and hydroxides) in a low 
pH (3.0 ̶ 6.0) aqueous solution has been reported through electrostatic interactions (Gao & 
Chorover, 2012). However, the pH of pore water in Column ZVI > 8.3 after 18 PV (Figure 5.2) 
resulted in negatively charged iron hydroxides, leading to a reduction in electrostatic interactions 
between negatively charged PFOA, PFOS, and the iron hydroxide surface. This pH induced 
decrease of electrostatic interaction possibly resulted in the desorption of PFOA from ZVI, 
accounting for the higher concentration of PFOA (10 ̶ 25 %) in the Column ZVI effluent 
compared to the influent PFOA (18  ̶ 50 PV) (Figure 5.10).  
 The H bonding between PFOA/PFOS and ZVI were likely formed between the   ̶ OH 
groups (H donors) on iron hydroxide surfaces and the carboxylic ( ̶ COO-, 2O as 2H acceptors) 
and sulfonic ( ̶ SO3
-, 3O as 3H acceptors) groups of PFOA and PFOS. The H bonding between 
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PFOS (3H acceptors) and ZVI was likely greater than between PFOA (2H acceptors) and ZVI; 
this may account for the greater removal of PFOS by ZVI than PFOA. The anionic PFOA and 
PFOS molecules can also develop ion-dipole interactions with the polar  ̶ OH functional groups 
(dipole) on the ZVI surface (Punyapalakul et al., 2013). In addition, the formation of Fe-
carboxylate complexes from the ferric Fe hydroxide on the surface of ZVI and the carboxylic 
group in PFOA may also contribute to sorption of PFOA by ZVI  (Gao & Chorover, 2012).  
Fluoride, the indicative by-product of defluorination, was not observed in the treated 
effluent of any column in this study likely due to either lack of defluorination reactions, 
analytical limitations, or the removal of F- by the reactive media. The sorption of F- by iron 
hydroxide (Sujana et al., 2009) and biochars (Guan et al., 2015) has been reported previously. In 
addition, Ca2+ in the simulated groundwater used in this study may have reacted with F- to form 
CaF2 precipitates which can also remove F
- from the column effluent and pore water. Therefore, 
reductive defluorination of PFOA and PFOS by ZVI cannot be confirmed in this study.  
However, the reductive defluorination of PFOA and PFOS is demonstrated by Arvaniti et al. 
(2015) using Mg-aminoclay modified nanoscale ZVI. Effective reductive defluorination of 
PFOA has been reported using photo-generated hydrated electrons (a powerful reductant, Eo = ̶ 
2.9 V) to initiate the cleavage of α-position C-F bond (Park et al., 2009; Song et al., 2013).  
Removal of PFOA and PFOS by BC was likely through hydrophobic interactions 
between the hydrophobic perfluoroalkyl tail and hydrophobic surface of BC (Du et al., 2014), 
which is consistent with high log Dow values in Table 5.4. In addition, H bonding, ion-dipole 
interactions may also contribute to the removal of PFOA and PFOS by BC. Greater removals of 
PFOS by BC compared to PFOA are attributed to the stronger hydrophobic interaction between 
PFOS and BC. Both PFOA and PFOS have the same carbon chain length (C8); however, PFOS 
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contains two additional C-F bonds compared to PFOA, which leads to stronger hydrophobicity 
of PFOS than PFOA (Higgins & Luthy, 2006). Similarly, H bonding between the  ̶ OH groups (H 
donors) in BC and the  ̶ SO3
- group (3H acceptors) in PFOS was likely greater than the H 
bonding between the  ̶ OH groups in BC and the  ̶COO- group (2H acceptors) in PFOA. This 
stronger H bonding between BC and PFOS may have contributed to the stronger sorption of 
PFOS by BC compared to PFOA (Gao & Chorover, 2012). A relatively weak ion-dipole 
interaction between the  ̶ OH dipole groups in BC and anionic PFOA and PFOS molecules can 
also contribute to the sorption of PFOA and PFOS to BC (Du et al., 2014; Karoyo & Wilson, 
2013). In addition, the Ca2+ present in simulated groundwater in this study has been reported to 
enhance the sorption of PFOA and PFOS to adsorbents due to the formation of a cation bridge 
between Ca2+ and negatively charged carboxyl and sulfonate groups (Wang & Shih, 2011). The 
electrostatic interaction between negatively charged PFOA and PFOS and negatively charged 
ZVI and BC (discussed in section 5.4.2.2) was likely limited at pH of 7 ̶ 9.5 in this study.  
 5.4.4.3 Removal Rates of PFOA and PFOS within Columns  
The removal rates of PFOA and PFOS were calculated using least-squares regression for the two 
experimental stages. The removal of PFOA and PFOS followed the first-order or zero-order rate 
models or followed the first-order rate in the early stage of the experiment followed by zero-
order rate in the late stage of the experiment (Figure 5.11). The removal rates, removal rate 
constants (kobs), mass normalized rate constants (kM), and surface area normalized rate constants 




The removal rate of PFOA followed: Column BC > Column (ZVI + BC) > Column ZVI 
(Figure 5.11 and Table D.13). The removal rate of PFOS: Column (ZVI + BC) > Column BC > 
Column ZVI during the first stage of the experiment and Column BC > Column (ZVI + BC) > 
Column ZVI during the second stage of the experiment (Figure 5.11 and Table D.14). Overall, 
PFOA and PFOS were removed more rapidly within the columns containing BC than Column 
ZVI.  
The decreasing removal rates of PFOA and PFOS by BC were likely due to the 
competitive sorption between PFASs and other organic contaminants pharmaceuticals and 
artificial sweeteners, which has been reported previously (Yu et al., 2012). In addition, Du et al. 
(2014) demonstrate that the adsorbed negatively charged PFAS molecules on the sorbents 
produce a repulsive force to prevent further adsorption of negatively charged PFASs. This 
repulsive interaction on the surface of BC also likely decreased the sorption efficiency of PFOA 
and PFOS by BC over time. The removal rates of PFOA and PFOS by ZVI and BC were slower 
than rates reported using the iron containing material hematite (Gao & Chorover, 2012) and 
carbonaceous sorbent GAC (Zhang et al., 2016).  
5.5 Conclusions 
Simultaneous removal of emerging contaminants pharmaceutical compounds (CBZ, CAF, 
MDA, MDMA, SMX, IBU, GEM, and NAP with removals > 97%), artificial sweeteners (ACE-
K, SAC, and SCL with partial removals), and perfluoroalkyl substances (PFOA and PFOS with 
partial removals) was observed in a passive treatment system (four columns) containing reactive 
media zero-valent iron (ZVI), biochar (BC), and a mixture of (ZVI + BC). No obvious signs of 
clogging or decrease in flow rates were observed over the course of the experiment. Eight 
152 
 
pharmaceuticals were more rapidly and completely removed in the columns containing ZVI than 
Column BC. In general, removal rates of pharmaceuticals within three treatment columns 
followed: SMX (in Column ZVI but not in the columns containing BC) > cationic (positively 
charged) compounds (MDMA, MDA, and CAF) > neutral compound (CBZ) > anionic 
(negatively charged) compounds (NAP, GEM, and IBU). The removal rates of artificial 
sweeteners within treatment columns followed: SCL > ACE-K and SAC > CYC (no removal). 
Unlike pharmaceuticals, greater and relatively more rapid removals of PFOA and PFOS were 
observed in the columns containing BC than Column ZVI; PFOS was more effectively removed 
than PFOA. Overall, target pharmaceuticals, artificial sweeteners (except for CYC with no 
removal), and perfluoroalkyl substances were more considerably removed using the combination 
of (ZVI + BC) than either ZVI alone or BC alone. These results suggest that the reactive mixture 
(ZVI + BC) has the potential to be an effective combination for use in large-scale field 
applications such as in-situ reactors and permeable reactive barriers (PRBs) for remediation of 
emerging contaminants. These materials are relatively low cost and when combined show 
considerable reactivity for ubiquitous trace organic emerging contaminants present in wastewater. 
However, more extensive study is required when the reactive mixture is applied to remove 
emerging contaminants from different wastewater streams; as the complex matrix of the 




Table 5.1 Physical characteristics of the columns used in this study, including a control and 
columns containing zero-valent Fe (ZVI), organic C (BC), and both. 
 
Column 1   
Control 




Column 4  
(ZVI + BC) 
Bulk density, g cm-3 1.77 2.39 1.18 1.46 
Porosity 0.39 0.32 0.59 0.40 





Table 5.2 Selected properties of target pharmaceuticals and potential interaction (removal mechanisms) between target 
pharmaceutical compounds and reactive media. N: Neutral; (+): Positive charged; ( ̶): Negative charged.  
Contaminant Reactive Media 
Potential interaction between 
contaminant and reactive 
media 
CAS#, therapeutic use, pKa, 
log Kow, log Dow, character 










pKa= -0.49a,  
log Kow=2.25, 
log Dow=2.25,  
Base (N),  
N
O NH2  




̶ NH2,  ̶ C=O ̶ OH on surface of ZVI H bonding 






̶ NH2,  ̶ C=O ̶ OH H bonding 
C=C bonds, 
aromatic structure, 






Catalytic hydrogenation1 , 
hydrophobic interaction2, π-π 
interaction, H bonding 
      




log Kow= -0.07, 















Core ZVI-shell structure 
(iron oxides and 
hydroxides) 
Reduction and adsorption3 
N, =O Electrostatic interaction 
+ charged ̶  charged H bonding 
N, =O Column 3/ 
BC 
̶ OH, graphene aromatic 
structure 
H bonding, 
π-π EDA interaction 




Core ZVI-shell structure 
(iron oxides and 
hydroxides),  ̶ OH 
Reduction and adsorption3, 





Table 5.2 Continued. 
Contaminant Reactive Media 
Potential interaction between 
contaminant and reactive media 
CAS#, therapeutic use, pKa, 
log Kow, log Dow, character 












pKa= 9.7,              
log Kow=1.64, 







̶ NH2, O Column 2/ 
ZVI 
̶ OH on surface of 
ZVI 
Electrostatic interaction  







̶ NH2, O 
̶ OH, graphene 
aromatic structure 
π-π EDA interaction, π-H bonding, 
H bonding, 
+ charged  ̶  charged  Electrostatic interaction 




̶ OH, graphene 
aromatic structure 
Electrostatic interaction, π-π 
stacking, π-π EDA interaction, π-H 
bonding, H bonding 




Ecstasy,   
pKa=9.9,  
log Kow=2.28,  








̶ NH ̶ , O Column 2/ 
ZVI 
̶ OH on surface of 
ZVI 
Electrostatic interaction  






π-π stacking  
̶̶ NH ̶ , O 
̶ OH, graphene 
aromatic structure
H bonding, π-π EDA interaction, π-
H bonding 
+ charged ̶  charged  Electrostatic interaction 




̶ OH, graphene 
aromatic structure 
Electrostatic interaction, π-π 
stacking, π-π EDA interaction, π-H 
bonding, H bonding 
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Table 5.2 Continued. 
Contaminant Reactive Media 
Potential interaction between 
contaminant and reactive 
media 
CAS#, therapeutic use, pKa, 
log Kow, log Dow, character 
(charge), and structure 
Reactive functional group 
Column/ 
Reactive  media 
Reactive functional 






log Kow=0.89,  
log Dow= -1.81,  





















π-π stacking  
̶ NH2, sulfonamide group,  
N-heterocyclic ring 
̶ OH, graphene 
aromatic structure 
H bonding, 
π-π EDA interaction4, 
π-H bonding 





̶ OH, graphene 
aromatic structure 
H bonding, π-π stacking, π-π 
EDA interaction, π-H 
bonding 
     
Ibuprofen 
(IBU) (15687-27-1), 
Anti-inflammatory drug,  
pKa=4.5,  
log Kow=3.5,  
log Dow= -0.3,  











̶ OH on surface of 
ZVI 
H bonding 








̶ OH, graphene 
aromatic structure 
H bonding, π-π EDA 
interaction6, π-H bonding 
Aromatic structure,  
 ̶ ̶ COOH 
Column 4/ 
(ZVI +BC) 
̶ OH, graphene 
aromatic structure 
Reduction, H bonding, π-π 
stacking, π-π EDA 




Table 5.2 Continued. 
Contaminant Reactive Media 
Potential interaction between 
contaminant and reactive media 
CAS#, therapeutic use, pKa, 
log Kow, log Dow, character 











log Kow=4.3,  
log Dow= 0.8,  











̶ OH on surface of ZVI H bonding 
Xylene aromatic 




π-π stacking  
̶ COOH 
̶ OH, graphene aromatic 
structure 






̶ OH, graphene aromatic 
structure 
H bonding, π-π stacking, π-π 
EDA interaction, π-H bonding 
     
Naproxen 
(NAP) (22204-53-1), 
 Anti-inflammatory drug, 
pKa=4.2,  
log Kow=2.8,  
log Dow= -1.3,  



















̶ OH, graphene aromatic 
structure 
H bonding, π-π EDA interaction 
and high Van der Waals forces7, 
π-H bonding 
Naphthalene 
aromatic structure,  
 ̶ ̶ COOH 
Column 4/ 
(ZVI +BC) 
̶ OH, graphene aromatic 
structure 
H bonding, π-π stacking, π-π 
EDA interaction, π-H bonding 
References: a From Schaffer et al. (2012). b From Martínez-Hernández et al. (2014).1. König et al. (2016); 2. Inyang and Dickenson 
(2015); 3. Tomizawa et al. (2016); 4. Zheng et al. (2013); 5. Machado et al. (2013); 6. (Jung et al. (2013)); 7. Jung et al. (2015a). 
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Table 5.3  Selected properties of target artificial sweeteners and potential interaction (removal mechanisms) between target artificial 
sweeteners and reactive media. N: Neutral; (+): Positive charged; ( ̶): Negative charged. 
Contaminant Reactive Media 
Potential interaction 
between contaminant and 
reactive media 
CAS#, pKa, log Kow, log Dow, 











log Kow= -1.33, 
log Dow= -1.33, 











 =O, N 
Column 2/ 
ZVI 
̶ OH on surface of ZVI 
H bonding 








̶ OH H bonding 




log Kow= -2.63,  
log Dow= -2.63, 
























Table 5.3 Continued. 
Contaminant Reactive Media 
Potential interaction 
between contaminant and 
reactive media 
CAS#, pKa, log Kow, log 











log Kow=0.91,  
log Dow= -5.39, 








̶ ̶ ̶ ̶ Not removed 
Aromatic structure,  




Graphene aromatic structure 
π-π stacking, 
π-π EDA interaction  
Aromatic structure,  
sulfonamide group,  
C=O group  
Column 4/ 
(ZVI +BC) 
Graphene aromatic structure 
π-π stacking, 
π-π EDA interaction 




log Kow= -1.0,  













̶ Cl Column 2/ 
ZVI 
ZVI Dechlorination 




̶ OH H bonding 
̶ Cl,  ̶ OH 
Column 4/ 
(ZVI +BC) 





Table 5.4 Selected properties of target perfluoroalkyl substances and potential interaction (removal mechanisms) between target 
perfluoroalkyl substances and reactive media. N: Neutral; (+): Positive charged; ( ̶): Negative charged. 
Contaminant Reactive Media 
Potential interaction between 
contaminant and reactive 
media 
CAS#, pKa, log Kow, 




















̶ OH on surface of ZVI 
H bonding, ion-dipole 
interaction 
CF3(CF2)6 ̶ Column 3/ 
BC 
Hydrophobicity Hydrophobic interaction 
̶ COOH 
̶ OH, graphene aromatic 
structure 






̶̶ OH, hydrophobicity, 
graphene aromatic structure 
H bonding, hydrophobic 
interaction, ion ̶ dipole 
interaction 














̶ OH on surface of ZVI 
H bonding, ion-dipole 
interaction 
CF3(CF2)7 ̶ Column 3/ 
BC 
Hydrophobicity Hydrophobic interaction 
̶ SOOH 
OH, graphene aromatic 
structure 






̶ OH, hydrophobicity, 
graphene aromatic structure 
H bonding, hydrophobic 
interaction, ion ̶ dipole 
interaction 




Figure 5.1 Values of pH, Eh, and concentrations of alkalinity as a function of distance along 
flow direction within control column and columns containing zero-valent Fe (ZVI), biochar (BC), 
and both.  Blue circle, orange square, and green triangle symbols represent data collected during 
the first stage of the experiment (flow rate = 0.3 PV/d), while grey diamond symbols represent 
data collected during the second stage of the experiment (flow rate = 0.1 PV/d), given in terms of 
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Figure 5.2 Values of pH, Eh, and concentrations of alkalinity as a function of pore volumes (PV) 
in effluent from control column and columns containing zero-valent Fe (ZVI), biochar (BC), and 
both; dash lines indicate a decrease in flow rate in each column, dividing the experiment into two 
stages.  
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Figure 5.3 Concentrations of neutral pharmaceutical carbamazepine (CBZ) and basic 
pharmaceuticals caffeine (CAF), 3,4-methylenedioxyamphetamine (MDA), and 3,4-
methylenedioxymethamphetamine (MDMA) as a function of pore volumes (PV) in effluent from 
control column and columns containing zero-valent Fe (ZVI), biochar (BC), and both; dash lines 
indicate a decrease in flow rate in each column, dividing the experiment into two stages. 
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Figure 5.4 Concentrations of acidic pharmaceuticals sulfamethoxazole (SMX), ibuprofen (IBU), 
gemfibrozil (GEM), and naproxen (NAP) as a function of pore volumes (PV) in effluent from 
control column and columns containing zero-valent Fe (ZVI), biochar (BC), and both; dash lines 
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Figure 5.5 pKa values of target contaminants plotted on the pH scale. The pH range in Column 
ZVI is between 7.5 ̶ 9.5; the pH range in Column BC is between 7.0 ̶ 8.3; the pH range in 
































Figure 5.6 Concentrations of neutral pharmaceutical carbamazepine (CBZ) and basic 
pharmaceuticals caffeine (CAF), 3,4-methylenedioxyamphetamine (MDA), and 3,4-
methylenedioxymethamphetamine (MDMA) as a function of distance along flow direction 
within control column and columns containing zero-valent Fe (ZVI), biochar (BC), and both.  
Blue circle, orange square, and green triangle symbols represent data collected during the first 
stage of the experiment (flow rate = 0.3 PV/d), while grey diamond symbols represent data 
collected during the second stage of the experiment (flow rate = 0.1 PV/d), given in terms of 
pore volumes (PV).  
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Figure 5.7 Concentrations of acidic pharmaceuticals sulfamethoxazole (SMX), ibuprofen (IBU), 
gemfibrozil (GEM), and naproxen (NAP) as a function of distance along flow direction within 
control column and columns containing zero-valent Fe (ZVI), biochar (BC), and both.  Blue 
circle, orange square, and green triangle symbols represent data collected during the first stage of 
the experiment (flow rate = 0.3 PV/d), while grey diamond symbols represent data collected 
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Figure 5.8 Concentrations of acefulfame-K (ACE-K), cyclamate (CYC), saccharine (SAC), and 
sucralose (SCL) as a function of pore volumes (PV) in effluent from control column and 
columns containing zero-valent Fe (ZVI), biochar (BC), and both; dash lines indicate a decrease 



















































0 20 40 60 80
Pore volume
0 20 40 60 80 0 20 40 60 80
Influent
Effluent




Figure 5.9 Concentrations of acefulfame-K (ACE-K), cyclamate (CYC), saccharine (SAC), and 
sucralose (SCL) as a function of distance along flow direction within control column and 
columns containing zero-valent Fe (ZVI), biochar (BC), and both.  Blue circle, orange square, 
and green triangle symbols represent data collected during the first stage of the experiment (flow 
rate = 0.3 PV/d), while grey diamond symbols represent data collected during the second stage of 
the experiment (flow rate = 0.1 PV/d), given in terms of pore volumes (PV). 
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Figure 5.10 Concentrations of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid 
(PFOS) as a function of pore volumes (PV) in effluent from control column and columns 
containing zero-valent Fe (ZVI), biochar (BC), and both; dash lines indicate a decrease in flow 
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Figure 5.11 Concentrations of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid 
(PFOS) as a function of distance along flow direction within control column and columns 
containing zero-valent Fe (ZVI), biochar (BC), and both. Blue circle, orange square, and green 
triangle symbols represent data collected during the first stage of the experiment (flow rate = 0.3 
PV/d), while grey diamond symbols represent data collected during the second stage of the 
experiment (flow rate = 0.1 PV/d), given in terms of pore volumes (PV). 
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Chapter 6: Removal of Perfluoroalkyl 
Carboxylic and Sulfonic Acids from Water 
Using Zero-valent Iron and Biochar 
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6.1 Executive Summary 
Perfluoroalkyl substances (PFASs), a class of Persistent Organic Pollutants, have received a 
great deal of attention due to their widespread occurrences and persistence in the environment 
and their potential toxicity to animals and humans. Effective decomposition of PFASs usually 
involves advanced oxidation or reduction processes under extremely acidic pH conditions, high 
temperature and pressure (except for activated carbon adsorption and nanofiltration), which 
makes these technologies costly and less feasible for full-scale applications. In this study, a series 
of laboratory batch experiments was conducted to evaluate the effectiveness of zero-valent iron 
(ZVI) alone and a mixture of ZVI and biochar (ZVI + BC) for removal of perfluoroalkyl 
carboxylic acids (PFCAs) and perfluoroalkyl sulfonic acids (PFSAs) from water under ambient 
environmental conditions. The target PFCAs include perfluorooctanoic acid (PFOA, C8-PFCA), 
perfluoroheptanoic acid (PFHpA, C7-PFCA), and perfluorohexanoic acid (PFHxA, C6-PFCA); 
the target PFSAs include perfluorooctane sulfonic acid (PFOS, C8-PFSA), perfluoroheptane 
sulfonic acid (PFHpS, C7-PFSA), perfluorohexane sulfonic acid (PFHxS, C6-PFSA), and 
perfluorobutane sulfonic acid (PFBS, C4-PFSA). The results show that PFCAs were less 
effectively removed than PFSAs when utilizing ZVI and (ZVI + BC). About 20% and 60% of 
input PFOA (~18,550 µg L-1) was removed by ZVI alone and the mixture of (ZVI + BC). Lower 
removal of short chain PFCAs was observed using ZVI alone and (ZVI + BC) compared to 
PFOA. The ZVI alone and (ZVI + BC) exhibited similar removal (~17%) of input PFHpA (26 
µg L-1); however, PFHxA was not removed by ZVI alone or (ZVI + BC). About 90% and 94% 
of input PFOS (~18,580 µg L-1) was removed by ZVI and (ZVI + BC). Similarly, the removal of 
short chain PFSAs by reactive media was lower than PFOS. About 57% and 70% of input 
PFHpS (330 µg L-1) were removed by ZVI and (ZVI + BC); ~30% and 40% of input PFHxS (13 
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µg L-1) were removed by ZVI and (ZVI + BC); ~20% of input PFBS (~ 6 µg L-1) by ZVI or (ZVI 
+ BC). The removal efficiencies of PFCAs and PFSAs by ZVI and (ZVI + BC) decreased with 
decreasing chain length. The removal of PFCAs and PFSAs by ZVI may be due to a combination 
of reductive defluorination and sorption; the removal of PFCAs and PFSAs by BC was likely 
due to hydrophobic sorption. About 5 ̶ 10 % of input PFOA and PFOS were partially 
defluorinated by ZVI alone as indicated by F- release, however, the defluorination efficiency of 
PFCAs and PFSAs by (ZVI + BC) may be underestimated due to sorption of F- by the reactive 





Perfluoroalkyl substances (PFASs) such as perfluoroalkyl carboxylic acids (PFCAs) and 
perfluoroalkyl sulfonic acids (PFSAs) are anthropogenic organic compounds that consist of a 
hydrophobic perfluorinated carbon (C-F) tail and a hydrophilic ionic head (carboxylic or sulfonic 
acid) (Rahman et al., 2014). Due to the presence of the strong C-F bond in their structure, these 
compounds exhibit high thermal and chemical stability. As a result, they have been widely used 
in a range of applications, such as polymer additives, fire retardants, pesticides, and surfactants 
(Kotthoff et al., 2015; Wang et al., 2014). The high stability of PFASs makes these compounds 
resistant to environmental degradation processes (Kissa, 2001), which results in their ubiquitous 
occurrence and persistence in the aquatic environment.  
PFASs have been globally detected in surface water (Liu et al., 2015a; Myers et al., 
2012), groundwater (Lin et al., 2015b; Schaider et al., 2014), and drinking water (Quiñones & 
Snyder, 2009; Yim et al., 2009) in the ng L-1 to µg L-1 range; these compounds have also been 
detected in Antarctic snow (Wang et al., 2015), animals (Furdui et al., 2008), and human bodies 
(Von Ehrenstein et al., 2009; Wang et al., 2011). Many studies demonstrate that PFASs have 
adverse impacts on humans and wildlife; they are bioaccumulative and possibly carcinogenic 
(Goudarzi et al., 2016; Suja et al., 2009). Consequently, perfluorooctane sulfonic acid (PFOS) 
has been included in the Annex B of the Stockholm Convention on Persistent Organic Pollutants, 
resulting in global restrictions on production (United Nations Environment Programme, 2009), 
In addition, the U.S. Environmental Protection Agency (U.S. EPA) has proposed a drinking 
water health advisory for PFOA (400 ng L-1) and PFOS (200 ng L-1) (US EPA, 2009a).   
176 
 
Emerging contaminants consumed by human beings are collected in the wastewater 
treatment plants (WWTPs); municipal wastewater and industrial discharges are considered to be 
the major point source release of PFAS to surface water bodies; non-point-sources of PFAS 
including agricultural run-off and atmospheric transport also contribute to PFAS contamination 
(Fujii et al., 2007). Giesy and Kannan (2001) report the widespread distribution of 
perfluorooctane sulfonate (PFOS) associated with the industrial production and application of 
PFASs. Conventional WWTPs typically do not effectively remove PFASs from water (Arvaniti 
& Stasinakis, 2015), unless activated carbon (AC) sorption, nanofiltration, or reverse osmosis are 
utilized (Fujii et al., 2007; Rayne & Forest, 2009). Due to the wide global distribution and 
toxicity of PFASs, a variety of treatment methods have been studied for removing these 
compounds from water.   
Advanced oxidation processes (using strong oxidizing radicals such as ·OH, O2·
-, and 
SO4·
-) have been extensively studied to degrade PFASs (Hori et al., 2005; Ochiai et al., 2011); 
however, low rates of PFASs degradation are typically observed under ambient temperature and 
environmental pH conditions due to the presence of the strong C-F bond and the electronegative 
fluorine atom in the structure. A combination of strong oxidizing radicals and extreme treatment 
conditions (such as low pH, high temperature, vacuum ultraviolet, and microwave) is more likely 
to lead to greater removal efficiency of PFASs. Yin et al. (2016) report 90% of input 
perfluorooctanoic acid (PFOA) (~20 µM) was degraded by activated persulfate (~2 mM) at a pH 
of 2.0, a reaction temperature of 50 oC, and reaction time of 100 h. Hori et al. (2008) report 
defluorination (78%) of 374 μM PFOA was achieved using 50 mM persulfate with 80 oC 
reaction temperature and 6 h reaction time.  Moriwaki et al. (2005) demonstrate the degradation 
of PFOS and PFOA under ultrasonic irradiation with half-life times for PFOS of 43 min and for 
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PFOA of 22 min under an argon atmosphere. Similarly, reductive removal of PFASs using 
nanoscale zero-valent iron (ZVI) or highly reactive reducing radicals such as aqueous electrons,  
H·, and SO3·
- also require extreme reaction conditions such as high pressure, ultraviolet, 
microwave, or ultrasound to facilitate treatment (Hori et al., 2006; Park et al., 2011; Song et al., 
2013). These harsh reaction conditions (such as low pH, high temperature) and high energy 
consumption of the advanced oxidative and reductive treatment hamper their large-scale 
application to municipal water treatment plants and WWTPs.  
Compared to the destructive oxidative and reductive methods, removal of PFASs by 
adsorption using activated carbon (AC) and filtration technologies such as nanofiltration and 
reverse osmosis are less energy demanding. However, the AC and membranes used for 
adsorption and filtration need to be frequently renewed or changed, which makes these 
technologies costly and less feasible for large-scale application. Zero-valent iron (ZVI) is a 
relatively inexpensive, abundant, and environmentally friendly reductant. ZVI has been 
successfully used in in-situ permeable reactive barriers (PRBs) for removing a wide range of 
environmental organic contaminants, including halogenated organic compounds, chlorinated 
methanes, and nitroaromatics (Jeen et al., 2013; Johnson et al., 1996; Lavine et al., 2001; 
Matheson & Tratnyek, 1994) and inorganic contaminants (such as As, Cd, Cr, Ni, Zn, V, NO3, 
PO4, SO4,  and ClO4
-.) (Blowes et al., 2000; Cantrell et al., 1995; Jamieson-Hanes et al., 2014; 
Liu et al., 2014c; Shrimpton et al., 2015) from wastewater and groundwater. Biochar (BC) is a 
stable carbon-rich product synthesized through pyrolysis/carbonization of plant- and animal-
based biomass under low oxygen (O2) and at relatively low temperature (< 700°C) condition 
(Lehmann & Joseph, 2009). Due to the relative low cost, abundance, and comparable sorption 
ability to AC, BC has been used as a potential alternative sorbent for AC for removal or 
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immobilization of a wide range of organic contaminants such as pharmaceutical compounds and 
polycyclic aromatic hydrocarbons (PAHs) (Oleszczuk et al., 2012; Rajapaksha et al., 2015) and 
inorganic contaminants such as heavy metals Hg, Cr, Cu, Ni, and Zn (Liu et al., 2016a; 
Uchimiya et al., 2010) from contaminated soil and wastewater. The combination of ZVI and BC 
is a promising reactive media for environmental soil and water remediation, which integrates 
both the strong reduction of ZVI and sorption capacity of BC. Enhanced removals of organic 
contaminants such as tetracycline, methyl orange, and methylene blue and inorganic 
contaminants such as Pb(II), Cr(VI), As(V), and phosphate (P) from contaminated water have 
been reported using biochar-supported ZVI (Han et al., 2015; Peng et al., 2014; Zhou et al., 
2014).  
In this study, a series of batch experiments was conducted to evaluate the effectiveness of 
the reactive media ZVI alone and a mixture of (ZVI + BC) for removal of three perfluoroalkyl 
carboxylic acids (PFCAs) and four perfluoroalkyl sulfonic acids (PFSAs) from water under 
environmental pH conditions and ambient temperature. The target PFCAs included 
perfluorooctanoic acid (PFOA, C8-PFCA), perfluoroheptanoic acid (PFHpA, C7-PFCA) and 
perfluorohexanoic acid (PFHxA, C6-PFCA). The target PFSAs included perfluorooctane 
sulfonic acid (PFOS, C8-PFSA), perfluoroheptane sulfonic acid (PFHpS, C7-PFSA), 
perfluorohexane sulfonic acid (PFHxS, C6-PFSA), and perfluorobutane sulfonic acid (PFBS, 
C4-PFSA).  
Fluoride (F-) is an indicative byproduct of defluorination of PFOA and PFOS. 
Defluorination of PFOS by ZVI has been observed in subcritical water in laboratory batch 
experiments with the production of F- and CHF3 gas (Hori et al., 2006). In column experiments 
using zero valent iron (Chapter 5), release of F- associated with defluorination of PFOA and 
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PFOS was not observed, likely due to either lack of defluorination reactions, analytical 
limitations, or other factors. Concentrations of F- in the column effluent and pore waters were 
below the analytical detection limit (0.02 mg L-1). Simulated groundwater (CaCO3 saturated H2O, 
pH=8.3) was used as an input solution matrix in the column experiment to represent the 
ubiquitous occurrence of HCO3
- and CO3
2- in natural waters. An alternative reason for lack of F- 
detection, is the potential removal of  F- through precipitation with Ca2+ (present in simulated 
groundwater) to form CaF2. In this study, batch experiments were conducted to evaluate 
potential defluorination of PFOA and PFOS by zero-valent iron (ZVI) under reducing conditions. 
In these experiments, NaHCO3 was used as an input solution matrix, and not CaCO3 (as was 
used in column experiments in Chapter 5) to minimize the removal of F- generated through 
defluorination reactions through formation of CaF2 precipitation. The concentrations of PFOA 
and PFOS in the input NaHCO3 solution were set at 20 mg L
-1 by assuming only one F atom 
defluorinated from 20 mg L-1 of PFOA or PFOS; the anticipated concentration of F- 
defluorinated from 20 mg L-1 of PFOA or PFOS would be ~1 mg L-1, which is well above the 
analytical detection limit of F- (0.02 mg L-1) for quantification. In addition, a series of batch 
experiments (F- sorption test) was conducted to evaluate the sorption of F- (at ~1 mg L-1, the 
anticipated concentration of F- defluorinated from 20 mg L-1 of PFOA or PFOS) by reactive 
media ZVI alone and the mixture of (ZVI + BC).  
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6.3 Materials and Methods  
6.3.1 Batch Experiments for Removal of Perfluoroalkyl Carboxylic Acids 
(PFCAs) and Perfluoroalkyl Sulfonic Acids (PFSAs) Using ZVI and Mixture 
of ZVI and BC 
6.3.1.1 Batch Experimental Setup 
Granular Fe0 (ZVI, 0.25–1.19 mm) was obtained from Connelly-GPM, and was washed five 
times using 1L of 1.2 M reagent-grade HCl acid (Fisher Scientific, Canada ) to remove the iron 
rust and impurities, followed by ten times rinse using 1L of ultrapure H2O (MilliQ A10, 18.2 
MΩ cm @ 25 oC,  Etobicoke, Canada). Hard-wood (oak) based biochar (BC, 0.5–2.36 mm) was 
obtained from Cowboy Charcoal Co., Brentwood, TN, USA. Dry perfluorooctanoic acid (PFOA) 
powder (96% purity) and perfluorooctane sulfonic acid potassium salt (PFOS) powder (98% 
purity) were obtained from Sigma-Aldrich, Canada. The input solution matrix consisted of a 0.8 
mM NaHCO3 in Ar(g) purged ultrapure H2O with pH of 8.54 
The individual PFOA and PFOS stock solutions containing 10,000 mg L-1 of PFOA and 
10,000 mg L-1 of PFOS were prepared by dissolving 0.100 g PFOA and 0.100 g PFOS dry 
powder in 10 mL methanol (HPLC grade, Sigma-Aldrich, Canada). Individual PFOA and PFOS 
input solutions contained 20 mg L-1 PFOA and 20 mg L-1 PFOS, which were prepared by spiking 
1 L of Ar(g) purged 0.8 mM NaHCO3 solution with 2 mL of 10,000 mg L
-1 of PFOA and PFOS 
stock solution. Blank samples including Blank NaHCO3, Blank ZVI, and Blank (ZVI + BC), 
were used to track the background concentrations of PFOA and PFOS in the NaHCO3 solution 
(input solution matrix), and on the reactive media of ZVI and (ZVI + BC). Blank NaHCO3 
sample consisted of 35 mL 0.8 mM NaHCO3 solution. Blank ZVI and Blank (ZVI + BC) 
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samples were prepared by adding 35 g ZVI alone or a mixture of 7 g ZVI and 3.5 g BC to 35 mL 
of 0.8 mM NaHCO3 solution. The volume ratio of 3.5 g BC to 7g ZVI was approximately 4, 
which was similar to the volume ratio of BC to ZVI used in the column experiment (Chapter 5). 
Control samples were used to determine the concentration losses of input PFOA and PFOS 
during the reaction period due to sorption to containers or photolysis. Control PFOA and Control 
PFOS were 35 mL of input PFOA and 35 mL of input PFOS solution. Treatment samples were 
used to determine the removals of PFOA and PFOS by reactive media ZVI alone and the mixture 
of (ZVI + BC) during the reaction period. Treatment PFOA + ZVI and Treatment PFOA + 
(ZVI+BC) samples were prepared by adding 35 g ZVI or a mixture of 7 g ZVI and 3.5 g BC to 
35 mL of PFOA input solutions. Treatment samples PFOS + ZVI and PFOS + (ZVI+BC) were 
prepared by adding 35 g ZVI or a mixture of 7 g ZVI and 3.5 g BC to 35 mL of PFOS input 
solutions (Table 6.1). Sampling times were set at Days 0, 20, 40, 60, 90, and 120. Duplicate 
batch samples were prepared at Days 40, 90, and 120. All batch mixtures were prepared in 50 
mL polypropylene centrifuge tubes with screw caps (Eppendorf, Canada). All batch mixtures 
were manually shaken every other day in an anaerobic glove box (COY Ltd.) that contained 3.5% 
H2 and 96.5% N2. The batch mixtures were taken out of the glove box for centrifugation (6000 
rpm for 15 min) and placed back in the glove box to collect samples of the supernatant and 
reactive media.  
6.3.1.2 Collection of Supernatant Samples  
Supernatant samples were collected using a needle attached to 24 mL plastic syringe. 
Supernatant samples for pH and Eh analyses were not filtered; samples for alkalinity analyses 
were filtered through 0.45-µm cellulose acetate membranes before measurement. Supernatant 
PFOA and PFOS samples were not filtered and collected in polyethylene bottles. Supernatant 
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anion samples were filtered through 0.45-µm cellulose acetate filters and collected in 
polyethylene bottles. The measurement of pH, Eh, and alkalinity were determined immediately 
after sampling, other samples were stored at 4 oC and analyzed within one week of collection.  
6.3.1.3 Aqueous Samples Extracted from Reactive Media   
Perfluoroalkyl substances (PFASs) were extracted from the reactive media (ZVI and mixture of 
ZVI and BC) following a previously described method (Arvaniti et al., 2014) with slight 
modifications to determine the amount of PFOA and PFOS adsorbed by ZVI and BC. The 
method reported by Arvaniti et al. (2014) was validated based on absolute analyte (target PFASs) 
recoveries that ranged from 78% to 115% and satisfactory precision (RSD < 15%) (N=6). An 
aliquot of 0.4 g of ZVI and the mixture of ZVI and BC (wet solid samples) from the Treatments 
PFOA + ZVI, PFOA + (ZVI + BC), PFOS + ZVI, PFOS + (ZVI + BC), Blank ZVI, and Blank 
(ZVI + BC) were transferred to 50 mL Eppendorf tubes. Liquid-solid extraction (LSE) was 
performed by adding 7.5 mL 1% (v/v) acetic acid and 1.5 mL methanol to the sample tubes. The 
samples were vortexed for 1 min, followed by 15 min sonication, and then centrifuged at 3500 
rpm for 15 min. The supernatants were transferred to 50 mL polypropylene centrifuge tubes with 
screw caps (Eppendorf, Canada). The LSE process was repeated another two successive times 
for each sample by only adding 7.5 mL 1% acetic acid followed by the same vortex, sonication, 
and centrifugation steps. The supernatants from the three LSE steps were collected together in 50 
mL polypropylene centrifuge tubes and stored at 4 oC for PFAS analysis. Water content of each 




6.3.2 Batch Experiments for Evaluating Sorption of F- by Reactive Media  
The F- sorption test was performed to evaluate the sorption of F- by ZVI alone and the mixture of 
ZVI and BC (Table 6.1). The F- stock solution containing 500 mg L-1 F- was prepared by mixing 
0.553 g sodium fluoride (NaF) dry powder (> 99%) (Anachemia, Canada) in 500 mL ultrapure 
H2O. The F
- input solution containing 1 mg L-1 F- in 0.8 mM NaHCO3
 solution was prepared by 
spiking 499 mL of 0.8 mM NaHCO3 solution with 1 mL of 500 mg L
-1 F- stock solution. Blank 
samples including Blank NaHCO3, Blank ZVI, and Blank (ZVI + BC) were used to track the 
background concentrations of F- in the NaHCO3 solution (input solution matrix), and on the 
reactive media of ZVI and (ZVI + BC). Blanks NaHCO3, ZVI, and (ZVI + BC) samples were 
prepared the same way as in section 6.3.1.1. Control F- samples contained 35 mL of 1 mg L-1 F- 
input solution in 50 mL polypropylene centrifuge tubes, which was used to track the loss of F- 
due to sorption to containers during the reaction period. Sorption test samples were used to 
determine the sorption of F- by ZVI alone and the mixture of (ZVI + BC). Sorption test samples 
F- + ZVI and F- + (ZVI + BC) were prepared by adding 35 g ZVI alone and the mixture of 7 g 
ZVI and 3.5 g BC to 35 mL of F- input solution in 50 mL polypropylene centrifuge tubes (Table 
6.1). All the batch samples were kept in the anaerobic glove box and manually shaken every 
other day. Samples were taken out of the glove box and centrifuged at 6000 rpm for 15 min, and 
placed back into the glove box for sampling at Days 0, 20, 40, 60, 90, and 120. Samples for F- 
analysis were filtered through 0.45-µm cellulose acetate filters and collected in 8 mL 
polyethylene bottles stored at 4 oC until analysis within one month of collection.  
6.3.3 Analysis of Water Samples and Solid-Phase Extracts 
6.3.3.1 Measurements of pH, Eh, and Alkalinity of Supernatant Samples  
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Measurements of pH were conducted using an Orion Ross combination electrode (model 815600) 
calibrated with standard buffer solutions of pH 7, 4, and 10, and checked against pH 7 and 10 
buffer solutions between samples. The redox potentials (corrected to the standard hydrogen 
electrode and reported as Eh values) were measured using a Pt-billeted Ag-AgCl combination 
electrode (Orion 9678BNWP), checked against A and B solutions (redox/ORP electrode user 
guide, Thermo Scientific, Canada) before measurement. Measurements of alkalinity were 
performed using a HACH digital titrator and bromocresol green/methyl red indicator and with 
0.08 mol L-1 H2SO4. 
6.3.3.2 Analysis of Fluoride in Supernatant Samples 
The concentrations of F- were determined by a Dionex ICS-5000 ion chromatography (IC) 
system (Thermo Scientific, Sunnyvale, CA, USA). The F- was separated by an IonPac AS11-HC 
(2 x 250 mm) column (Thermo Scientific) using a potassium hydroxide (KOH) gradient. The 
EGC III KOH eluent generator cartridge (Dionex) was used to generate the KOH gradient. The 
KOH gradient elution initially started at 10 mM, increased to 22 mM in 12 min and increased to 
40 mM in 8 min, held at 40 mM for 8 min, then decreased to 22 mM at 28.1 min and decreased 
to 10 mM in 5 min, and then held at 10 mM for 5 min. The flow rate was 0.25 mL min-1 and the 
injection volume was 10 µL. The system operating pressure was 139 ̶ 142 bars. The retention 
time of F- was around 14.0 min. The electrolytically regenerated suppressor ERS 500 (Dionex, 
Canada) with the applied current of 40 mA and the carbonate removal device CRD 200 (2 mm) 
(Dionex, Canada) were used in the system. A seven point calibration curve (0.01-2.0 mg L-1) was 
used to quantify F- concentrations. The method detection limit (MDL) for F- was 0.02 mg L-1. To 
ensure the identification of F- peak (not acetate peak which is eluted right after F-), the 
supernatant samples of Treatment PFOA + ZVI and Treatment PFOS + ZVI at Days 90 and 120 
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were fortified with either a known amount of F- or acetate or both F- and acetate. The 
concentrations of spiked F- and acetate in supernatant samples were 0.1 mg L-1 (F-) and 1 mg L-1 
(acetate). The recoveries of spiked F- and acetate were between 73% and 101%. The spiking 
strategy and IC chromatograms are provided in Appendix E (Table E.1 and Figures E.1 ̶ E.4). 
6.3.3.3 Analysis of PFOA and PFOS 
The diluted samples (20 mL) for PFOA and PFOS analysis were spiked with 400 µL internal 
standards (IS) mixture which contained 10 µg L-1 [13C]-PFOA and 20 µg L-1 [13C]-PFOS 
(Wellington Laboratories Inc., Guelph, Canada). The IS spiked PFOA and PFOS samples (20 
mL) were passed through solid-phase extraction (SPE) cartridges (Oasis HLB 3 cc glass 
cartridges; Waters Corp., Mississauga, Canada). The cartridges were preconditioned with 2 x 1 
mL methanol (HPLC grade), washed with 2 x 1 mL ultrapure H2O, then loaded with 20 mL IS 
spiked PFOA and PFOS samples, washed with 2 x 1 mL ultrapure H2O, vacuum dried for 1 min, 
finally eluted with 2 x 1 mL methanol (HPLC grade). The 2 mL PFOA and PFOS methanol 
extracts were collected in 5 mL polypropylene centrifuge tubes (Eppendorf, Canada) and kept at 
room temperature until analysis. 
The concentrations of PFOA and PFOS in methanol extracts were determined by high 
performance liquid chromatography (1290 HPLC, Agilent Technologies, Mississauga, Canada) 
followed by tandem mass spectrometry (6460 QQQ, Agilent Technologies, Mississauga, Canada) 
in ESI- mode using EPA Method 537 (Shoemaker, 2013) with recommended modifications 
(Yamashita et al., 2004) to enhance the instrument performance. The PFOA and PFOS were 
separated using a Zorbax Eclipse C18 column (4.6 × 150 mm, 5 μm i.d.) (Agilent, Mississauga, 
Canada) at 55 oC. The mobile phase A contained 2 mM ammonium acetate (HPLC grade, 
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Sigma-Aldrich, Oakville, Canada) in water; the mobile phase B contained 2 mM ammonium 
acetate in methanol. The mobile phase elution gradient, instrument operating conditions, and 
preparations of the calibration curves were the same as described in section 5.3.2. The accuracy 
of a sample was calculated as the ratio of the measured PFOA and PFOS concentrations to the 
expected PFOA and PFOS concentrations. The accuracy of PFOA and PFOS calibration, 
determined by calibration verification (CV) and continuous calibration verification (CCV) 
samples was between 85% and 113%. Tap water samples and unknown samples were spiked 
with PFOA and PFOS analyte and IS to track the accuracy of SPE procedures. The accuracy of 
PFOA and PFOS for spiked tap water and unknown samples were between 87% and 114%.  The 
absolute IS recoveries of PFOA and PFOS for the CV, CCV, tap water samples, and unknown 
samples (including PFOA and PFOS supernatant samples and aqueous PFOA samples extracted 
from the reactive media) were between 74 ̶ 118%. The IS recoveries of PFOS for the aqueous 
samples extracted from the reactive media were likely affected by acetic acid used in LSE 
process, and the relative IS recoveries were between 81% and 115%. The method detection 
limits (MDLs) of PFOA and PFOS were 45 and 110 ng L-1. 
6.3.3.4 Analysis of Short Chain Perfluoroalkyl Carboxylic Acids (PFCAs) and 
Perfluoroalkyl Sulfonic Acids (PFSAs) 
The short chain perfluoroalkyl carboxylic acids (PFCAs) and perfluoroalkyl sulfonic acids 
(PFSAs) samples (20 mL) were spiked with 400 µL of 20 µg L-1 [1,2-13C2]-PFHxA and [18O]-
PFHxS (Wellington Laboratories Inc., Canada) internal standard (IS) mixture to yield 2 µg L-1 of 
ISs in 20 mL samples. The IS spiked 20 mL diluted samples were then prepared following the 
same solid phase extraction (SPE) procedures with the ones for PFOA and PFOS (section 
6.3.3.3). The short chain PFCAs and PFSAs extracts were analyzed by high performance liquid 
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chromatography (1290 HPLC, Agilent Technologies, Mississauga, Canada) followed by tandem 
mass spectrometry (6460 QQQ, Agilent Technologies, Mississauga, Canada) in ESI- mode 
following the method of Houtz and Sedlak (2012) with slight modifications to optimize the 
instrument performance. The analytes were separated using Poroshell 120 EC-C18, 3 x 5 mm, 
2.7 µm i.d. (Agilent, Mississauga, Canada) at 55 oC. The mobile phases were the same as used 
for PFOA and PFOS analysis. A gradient elution started at 40 % B for 1.5 min, increased linearly 
to 100 % B within 6 min  and held at 100% for 3 min, then decreased to 40 % B at 9.5 min and 
held at 40 % until 13.5 min. The flow rate was 0.5 mL min-1 and the injection volume was 2 µL. 
The calibration standards prepared in 96 : 4% (v/v) methanol/water were serially diluted from the 
analyte standard stock (1000 µg L-1) of short chain PFCAs including perfluoroheptanoic acid 
(PFHpA), perfluorohexanoic acid (PFHxA), perfluropentanoic acid (PFPeA) and the short chain 
PFSAs including perfluoroheptane sulfonic acid (PFHpS), perfluorohexane sulfonic acid 
(PFHxS), perfluorobutane sulfonic acid (PFBS) (Wellington Laboratories Inc., Canada) (Table 
6.2). Seven to nine points calibration curves (PFBS: 0.1 ̶ 30 µg L-1; PFBA and PFHxA: 0.2 ̶ 30 
µg L-1; PFHpA, PFPeA, PFHpS, and PFHxS: 0.5 ̶ 30 µg L
-1) were used for PFCAs and PFSAs 
quantitation with 2 µg L-1 of [1,2-13C2]-PFHxA and [18O]-PFHxS (Wellington Laboratories Inc., 
Canada). The accuracy of calibration, CV, and CCV samples was between 89 ̶ 120%. Tap water 
samples and unknown samples spiked with analyte and IS was used to track the precision of SPE 
procedures. The absolute IS recoveries of the CV, CCV, tap water samples, and unknown 
samples were 82 ̶ 125%. The instrument limits of quantification (LOQ) were calculated at 10 
times the signal-to-noise value. The LOQ of PFBS and PFHxS was 0.2 µg L-1; the LOQ of 
PFHpS, PFHxA, and PFHpA were 0.5 µg L-1; the LOQ of PFBA and PFPeA were 1 µg L-1 and 2 
µg L-1.  
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6.4 Results and Discussion 
6.4.1 Removal of Perfluoroalkyl Carboxylic Acids (PFCAs) and 
Perfluoroalkyl Sulfonic Acids (PFSAs) Using ZVI and Mixture of ZVI and BC 
6.4.1.1 Geochemistry of Supernatant Samples 
The pH values of the Treatment PFOA/PFOS + (ZVI + BC) supernatant samples were constant 
at ~8.5, which were consistent with that of the control samples. However, relatively higher pH 
values of ~10.5 (except for Day 0) were observed for the supernatant samples of Treatment 
PFOA/PFOS + ZVI, likely due to the corrosion of ZVI in H2O. The Eh values of the treatment 
supernatant samples were consistent with the control samples, which increased slightly from ‐
368 mV at Day 0 to -230 mV at Day 40 and maintained at -230 to -293 mV, indicating strong 
reducing conditions in the treatment and control samples during the 120 days of reaction time. 
The alkalinity of Control PFOA/PFOS and Treatment PFOA/PFOS supernatant samples 
exhibited a slightly increasing trend from Day 0 to Day 90, followed by a slight decrease at Day 
120, with concentrations ranging from 12 to 38 mg L-1 as CaCO3
 during the entire batch 
experiment (Figure 6.1).  
6.4.1.2 Removal of Perfluoroalkyl Carboxylic Acids (PFCAs) and Perfluoroalkyl Sulfonic 
Acids (PFSAs) Using ZVI and Mixture of ZVI and BC in Supernatant Samples 
The concentrations of perfluoroalkyl carboxylic acids (PFCAs) including PFOA (C8-PFCA), 
PFHpA (C7-PFCA), PFHxA (C6-PFCA), PFPeA (C5-PFCA), and PFBA (C4-PFCA) and 
perfluoroalkyl sulfonic acids (PFSAs) including PFOS (C8-PFSA), PFHpS (C7-PFSA), PFHxS 
(C6-PFSA), and PFBS (C4-PFSA) in the Blank NaHCO3, Blank ZVI, and Blank (ZVI + BC) 
samples were below the MDLs or LOQs, indicating there was no background contaminations of 
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these compounds in the input solution or on the reactive media. The input concentrations of 
PFOA in the Control PFOA samples and PFOS in the Control PFOS samples were about 18,500 
µg L-1 (Figure 6.2). Three to four orders of magnitude lower concentrations of short chain 
PFCAs including PFHpA (C7-PFCA) at ~26 µg L-1 and PFHxA (C6-PFCA) at ~0.8 µg L-1 were 
detected in the Control PFOA samples compared to input PFOA; the concentrations of PFPeA 
(C5-PFCA) and PFBA (C4-PFCA) were below the LOQ (Figure 6.3). Similarly, two to four 
orders of magnitude lower concentrations of short chain PFSAs including PFHpS (C7-PFSA) at 
~330 µg L-1, PFHxS (C6-PFSA) at ~13 µg L-1, and PFBS (C4-PFSA) at ~6 µg L-1 were detected 
in the Control PFOS samples compared to input PFOS (Figure 6.4). The detections of short 
chains PFCAs in the Control PFOA samples and PFSAs in the Control PFOS samples were 
likely due to the impurity of PFOA (96%) and PFOS (98%) dry stock (see section 6.3.1.1).   
The concentrations of PFOA, PFOS, and short chain PFCAs and PFSAs in the Control 
samples were constant over the reaction time (Figures 6.2 ̶ 6.4), indicating the sorption of these 
compounds to the sample containers or the photolysis of these compounds under natural light 
was limited. The concentration of PFOA in the Treatment PFOA + ZVI supernatant samples 
decreased from input concentration of 18,550 µg L-1 to 14,240 µg L-1 at Day 20 and were 
maintained at ~14,500 µg L-1 until Day 120, representing ~20% of input PFOA removed by ZVI 
alone. However, the mixture of (ZVI + BC) exhibited a greater removal of PFOA (~60%) than 
ZVI alone; the concentration of PFOA in the Treatment PFOA + (ZVI + BC) supernatant 
samples decreased from 20,000 µg L-1 at Day 0 to 6,041 µg L-1 at Day 20, but then gradually 
increased to 8,560 µg L-1 at Day 120 (Figure 6.2). Compared to PFOA, lower removals of the 
short chain PFCAs were observed by ZVI and (ZVI + BC). The concentration of PFHpA (C7-
PFCA) decreased from the input concentration of 26 µg L-1 at Day 0 to 24.4 µg L-1 in the 
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Treatment PFOA + ZVI supernatant sample and 18.4 µg L-1 in the Treatment PFOA + (ZVI + 
BC) supernatant sample at Day 20, and then remained at ~22.0 µg L-1 during the rest of the 
experiment with an average PFHpA removal of 17%. The concentrations of PFHxA (C6-PFCA) 
in the Treatment PFOA + ZVI and PFOA + (ZVI + BC) supernatant samples were consistent 
with the control samples from Day 0 to Day 120 indicating no removals of PFHxA throughout 
the batch experiment (Figure 6.3).  
The input PFOS (~18,580 µg L-1) was effectively removed by ZVI and (ZVI + BC). The 
concentration of PFOS rapidly decreased from 18,580 µg L-1 at Day 0 to 4,120 µg L-1 in the 
Treatment PFOS + ZVI supernatant sample and 1,780 µg L-1 in the Treatment PFOS + (ZVI + 
BC) supernatant sample at Day 20, then continued to decrease until Day 120 with removals of 90% 
and 94% (Figure 6.2). Lower removals of short chain PFSAs were observed using ZVI and (ZVI 
+ BC) compared to PFOS. Greater removals of PFHpS (C7-PFSA) and PFHxS (C6-PFSA) were 
observed using (ZVI + BC) than ZVI alone. The concentration of PFHpS in the Treatment PFOS 
+ ZVI supernatant sample decreased from input concentration of 330 µg L-1 at Day 0 to 225 µg 
L-1 at Day 20, and then continued to decrease to 142 µg L-1 at Day 120 with removal of 57%. 
The concentration of PFHpS in the Treatment PFOS + (ZVI + BC) supernatant sample decreased 
from 330 µg L-1 at Day 0 to 91.6 µg L-1 at Day 20 and remained at 95 µg L-1 until Day 120 with 
removal of 70%. Similarly, the concentrations of input PFHxS (~13 µg L-1) in the Treatment 
PFOS + ZVI and PFOS + (ZVI + BC) supernatant samples gradually decreased over reaction 
time with removals of 30% and 40% at Day 120. Only ~20% of input PFBS (C4-PFSA) (~ 6 µg 




6.4.1.3 Production of F- in Supernatant Samples  
Fluoride (F-) is the indicative by-product of defluorination of PFOA and PFOS; its concentration 
in the Blank NaHCO3, Blank ZVI, and Blank (ZVI + BC) supernatant samples and aqueous 
samples extracted from the reactive media remained below the MDL (0.02 mg L-1) in this study. 
However, increasing concentrations of F- were observed in the Treatment PFOA/PFOS + ZVI 
supernatant samples; the concentration of F- gradually increased from undetectable level at Day 0 
to 0.14 mg L-1 in the Treatment PFOA + ZVI supernatant samples and 0.06 mg L-1 in treatment 
PFOS + ZVI supernatant samples at Day 120 (Figure 6.5). Similarly, the reductive defluorination 
of PFOA and PFOS using Mg-aminoclay coated nanoscale ZVI led to production of F- but no 
detection of organic byproducts, with a higher removal efficiency for PFOS (95% at 20 oC) than 
for PFOA (40% at 20 oC) (Arvaniti et al., 2015). The measured F- concentrations in the 
Treatment PFOA/PFOS + ZVI supernatant samples were stoichiometrically back-calculated to 
determine the concentrations of defluorinated PFOA and PFOS; results showed that 
approximately 8% of input PFOA and 4% of input PFOS were partially defluorinated by ZVI 
(2F defluorinated from 15F of 8% input PFOA and 17F of 4% input PFOS). These defluorination 
efficiencies were not corrected for the adsorption F- by reactive media (discussed in section 
6.4.2). The concentrations of F- in the Treatment PFOA/PFOS + (ZVI + BC) supernatant samples 
were below the method detection limit, likely due to the sorption of F- to BC.   
6.4.2 Sorption of F- by Reactive Media ZVI and Mixture of ZVI and BC 
The concentration of F- provides a direct measurement of the extent of PFAS defluorination; 
however, the sorption of F- by the reactive media ZVI and BC will result in a lower back-
calculated defluorination efficiency of PFAS. The concentration of F- in the input solution for F- 
sorption test was set at 1 mg L-1 to represent only one F atom defluorinated from 20 mg L-1 of the 
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input PFOA or PFOS during the treatment using ZVI and (ZVI +BC). The results of the F- 
sorption test showed that ~20% and ~75% of the input F- (1 mg L-1) were adsorbed by ZVI and 
(ZVI + BC) over 120 d  (Figure 6.6). The F- ions produced from defluorination of PFOA, PFOS, 
and short chain PFCAs and PFSAs were possibly partially or completely adsorbed to the reactive 
media ZVI and (ZVI + BC). The defluorination efficiency of PFOA and PFOS by ZVI and (ZVI 
+ BC) were likely under estimated due to the sorption of F- by reactive media.  





x(OH)2+xCO3] was the major iron corrosion product formed on the surface of ZVI when the 
ZVI were exposed in the CaCO3 solution (pH=8.2-8.3) under reducing conditions. Similarly, the 
iron hydroxy carbonate (chukanovite) is observed as a secondary mineral precipitate in several 
granular ZVI PRBs (Lee & Wilkin, 2010). In this study, the corrosion of Fe0 in the input 
NaHCO3 solution (similar to CaCO3 solution pH=8.3) likely resulted in the same corrosion 
product iron hydroxyl carbonate on ZVI surface, which may have led to sorption of F- by ZVI. 
The sorption of F- on iron hydroxide has been reported by Sujana et al. (2009), and the removal 
of F- (20 mg L-1) from aqueous solution using Fe hydroxides followed first-order kinetics with a 
sorption capacity of  77 mg g-1, which is much higher than sorption capacity of ZVI for F- (2.0 E-
4 mg g-1) in this study. In addition, Guan et al. (2015) report effective sorption of F- using a pine 
tree sawdust biochar.  
6.4.3 Correction of Defluorination Efficiency  
The defluorination efficiencies of PFOA and PFOS were likely underestimated due to the 
sorption of F- by reactive media; ~20% of input F- was adsorbed by ZVI and ~80% of input F- 
was in the supernatant (discussed in section 6.4.2). The defluorination efficiencies of PFOA and 
PFOS by ZVI were corrected (divided by 80%) to account for the amount of F- adsorbed by ZVI. 
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Corrected results showed that approximately 10% of input PFOA and 5% of input PFOS were 
partially defluorinated by ZVI (2F defluorinated from 15F of 10% input PFOA and 2F 
defluorinated from 17F of 5% input PFOS). The defluorination efficiencies of PFOA and PFOS 
by (ZVI + BC) cannot be  confirmed and corrected because the concentrations of F- in the 
supernatant samples of PFOA/PFOS + (ZVI+BC) were below the detection limit (0.02 mgL-1) 
due to sorption of F- by (ZVI + BC).  
6.4.4 Possible Removal Mechanisms of PFCAs and PFSAs by ZVI and BC 
6.4.4.1 Possible Removal Mechanisms of PFCAs and PFSAs by ZVI 
The removal mechanisms of PFCAs and PFSAs by ZVI was likely through reductive 
defluorination and H bonding. The potential reductive defluorination pathway for PFOA (for 
instance) is shown in Figure 6.7 (reproduced from Song et al., 2013). The defluorination of 
PFOA (C6F13CF2COOH) is initiated by the cleavage of α-position C-F bond by electron transfer 
from ZVI, leading to the formation of increasing concentrations of C6F13CFHCOOH (m/z=395), 
C6F13CH2COOH (m/z=377), and F
- as degradation products. The generated C6F13CH2COOH is 
further decomposed to C6F13COOH through UV radical splitting of α-position CH2- and 
recombination; this defluorination reaction repeats to further decrease the chain length (Song et 
al., 2013). However, splitting of α-position CH2- (chain decreasing) from PFOA and PFOS with 
formation of short chain PFCAs and PFSAS likely was limited in this study, because the 
concentrations of potential α-position CH2- splitting products such as C7-PFCA (PFHpA, 




The greater defluorination efficiency of PFOA compared to PFOS (section 6.4.1.3 and 
Figure 6.5) is likely due to stronger C-F bonds in PFOS than PFOA. Both PFOA 
[CF3(CF2)6COOH] and PFOS [CF3(CF2)7SO3H] have 8C in their structure; however, PFOS 
contains one more CF2 moiety compared to PFOA resulting in a stronger C-F bond in PFOS. In 
addition, the sulfonic group in PFOS is more electronegative than the carboxylic groups in 
PFOA, which also contributes to the stronger C-F in PFOS than PFOA.    
 Formation of gaseous phase byproducts during reductive defluorination of PFOA and 
PFOS by ZVI was not monitored in this study. However, it should be noted that the formation of 
gas byproducts such as CO2 and CHF3 during decomposition of PFOA and PFOS is usually 
accompanied by an effective defluorination (complete defluorination efficiency > 50%). Hori et 
al. (2004) and Hori et al. (2007) report the production of CO2 gas coupled with a high 
defluorination efficiency (~95% completely defluorinated) during advanced photochemical 
decomposition of PFOA. Similarly, a trace amount (0.7%) of volatile unstable degradation 
products CHF3 was detected during advanced reductive decomposition of PFOS using ZVI in 
subcritical water with a complete defluorination efficiency of ~50% (Hori et al., 2006). Given the 
relatively low defluorination efficiency of PFOA and PFOS (5 ̶ 10% was partially defluorinated 
or 0.5 ̶ 1% was completely defluorinated) in this study compared to previously reported studies, 
substantial formation of these gas phase byproducts was unlikely.   
Besides reductive defluorination, the target PFCAs and PFSAs were also likely removed 
by ZVI through H bonding. The corrosion of ZVI in H2O likely results in a complex mixture of 
amorphous and crystalline iron oxyhydroxides (Fe3O4, Fe2O3, FeOOH, Fe(OH)2, Fe(OH)3, etc.) 
coated on the ZVI surface (Mukesh & Panday, 2001; Sun et al., 2016; Wilson, 1923). The 
hydroxyl ( ̶ OH) groups (H donors) on the surface of ZVI likely interact with the electronegative 
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O atoms (H acceptors) in the functional carboxylic and sulfonic heads of PFASs through H 
bonding. Many researchers indicate that the H bonding formed between the O atoms in 
carboxylic and sulfonic heads of PFAS and H donor functional groups on the sorbents play an 
important role for PFASs sorption (Gao & Chorover, 2012; Karoyo & Wilson, 2013; Xiao et al., 
2012).     
The electrostatic interaction between PFOA and PFOS and iron oxides (hydroxides) on 
the surface of ZVI was likely limited in this study. The low pKa values of PFASs (-0.2 for PFOA 
and -3.3 for PFOS) (Deng et al., 2012) indicate that these PFASs will predominantly exist in 
their dissociated, negatively charged anionic forms at environmentally relevant pH condition (or 
in this study pH: 8.3 ̶ 10.0). The iron hydroxy carbonate as the primary iron corrosion product 
formed on the surface of ZVI (formation discussed in section 6.4.2) was more likely neutral or 
negatively charged in this study (pH: 8.3 ̶ 10.5) (Guilbaud et al., 2013; Kosmulski, 2009; Parks, 
1965). The electrostatic interaction between negatively charged PFASs and neutral or negatively 
charged iron oxides was likely not predominant in this study. However, electrostatic interaction 
has been proposed to be an important sorption mechanism for PFASs. Gao and Chorover (2012) 
report that PFOA and PFOS can be adsorbed by iron oxide (hematite) through electrostatic 
interaction as well as the formation of inner-sphere Fe-carboxylate complexes (for PFOA) by 
ligand exchange and outer-sphere complexes and hydrogen-bonds (for PFOS) at the mineral 
surfaces. In addition, the relatively weak ion-dipole interaction between the polar hydroxyl group 
on iron hydroxides and the anionic PFOA/PFOS may also contribute to the sorption of 
PFOA/PFOS by iron corrosion products (Punyapalakul et al., 2013). Lin et al. (2015a) observe 
the removal of PFCAs and PFOS by iron hydroxides generated by electrocoagulation likely as a 
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result of electrostatic interactions, hydrogen bonding, ion and/or ligand exchange, and possibly 
hydrophobic effects.    
6.4.4.2 Potential Removal Mechanisms of PFCAs and PFSAs by BC 
The removal of target PFCAs and PFSAs by BC was likely due to hydrophobic 
interaction between the C-F chains and hydrophobic sites on BC. In addition, H bonding and ion-
dipole interaction may also contribute to the sorption of PFCAs and PFSAs by BC (Du et al., 
2014). The hydrophobic sorption of PFOS by maize straw- and willow- derived biochars has 
been reported previously (Chen et al., 2011b). Overall, PFOS and short chain PFSAs were more 
effectively removed by (ZVI + BC) compared to the same C chain length of PFOA and short 
chain PFCAs, which is attributed to the greater hydrophobicity of PFSAs than PFCAs. With the 
same number of C in their structure, PFSA such as PFOS contain two more C-F bond than the 
corresponding PFCA such as PFOA, contributing to stronger hydrophobicity and enhanced 
sorption (Merino et al., 2016; Zhou et al., 2010). Moreover, the addition of each extra CF2 
moiety to PFCAs and PFSAs structure results in stronger hydrophobicity and increased sorption 
(Merino et al., 2016), which explains the greater removals of PFOA and PFOS by BC compared 
to the short chain PFCAs (such as PFHpA and PFHxA) and PFSAs (such as PFHpS, PFHxS, and 
PFBS). Higgins and Luthy (2006) demonstrate a stronger sorption potential of long chain PFASs 
to sediment compared to the short chain counterparts. In addition, the stronger sorption (0.71–
0.76 log units higher) of PFSAs to suspended sediment particulate matter compared to the PFCA 
analogs has been reported by Ahrens et al. (2010).   
The H bonding formed between the hydroxyl ( ̶ OH) groups (H donors) on BC (Liu et al., 
2015b) and the electronegative O atoms (H acceptors) in carboxylic (2O, 2H acceptors) and 
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sulfonic (3O, 3H acceptors) groups of PFCAs and PFSAs may also contribute to the sorption of 
target PFASs to BC. The H bonding between PFOS and BC was likely stronger than between 
PFOA and BC, possibly due to the presence of one more H acceptor in PFOS than PFOA. This 
greater H bonding between PFOS and BC may also contribute to greater removal of PFOS by 
BC compared to PFOA. Similar to the possible ion-dipole interaction between ZVI and 
PFOA/PFOS, a relatively weak ion-dipole interaction between the polar hydroxyl group on BC 
and the anionic PFOA/PFOS may also contribute to the sorption of PFOA/PFOS by BC 
(Punyapalakul et al., 2013). 
Electrostatic interactions between negatively charged PFASs and BC were likely limited. 
The biochar used in this study is oak wood biochar pyrolyzed at 700 oC which likely had a net 
negative surface charge under most pH conditions (2 ̶ 14) (Mukherjee et al., 2011). The 
negatively charged BC likely repulsed the negatively charged PFASs. 
6.4.5 Mass Balance of PFOA (PFCAs) and PFOS (PFSAs) in Treatment 
Samples 
Mass balance of PFOA and PFOS during the treatment using ZVI alone and (ZVI + BC) 
was calculated and illustrated in Figure 6.8. Between 5% and 10% of input PFOA/PFOS was 
removed through reductive defluorination (partially) by ZVI, between 10% and 40% of input 
PFOA/PFOS was removed through sorption by ZVI or (ZVI + BC), and between 2% and 85% of 
input PFOA/PFOS was removed through unknown mechanisms.   
Because the concentrations of PFOA and PFOS in the supernatant samples and aqueous 
samples extracted from the reactive media were two to five orders of magnitude higher than the 
concentrations of short chain PFCAs and PFSAs, the concentrations of short chain PFCAs 
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(PFHpA and PFHxA) and short chains of PFSAs (PFHpS, PFHxS, and PFBS) are negligible 
compared to PFOA and PFOS. The change in mass balance of PFOA and PFOS as a function of 
reaction time in Figure 6.8 also represents the mass balance of total PFCAs (sum of PFOA, 
PFHpA, and PFHxA) and total PFSAs (sum of PFOS, PFHpS, PFHxS, and PFBS) over the 
reaction time. The percentage of PFOA/PFOS in supernatant samples represents the remaining 
(not removed) PFOA/PFOS. The percentage of adsorbed PFOA/PFOS was the percentage of 
extractable PFOA/PFOS on reactive media. The sum of adsorbed PFOA/PFOS on reactive media, 
partially defluorinated PFOA/PFOS, and unknown PFOA/PFOS represents the total removed 
PFOA/PFOS from input solution.  
Mass balance results showed that ~20% of input PFOA (PFCAs) was removed by ZVI 
alone (Figure 6.8). Partial defluorination, sorption and unknown accounted for ~10%, ~10%, and 
~2% of PFOA removal by ZVI. PFOA was more effectively removed by (ZVI + BC) compared 
to ZVI alone, with an average removal of ~60%, which consisted of ~24% of sorption and ~36% 
of unknown. About 90% and 94% of input PFOS (PFSAs) was removed using ZVI and (ZVI + 
BC). Partial defluorination, sorption and unknown accounted for ~5%, ~40%, and ~45% of 
PFOS removal (~90%) by ZVI; sorption and unknown accounted for ~8% and ~86% of PFOS 
(PFSAs) removal (~94%) by (ZVI + BC) (Figure 6.8).  
Addition of BC to ZVI increased the removals of PFOA (PFCAs) and PFOS (PFSAs) 
compared to ZVI alone. The sorption percentage (24%) of PFOA (PFCAs) by (ZVI + BC) was 
relatively greater than that (10%) by ZVI alone. However, a smaller percentage of PFOS (PFSAs) 
(8%) was adsorbed by (ZVI + BC) than that (40%) by ZVI alone likely due to the stronger 
hydrophobic interaction between BC and PFOS (PFSAs) compared to PFOA which might not be 
extracted from the solid phase.   
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The unknown percentage of PFOA/PFOS in the mass balance calculation varied greatly 
from ~2% to ~85% and may include the following portions: (1) uncounted defluorinated 
PFOA/PFOS due to the sorption of F- by the reactive media; (2) non-extractable PFOA/PFOS; 
and (3) other intermediate degradation products which were not monitored in this study. The 
defluorination efficiencies (5 ̶ 10%) of PFOA/PFOS by ZVI was corrected to account for the 
sorption of F- by ZVI; however, defluorination of PFOA/PFOS by (ZVI + BC) cannot be 
confirmed due to the sorption F- by (ZVI + BC) resulting in undetectable F-. This unaccounted 
defluorinated PFOA/PFOS by (ZVI + BC) likely contributed to the large unknown percentage of 
PFOA/PFOS in Treatment PFOA/PFOS + (ZVI+BC) samples. The non-extractable PFOA/PFOS 
refers to the adsorbed PFOA and PFOS which was possibly stabilized in ZVI and BC through 
strong hydrophobic interaction and(or) covalent bonding and cannot be extracted through the 
aqueous extraction process. This non-extractable PFOA/PFOS also likely increased the mass 
percentage of the unknown portion. In addition, other unknown intermediate PFOA/PFOS 
degradation products which were not analyzed in this study may also contribute to the unknown 
PFOA/PFOS mass percentage. Such unknown intermediate degradation products might include 
C6F13CFHCOOH (m/z=395), C6F13CH2COOH (m/z=377) (discussed in section 6.4.4.1 and 
shown in Figure 6.7), and similar PFOS degradation products such as C7F15CFHSO3H and 
C7F15CH2SO3H.  
6.5 Conclusions  
Approximately 60% and 94% of input PFOA and PFOS (average input concentration: 18,600 µg 
L-1) were removed by the combination of the reactive media (ZVI + BC). Less input PFOA (20%) 
and PFOS (90%) were removed using ZVI alone compared to (ZVI + BC). The short chain 
PFCAs (PFHpA) and PFSAs (PFHpS, PFHxS, and PFBS) were less removed (17 ̶ 70%) by 
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reactive media ZVI and (ZVI + BC) compared to PFOA and PFOS. The removals of short chain 
PFCAs and PFSAs by ZVI and (ZVI + BC) decreased with the decreasing chain length. 
Removals of PFOA (PFCAs) and PFOS (PFSAs) by ZVI and BC were likely through reductive 
defluorination and sorption. Fluoride, as the indicative product of defluorination of PFCAs and 
PFSAs, was used to back calculate the defluorination efficiencies of PFCAs and PFSAs; results 
showed that 10% of PFOA (PFCAs) and 5% of PFOS (PFSAs) were partially defluorinated by 
ZVI alone. The defluorination of PFOA (PFCAs) and PFOS (PFSAs) by (ZVI + BC) was likely 
underestimated due to sorption of F- by the reactive media. The combination of ZVI and BC may 
be cost-effective for potential use in passive treatment systems and in-situ reactors for removing 


















NaHCO3 solution ̶ ̶
̶ ZVI 35 ̶
ZVI + BC 7 3.5 
Control 
PFOA ̶ ̶




PFOA + ZVI 35 ̶ 
PFOA + (ZVI + BC) 7 3.5 
PFOS + ZVI 35 ̶ 
PFOS + (ZVI + BC) 7 3.5 
F- 
adsorption 
Control  F- ̶ ̶ 
1 mg L-1 F- 
adsorption 
F- + ZVI 35 ̶ 
F- + (ZVI + BC) 7 3.5 
Note: input solution matrix for both PFOA/PFOS removal test and F- adsorption test was 35 mL 




Table 6.2 Selected properties for target perfluoroalkyl carboxylic acids (PFCAs) and 
perfluoroalkyl sulfonic acids (PFSAs). 
























































































Figure 6.1 Values of pH, Eh, and concentrations of alkalinity as a function of reaction time in the 
supernatant samples of batch experiment for removal of PFOA and PFOS using zero-valent Fe 
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Figure 6.2 Concentrations of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid 
(PFOS) as a function of reaction time in the supernatant samples of batch experiment for 
removal of PFOA and PFOS using zero-valent Fe (ZVI) alone and a 1:4 (v/v) mixture of ZVI 
and biochar (ZVI + BC). Duplicate samples were prepared at Days 40, 90, and 120 where were 
indicated with error bars. The method detection limits (MDLs) of PFOA and PFOS were 45 and 
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Figure 6.3 Concentrations of perfluoroheptanoic acid (PFHpA, C7-PFCA) and 
perfluorohexanoic acid (PFHxA, C6-PFCA) as a function of reaction time in the supernatant 
samples of batch experiment for removal of PFOA and PFOS using zero-valent Fe (ZVI) alone 
and a 1:4 (v/v) mixture of ZVI and biochar (ZVI + BC). Duplicate samples were prepared at 
Days 40, 90, and 120 where were indicated with error bars. The instrument limits of 
quantification (LOQ) of PFHpA and PFHxA were 0.5 µg L-1. The LOQ of PFHpA was too low 
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Figure 6.4 Concentrations of perfluoroheptane sulfonic acid (PFHpS, C7-PFSA), 
perfluorohexane sulfonic acid (PFHxS, C6-PFSA), and perfluorobutane sulfonic acid (PFBS, 
C4-PFSA) as a function of reaction time in the supernatant samples of batch experiment for 
removal of PFOA and PFOS using zero-valent Fe (ZVI) alone and a 1:4 (v/v) mixture of ZVI 
and biochar (ZVI + BC). Duplicate samples were prepared at Days 40, 90, and 120 where were 
indicated with error bars. The instrument limit of quantification (LOQ) of PFHpS was 0.5 µg L-1; 
the LOQ of PFHxS and PFBS was 0.2 µg L-1. The LOQ of PFHpS, PFHxS, and PFBS were too 
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Figure 6.5 Concentrations of F- as a function of reaction time in the supernatant samples of batch 
experiment for removal of PFOA and PFOS using zero-valent Fe (ZVI) alone and a 1:4 (v/v) 
mixture of ZVI and biochar (ZVI + BC). The concentrations of F- in the supernatant samples 
PFOA/PFOS + (ZVI +BC) were below the method detection limits. Duplicate samples were 
prepared at Days 40, 90, and 120 where were indicated with error bars.   
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Figure 6.6 Percentage of F- remaining in the supernatant samples of F- sorption test as a function 
of reaction time.  
   
Reaction time, d
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Figure 6.8 Mass balances for PFOA and PFOS in batch experiments as a function of reaction 
time. Because the concentrations of PFOA and PFOS were two to four orders of magnitude 
higher than that of the short chain PFCAs and PFSAs in both supernatant samples and aqueous 
samples extracted from reactive media, this figure also represents the mass balances of total 
perfluoroalkyl carboxylic acids (PFCAs, including PFOA, PFHpA, and PFHxA) and total 
perfluoroalkyl sulfonic acids (PFSAs, including PFOS, PFHpS, PFHxS, and PFBS) in the batch 
experiments as a function of reaction time. Partial defluorination percentages were 
stoicmetrically back-calculated based on the observed F- concentrations in the supernatant, 
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7.1 Summary of Findings and Comparison of Contaminant Removals Using 
Photocatalytic and Passive Treatment Systems 
7.1.1 Summary of Findings 
Laboratory column and batch experiments were conducted to evaluate the effectiveness of 
passive treatment systems that contain zero-valent iron (ZVI), organic carbon (OC), and biochar 
(BC) for removal of NO3
-, SO4
2- and emerging contaminants perchlorate, pharmaceuticals, 
artificial sweeteners, and perfluoroalkyl substances from simulated groundwater. Laboratory 
batch experiments were conducted to evaluate the effectiveness of ultraviolet light (UV) 
photocatalytic treatment using magnetically recoverable TiO2 nanoparticles for removing 
artificial sweetener acesulfame-K and pharmaceuticals from water. In addition, a field 
investigation was conducted to evaluate the use of potential multiple tracers including an 
artificial sweetener and several pharmaceuticals to track wastewater derived from two 
wastewater treatment plants (WWTPs) in a receiving river.  
Water contaminated by co-mingled ClO4
-, NO3
-, and SO4
2- are associated with sulfide-
bearing mine sites when ClO4
- and NO3
- containing blasting agents are used in the ore extraction 
process. Four column experiments containing ZVI, wood chips (OC), and a mixture of (ZVI + 
OC) were conducted to remove ClO4
-, NO3
-, and SO4
2- from water (described in Chapter 2). 
Complete removals of NO3
- were achieved in all treatment columns ZVI, OC, and the mixture of 
(ZVI + OC). However, the by-product NH4
+ was produced during NO3
- reduction by ZVI alone 
(Equation 2.1). The bacterial mediated denitrification of NO3
- by OC was observed and is 
consistent with thermodynamic predictions for the conversion to the environmentally innocuous 
N2 gas (Equation 2.3). The extensive removal of NO3
- in Column (ZVI + OC) likely involved 
both NO3




- removal rate compared to the other two treatment columns. The removal of 
SO4
2- was only observed in Column OC (pH=7.4) through the onset of biologically mediated 
SO4
2- reduction coupled to OC oxidation (Equation 2.4); the higher pH (8.6) in Column (ZVI + 
OC) likely inhibited biological sulfate reduction. Effective removal of ClO4
- was only observed 
in the columns containing OC through biological degradation of ClO4
- to Cl- following the 
zeroth-order rate; however, ClO4
- was not removed in Column ZVI. As the potential end product 
of ClO4
- biological degradation, Cl- was observed at the concentrations equivalent to the 
concentration of ClO4
- removed in the effluents of Columns OC and (ZVI + OC). Complete 
removal of ClO4
- occurred after the complete removal of NO3
- due to the inhibition of NO3
- (> 2 
mg L-1 NO3-N) on ClO4
- removal. However, augmentation of OC by a small fraction of ZVI 
reduced the inhibition of NO3
- (> 2 mg L-1 NO3-N) on ClO4




2- were attributed to the decrease in flow rate from 0.5 to 0.1 
pore volume (PV) d-1 in Columns OC and (ZVI + OC).  
Chloride, nutrients, and some of the emerging contaminants such as artificial sweetener 
acesulfame-K (ACE-K) and pharmaceuticals carbamazepine (CBZ) and caffeine (CAF) are 
proposed as tracers of municipal wastewater in the aquatic environment. However, the 
anthropogenic sources of contamination such as road salts, fertilizer, and the natural attenuation 
processes make these tracers less reliable and ideal to track wastewater. Use of multiple tracers 
will greatly increase the confidence of tracking wastewater in the environment. A two-year study 
was conducted along a river downstream of two WWTPs to identify potential tracers to track the 
wastewater (described in Chapter 3). The results indicate that elevated concentrations of artificial 
sweetener ACE-K and pharmaceuticals CBZ, CAF, sulfamethoxazole (SMX), ibuprofen (IBU), 
gemfibrozil (GEM), and naproxen (NAP) were observed near the WWTP 1 as a result of human 
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excretion in the study area of the receiving river. The artificial sweetener ACE-K combined with 
pharmaceuticals CBZ, GEM, and NAP were strongly correlated and can be used as potential co-
tracers to track the wastewater.  
TiO2 nanoparticles are effective photocatalysts used in UV photocatalytic treatment of 
emerging contaminants. However, the non-recoverable TiO2 nanoparticles themselves are 
emerging contaminants which could cause adverse impacts on human and ecosystem health after 
entering the environment. The use of recoverable photocatalysts rather than the non-recoverable 
ones can mitigate the release of these nanoparticles to the environment. In Chapter 4, the 
photocatalytic ability of two magnetically recoverable TiO2 nanoparticles (MST: magnetically 
separable TiO2 nanoparticles; GO TiO2: graphene oxide supported TiO2 nanoparticles) were 
evaluated compared to the commercial non-recoverable P25 TiO2 nanoparticles in UV 
photocatalysis of an artificial sweetener ACE-K and a suite of pharmaceutical compounds (CBZ, 
CAF, SMX, MDA, MDMA, IBU, GEM, and NAP). The results show the GO TiO2 nanoparticles 
exhibited competitive or greater catalytic ability compared to P25 TiO2 nanoparticles in assisting 
photocatalytic treatment of target contaminants (> 99% removal of ACE-K and > 92% removal 
of pharmaceuticals); however, the MST nanoparticles were less effective in inducing 
photocatalysis of the contaminants than P25 and GO TiO2 nanoparticles. The UV photocatalytic 
treatment of target contaminants followed a pseudo-first-order rate. The recoverable GO TiO2 
nanoparticles could be a potential substitute for commercial P25 TiO2 nanoparticles in the water 
treatment industry due to their high magnetic recovery (> 90%) and photocatalytic efficiency. 
Four column experiments consisting of ZVI, biochar (BC), and a mixture of (ZVI + BC) 
were conducted for simultaneous removal of pharmaceutical compounds, artificial sweeteners, 
and perfluoroalkyl substances from water (described in Chapter 5). More than 97% of input 
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pharmaceuticals (~9 μg L-1) CBZ, CAF, SMX, MDA, MDMA, IBU, GEM, and NAP were 
removed in three treatment Columns ZVI, BC, and (ZVI + BC), and the removals of 
pharmaceuticals followed the first-order rate. Artificial sweetener sucralose (SUC) at input 
concentration of ~110 μg L-1 were removed in three treatment columns with removals > 76%. 
Poor removals of artificial sweetener ACE-K were observed in Column ZVI (27% removed) and 
Column (ZVI + BC) (14% removed) when the flow rate was maintained at 0.3 PV d-1; however, 
the removals of ACE-K increased to 60% in Column ZVI and 30% in Column (ZVI + BC) when 
the flow rate was decreased to 0.1 PV d-1. ACE-K was not removed in Column BC. Artificial 
sweetener saccharin (SAC) was not removed in Column ZVI; removals of SAC in the columns 
containing BC decreased over time. Artificial sweetener cyclamate (CYC) was not removed in 
any column in this study. Partial removals of input perfluorooctanoic acid (PFOA) (~45 μg L-1) 
were observed in Column BC and Column (ZVI + BC) with decreasing removal efficiencies. 
Removals of input PFOA in Column ZVI was only observed during the early stage of the 
experiment. About 60 ̶ 99% of input perfluorooctane sulfonic acid (PFOS) (24 ̶ 90 μg L-1) was 
removed in Columns BC and (ZVI + BC) throughout the experimental period. More than 80% of 
input PFOS was removed in Column ZVI during the first 37 PV of the experiment with possible 
conversion of PFOS to PFOA from 18 to 50 PV. The removal rates of target contaminants 
decreased over time; the removals of target contaminants were not enhanced by the decrease in 
flow rate, except for ACE-K.  
A series of batch experiments were conducted to assist in the interpretation of the date 
derived from the column experiments (Chapter 5) to investigate the removal mechanisms of 
PFOA and PFOS by ZVI and BC (described in Chapter 6). The results show about 20 and 60% 
of the input PFOA (~18,550 µg L-1) was removed by ZVI and the mixture of (ZVI + BC) after 
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120 d. Greater removals of input PFOS (~18,580 µg L-1) were observed by ZVI (90% removed) 
and (ZVI + BC) (94% removed) compared to PFOA. The removals of PFOA and PFOS by ZVI 
were likely due to sorption of PFOA and PFOS to iron oxides and hydroxides through H bonding 
and possibly reductive defluorination (10% of PFOA and 5% of PFOS were partially 
defluorinated). The removals of PFOA and PFOS by BC were likely due to hydrophobic sorption. 
Trace concentrations of short chain perfluoroalkyl carboxylic acids (PFCAs) including 
perfluoroheptanoic acid (PFHpA, C7-PFCA) and perfluorohexanoic acid (PFHxA, C6-PFCA) 
were detected in the PFOA input solution; however, only 17% of input PFHpA (26 µg L-1) was 
removed by ZVI and (ZVI + BC),  input PFHxA (0.8 µg L-1) were not removed. Similarly, trace 
concentrations of short chain perfluoroalkyl sulfonic acids (PFSAs) including 330 µg L-1 of 
perfluoroheptane sulfonic acid (PFHpS, C7-PFSA), 13 µg L-1 of perfluorohexane sulfonic acid 
(PFHxS, C6-PFSA) and 6 µg L-1 perfluorobutane sulfonic acid (PFBS, C4-PFSA) were detected 
in the PFOS input solution. Up to 70%, 40%, and 20% of input PFHpS, PFHxS, and PFBS were 
removed by the reactive media; the removal efficiency decreased with a decreasing PFSAs chain 
length. Fluoride (F-) as the indicative by-product of defluorination of PFOA and PFOS was 
adsorbed by ZVI (~20% from 1mg L-1) and (ZVI + BC) (~75% from 1mg L-1). The 
defluorination of PFOA and PFOS by ZVI and (ZVI + BC) may have been under estimated due 
to the sorption of F- by ZVI and BC.  
The results of these studies indicate that passive treatment systems such as permeable 
reactive barriers or in-situ bioreactors containing ZVI and OC (wood chips and biochar) may be 
promising and cost-effective technologies for considerable removal of NO3
-, SO4
2-, and emerging 
contaminants ClO4
-, pharmaceuticals (CBZ, CAF, SMX, MDA, MDMA, IBU, GEM, and NAP), 
artificial sweeteners (ACE-K, SUC, and SAC), and perfluoroalkyl substances (PFOA, PFOS, and 
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short chain PFSAs) from simulated groundwater under ambient environmental conditions. The 
magnetically recoverable GO TiO2 nanoparticles could be a potential substitute for the 
commercial non-recoverable P25 TiO2 nanoparticles used in water treatment applications due to 
its competitive or greater photcatalytic ability and environmental benefit (high magnetic 
recovery) compared to P25. Artificial sweetener ACE-K and pharmaceuticals CBZ, GEM, and 
NAP can be used as co-tracers to track wastewater.  
7.1.2 Comparison of Contaminant Removals Using Photocatalytic and Passive 
Treatment Systems 
Effective removals (>92%) of target contaminants ACE-K and eight pharmaceuticals were 
observed using both oxidative treatment (photocatalytic study in Chapter 4) and passive 
treatment (Column study in Chapter 5, except for ACE-K with 30 ̶ 60% removals); however, the 
removal efficiencies, rates, and mechanisms varied greatly. The average surface area normalized 
rate constants KSA (L m
-2 d-1), average removal efficiencies, and potential removal mechanisms 
of ACE-K and eight pharmaceuticals using photocatalytic and passive treatment systems are 
compared and summarized in Table 7.1.  
 The removal of target contaminants by UV photocatalysis was attributed to the oxidation 
of these contaminants by hydroxyl radical ·OH under UV irradiation. The removal of target 
contaminants by passive treatment systems containing ZVI and BC was likely through reduction 
(by ZVI), electrostatic interactions, hydrophobic interactions, π ̶ π stacking and(or) EDA 
interactions, and H bonding between contaminants and reactive media under reducing conditions. 
Effective removal of target contaminants was observed using both photocatalytic treatment 
(>92%) and passive treatment (>97%, except for ACE-K). Removal of ACE-K and eight 
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pharmaceuticals by photocatalytic and passive treatment systems (removal of ACE-K within 
Column ZVI) followed the first-order reaction model; however, the removal rates (or rate 
constants KSA) of ACE-K and eight pharmaceuticals using photocatalytic treatment were 
approximately 5 ̶ 7 orders of magnitude greater than that using the passive treatment systems 
(Table 7.1).  
Overall, photocatalytic treatment is more effective than the passive treatment system for 
removing ACE-K and pharmaceuticals with higher removal efficiencies and much more rapid 
removal rates. However, passive treatment systems require less energy (under ambient 
environmental conditions) and use of relatively inexpensive reactive media compared to 
photocatalytic treatment system which has high energy consumption (UV irradiation) and use of 
expensive photocatalysts (Table 7.2). Many factors should be considered when selecting a 
treatment method, such as the requirement of remediation rates and efficiencies and funding 
available for the remediation. The remediation strategy can vary greatly as the situation dictates.  
7.2 Scientific Contributions 
Research presented in this thesis contributed information related to removal of emerging 
contaminants ClO4
-, pharmaceuticals (CBZ, CAF, SMX, MDA, MDMA, IBU, GEM, and NAP), 
artificial sweeteners (ACE-K, SUC, SAC, and CYC), and perfluoroalkyl substances (PFOA, 
short chain PFCAs, PFOS, and short chain PFSAs) from aqueous solution using UV 
photocatalytic treatment and passive treatment systems, and use of emerging contaminants as co-
tracers to track wastewater. New scientific contributions resulting from this thesis include: 
 Demonstrating that simultaneous removal of NO3-, SO42-, and ClO4- from water can be 
achieved using a passive treatment system consisting of the mixture of ZVI and OC.     
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 Demonstrating that complete biological degradation of ClO4- to Cl- can be achieved using 
OC under reducing conditions.  
 Illustrating that addition of ZVI to OC can reduce the inhibition of NO3- (> 2 mg L-1 NO3-
N) on ClO4
- removal.  
 Investigating the correlation between the conventional tracer Cl- and the emerging 
contaminants as they dissipated downstream from the WWTPs in a receiving river.  
 Illustrating the artificial sweetener ACE-K and pharmaceuticals CBZ, NAP, and GEM 
can be used as co-tracers to track wastewater. 
 Demonstrating that the recoverable GO TiO2 nanoparticles could be an alternative  for 
commercial P25 TiO2 nanoparticles in inducing photocatalytic treatment of emerging 
contaminants ACE-K and a suite of pharmaceuticals (CBZ, CAF, SMX, MDA, MDMA, 
IBU, GEM, and NAP) due to its photocatalytic efficiency and environmental benefit 
(high recovery). 
 Demonstrating that simultaneous removal of pharmaceuticals (CBZ, CAF, SMX, MDA, 
MDMA, IBU, GEM, and NAP), artificial sweeteners (ACE-K, SUC, and SAC), and 
perfluoroalkyl substances (PFOA and PFOS) from water can be achieved using a passive 
treatment system consisting of the mixture of (ZVI + BC). 
 Illustrating the removals of PFOA and PFOS by ZVI and BC were likely through 
sorption and possibly reductive defluorination.  
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 Demonstrating that the removal efficiencies of PFCAs and PFSAs by ZVI and BC 
decreased with the decreasing chain length.   
7.3 Recommendations 
Passive treatment systems consisting of the reactive mixture of (ZVI + OC) or (ZVI + BC) are 




-, pharmaceutical compounds, artificial sweeteners, and 
perfluoroalkyl substances from water. In addition to the target emerging contaminants, the 
reactive media ZVI and OC have also been demonstrated to be effective for removals of different 
types of the inorganic and organic contaminants (described in Chapter 1). Due to their high 
removal efficiencies of different types of contaminants, cost-effectiveness, and low maintenance, 
these reactive mixture can be widely used to enhance the performance of various onsite 
wastewater and water treatment systems, such as in septic treatment systems (Figures 7.1 and 
7.2), permeable reactive barriers (Figure 7.3), tile drainage treatment systems (Figure 7.4), soil 
aquifer treatment systems (Figure 7.5), river bank filtration systems (Figure 7.6), and polishing 
cells for WWTPs effluent (Figure 7.7).    
On-site wastewater treatment and disposal systems are widely used in North America and 
elsewhere in the world to treat wastewater derived from homes or businesses in rural areas that 
are not served by community public sewers, often leading to release of partially treated 
wastewater back into the receiving environment. Septic tank/soil absorption systems are the most 
common used on-site wastewater treatment units in North America (website: 
nepis.epa.gov/Exe/ZyPURL.cgi?Dockey=9101NLXN.TXT). In septic tanks, most of the 
settleable solids are separated from wastewater to allow for digestion of organic matter. The 
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clarified wastewater is then fed to the soil absorption system to further filter and treat the effluent 
before it enters the groundwater zone.  However, emerging contaminants in wastewater often are 
not effectively removed by soil adsorption process (Carrara et al., 2008; Onesios & Bouwer, 
2012; Patterson et al., 2011; Robertson et al., 2013; Scheurer et al., 2009) which likely results in 
the broader distribution of emerging contaminants to the environment (described in Chapter 1). 
The augmentation of soil adsorption systems with reactive mixtures (ZVI + OC) or (ZVI + BC) 
can potentially improve water quality by reducing the flux of emerging contaminants entering 
groundwater. A horizontal layer containing the reactive media can be installed beneath the drain 
field to enhance the performance of soil absorption systems (Figure 7.1). A passive flow-through 
reactor packed with the reactive media can be installed after the primary wastewater treatment 
unit to remove the emerging contaminants before discharging to soil (Figure 7.2). A vertical 
permeable reactive barrier containing reactive media can be installed downgradient of the septic 
drainage tile to remove emerging contaminants from the wastewater before it discharges to 
receiving surface waters (Figure 7.3).    
The reactive mixture can also be utilized in subsurface tile drainage systems to remove 
contaminants derived from agricultural lands. Tile drainage systems are designed to collect 
excess water from the soil zone to lower the water table and increase crop yields. However, the 
application of fertilizer (containing NO3
- and ClO4
- described in Chapter 2), pesticides such as 
atrazine, liquid manure (containing veterinary drugs and nutrients), and municipal biosolids 
(containing human pharmaceuticals, artificial sweeteners, and nutrients) to farm lands causes the 
release of these contaminants to soil and soil water. As a result of the tile systems, soluble 
contaminants will end up in the drainage system. An in-line reactor containing ZVI, OC, and BC 
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mixtures can be installed in the effluent drainage pipe to remove the contaminants collected from 
the farm lands before they enter receiving waters (Figure 7.4).  
Another potential application of the passive treatment systems is in the managed aquifer 
recharge (MAR) process where reactive media can be used to improve the quality of the 
recovered water.  In a soil aquifer treatment system, the pre-treated wastewater is introduced to a 
recharge basin (infiltration basin); the contaminants in the wastewater can be partially removed 
through different natural processes (such as physical, chemical and biological processes) as the 
wastewater moves through soil and aquifer. The treated wastewater will be stored in the aquifer 
for future use. In this case, a horizontal layer containing reactive media can be placed at the base 
of the recharge basin to enhance the removal of emerging contaminants from the wastewater 
before it enters groundwater (Figure 7.5). In a river bank filtration system, a vertical permeable 
reactive barrier packed with the reactive mixture can be installed between the river and the 
production well to enhance the removal of emerging contaminants from the recovery river water 
before end uses (Figure 7.6). In addition, when emerging contaminants cannot be removed in 
WWTPs (described in Chapter 1); a flow-through reactor packed with the reactive mixture or 
facilitated with UV photocatalytic treatment using recoverable GO TiO2 nanoparticles can be 
installed to polish treated water before discharge (Figure 7.7).  
Passive treatment systems consisting of (ZVI + OC) or (ZVI + BC) could be an 
economical and practical technology for augmentation of the current and future on-site 
wastewater treatment and disposal systems, tile drainage systems, and managed aquifer recharge 
systems, and WWTPs for enhanced removal of the emerging contaminants. The application of 
these passive treatment technologies can reduce the amount of NO3
-, SO4
2- and emerging 
contaminants ClO4
-, pharmaceutical compounds, artificial sweeteners, and perfluoroalkyl 
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substances entering the natural waters through wastewater disposal and water reuse, providing 
environmental benefits in heavily populated and water shortage (reuse) areas.  
In this study, there were no obvious signs of system clogging or decrease in hydraulic 
conductivity when 50% (v/v) of silica sand was used as supporting material in the experiments. 
When passive treatment systems are used in field applications, mixing of the reactive mixture 
with sand or gravel (e.g., 50%, v/v) is recommended to maintain the hydraulics of the system. 
Furthermore, addition of a small fraction (e.g., 10%, v/v) of ZVI to wood chips or biochar (e.g., 
40%, v/v) is recommended based on findings from this study. Higher ZVI amendment rates not 
only increase the remedy cost (because ZVI is more expensive compared to wood chips and 
biochar), but may also increase the pH values of the wastewater which will potentially inhibit the 
microbial degradation of the contaminants (such as biological degradation of SO4
2-, described in 
Chapter 2). The flow rates used in the column experiments were set at 0.1, 0.3, or 0.5 PV d-1 
(linear velocities: 3, 9, or 15 cm d-1), which is in the range of typical groundwater velocities. 
However, when passive treatment systems are used in field applications, an increase in flow rate 
may lead to decreases in removal efficiencies. In addition, the concurrence of other organic 
constituents such as organic carbon and inorganic components in the wastewater may also affect 
the performance of passive treatment systems. Similarly, the presence of dissolved organic 
carbon (DOC) and inorganic constitutes in the wastewater will also likely affect the performance 
of active treatment systems, such as UV photocatalytic treatment and WWTPs. The effect of 
changes in flow rates and constituents of influent wastewater on the treatment performance 
should be considered when passive treatment systems are applied to the field applications.  
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7.4 Future Research 
Samples of Grand River water were only collected once in the summers of 2012 and 2013, and in 
the winter of 2014 (Appendix B; Chapter 3). These three sampling events only reflect the 
distribution of the target emerging contaminants in the Grand River during the sampling days in 
2012, 2013, and 2014, and do not represent the entire year. More frequent sampling such as 
sampling on daily or monthly basis should be considered in future studies to enhance the 
understanding of variability in the Grand River. In addition, alternative sampling device such as 
the passive polar organic chemical integrative samplers (Li et al., 2010a) should be considered to 
collect time-integrated samples and determine time-weighted average concentrations of 
emerging contaminants from water in future studies.  
The removal mechanisms of artificial sweetener ACE-K and pharmaceuticals by UV 
photo- and photocatalytic treatment were not investigated in this thesis, but can be considered 
when planning future experiments. In addition, the application of recoverable GO TiO2 
nanoparticles to water treatment industry requires additional information, including optimizing 
UV photocatalytic reactor design to maximize both the removal of the target contaminants and 
recovery of the GO TiO2 nanoparticles, and to evaluate the influence of water chemistry changes 
on the removal efficiency of contaminants and reaction kinetics. The UV intensity of the UVP 
CL-1000 Ultraviolet Crosslinker reactor used in this study was 66.7 W m-2 and the UV 
irradiation time was 1 h (3600 s), which gave the target contaminants a UV dose of 24 J cm-2. 
The UV dose used in this study was much higher than the typical UV dose applied for 
disinfection systems in water treatment plants (e.g., Trojan UV bulbs with UV intensity of ~33 
mW cm-2 and UV dose of 40 mJ cm-2). The removal efficiency of the target contaminants under 
typical UV disinfection dose would likely be reduced. Future batch experiments can be 
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performed to evaluate the effectiveness of common UV bulbs in facilitating the photocatalysis of 
the target contaminants using recoverable GO TiO2 nanoparticles.     
Passive treatment systems containing (ZVI + OC) or (ZVI + BC) have shown promising 
removals of NO3
-, SO4
2- and emerging contaminants ClO4
-, pharmaceutical compounds, artificial 
sweeteners, and perfluoroalkyl substances from the water under reducing anaerobic conditions. 
The removal efficiency of the target contaminants might be different when the passive treatment 
system is applied to the mildy anoxic or oxic wastewater treatment conditions. In addition, 
simulated groundwater (CaCO3 saturated solution) was used as input solution matrix (Chapter 1 
and Chapter 5); the velocity of the column experiments was set at 3 ̶ 15 cm d-1 to represent 
typical average groundwater velocities in shallow aquifers. Future laboratory experiments should 
be conducted to evaluate the removal of target contaminants by reactive mixtures under mildly 
anoxic or oxic conditions, at higher flow rates, and with spiked wastewater as an input matrix to 
simulate potential field conditions. The ZVI is more expensive than wood chips and biochar; the 
cost of the passive treatment system could be reduced by decreasing the amount of ZVI used. 
Lower amendment rates of ZVI to OC and BC such as (5%, v/v) could be evaluated to determine 
whether similar removals of the target contaminants can be achieved using less ZVI.  
Removal of PFOA and PFOS by ZVI and BC was likely through sorption in this study 
(described in Chapters 5 and 6); however, the sorption mechanism was not confirmed. 
Application of Attenuated Total Reflection (ATR)-Fourier Transform Infrared (FTIR) 
spectroscopy could be considered in future research to determine the functionalities on the 
surface of ZVI (ion oxides and hydroxides) and BC. The results of ATR-FTIR might assist in the 
explanation of the sorption mechanism of PFCAs and PFSAs by ZVI (ion oxides and hydroxides) 
and BC. In addition, the defluorination efficiency of PFOA and PFOS was not confirmed in the 
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PFAS column study and was likely underestimated in the PFAS batch study due to the potential 
sorption of F- by the reactive media. Extraction of F- from the reactive media should be 







Table 7.1 Comparison of average surface area normalized rate constants (KSA, L m
-2 d-1), average removal efficiencies, and potential 
removal mechanisms of target contaminants during UV photocatalytic treatment using GO TiO2 nanoparticles (Chapter 4) and passive 
treatment using ZVI and BC (Chapter 5).  
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 6.0E-04 99% 
Electrostatic interaction, 
π-π stacking, π-π EDA 
















·OH radical cleavage of 
methylenedioxy group7 
 1.6E-03 99% 
Electrostatic interaction, 
π-π stacking, π-π EDA 
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carbon position of isoxazole 
ring and aromatic ring8, 9 
 6.5E-03 >97% 
π-π stacking, π-π EDA 
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radicals addition to the 
alkane Cs10, 11 
 3.8E-05 >97% 
Reduction21, H bonding, 











·OH radicals addition to 
benzene ring and breakage of 
ethereal bond 12, 13  
 9.2E-05 99% 
π-π stacking, π-π EDA 
interaction, π-H bonding, 
H bonding 









photoionization14, 15, 16 
 7.1E-05 99% 
π-π stacking, π-π EDA 
interaction23, π-H 
bonding, H bonding 
References: 1. Scheurer et al. (2014); 2. Li et al. (2016); 3. Jelic et al. (2013); 4. Doll and Frimmel (2005); 5.  Dalmázio et al. (2005); 
6. Chuang et al. (2011); 7. Kumagai et al. (1991); 8. Hu et al. (2007); 9. Abellán et al. (2007); 10. Méndez-Arriaga et al. (2008a); 11. 
Jacobs et al. (2011). 12. Razavi et al. (2009); 13. Yurdakal et al. (2007); 14. Méndez-Arriaga et al. (2008b); 15. Boscá et al. (2001); 16. 
Moore and Chappuis (1988). 17. König et al. (2016); 18. Inyang and Dickenson (2015); 19. Tomizawa et al. (2016); 20. Zheng et al. 
(2013); 21. Machado et al. (2013); 22. Jung et al. (2013); 23. Jung et al. (2015a). 
a The average first order removal rate constant of ACE-K within Column ZVI. 
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Table 7.2 Comparison of removal efficiency and removal rate (surface area normalized rate 
constant, KSA, L  m
-2 d-1), treatment conditions, energy consumption, and required 
catalysts/reactive media during photocatalytic and passive treatment systems for removing ACE-
K and eight pharmaceuticals. 
 Photocatalytic Treatment Passive Treatment 
Removal efficiency High: 92 ̶ 99% 
Moderate to high:  
30 ̶ 60% for ACE-K 
97 ̶ 99% for pharmaceuticals  
Removal rate (KSA)   
Rapid  
(E+1 – E+2) 
Slow  
(E-3 – E-6) 
Treatment conditions UV irradiation conditions Ambient T, reducing conditions  
Energy consumption High Low 
Use of reactive 
media/catalysts 
Use of high-cost 
photocatalysts 









Figure 7.1 Schematic cross-section showing application of reactive mixture of zero-valent iron 
(ZVI) and organic carbon (OC) as a horizontal reactive layer underneath the septic drain tiles. 
The reactive layer is expected to remove NO3
-, SO4
2- and emerging contaminants from  








Figure 7.2 Schematic cross-section showing application of reactive mixture of zero-valent iron 
(ZVI) and organic carbon (OC) in a reactor attached to the effluent pipe derived from the 
primary treatment unit of the facility. The reactor is expected to remove NO3
-, SO4
2- and 
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Table A.1 Data used for regression fits of NO3-N removal as a function of residence time 
in columns containing zero-valent Fe (ZVI), organic C (OC), or both. PV: pore volumes; 




Column 2 (ZVI)  Column 3 (OC)  Column 4 (ZVI + OC)  
Stage 1:  
95 PV 
Stage 2:  
115 PV 
Stage 1:  
108 PV 
Stage 2:  
132 PV 
Stage 1:  
106 PV 


























0 0 11.0 0 11.0 0 11.0 0 11.0 0 11.0 0 11.0 
4.3 0.4 6.4 1.3 4.2 0.3 8.7 1.0 5.8 0.3 7.9 1.0 3.8 
8.6 0.8 4.8 2.7 2.0 0.6 7.3 1.9 3.6 0.7 4.7 2.0 < DL 
13 1.2 3.8 4.0 0.7 1.0 6.3 2.9 2.1 1.0 1.7 3.0 < DL 
17 1.6 2.8 5.3 0.3 1.3 5.4 3.8 0.9 1.3 0.1 4.1 < DL 
21 1.9 1.8 6.7 0.1 1.6 3.8 4.8 0.4 1.7 < DL 5.1 < DL 
26 2.3 1.1 8.0 < DL 1.9 3.2 5.8 0.1 2.0 < DL 6.1 < DL 





Table A. 2 Data used for regression fits of ClO4
- removal as a function of residence time 
in columns containing organic C (OC) and both zero-valent Fe (ZVI) and OC. PV: pore 




Column 3 (OC) Column 4 (ZVI + OC) 
Stage 1: 108 PV Stage 2: 132 PV Stage 1: 106 PV Stage 2: 128 PV 
RT, d 
ClO4














0 0 919 0 857 0 919 0 857 
4.3 0.3 830 1.0 798 0.3 831 1.0 747 
8.6 0.6 833 1.9 745 0.7 848 2.0 668 
13 1.0 790 2.9 679 1.0 827 3.0 564 
17 1.3 783 3.8 506 1.3 ̶ 4.1 475 
21 1.6 751 4.8 309 1.7 739 5.1 398 
26 1.9 651 5.8 104 2.0 717 6.1 200 





Appendix B: Supplementary Information 




Table B.1 Spearman rank correlation coefficients (ρ)† of the target compounds and Cl- 
over the sampling distance in the Grand River in December 2014. 
 SUC SAC CBZ IBU GEM NAP Cl 
ACE 0.90 0.54 0.81 0.74 0.74 0.71 0.55 
SUC  0.48 0.88 0.74 0.74 0.90 0.48 
SAC   0.57 0.80 0.80 0.45 0.73 
CBZ    0.74 0.74 0.93 0.55 
IBU     1.00 0.74 0.74 
GEM      0.74 0.74 
NAP       0.43 
Note: † Positive values were interpreted as follows: 0.8-1.0 = very strong; 0.6-0.8 = 








































































































































Data collected in Aug 2012
Data collected in July 2013
Note: 
0 km: WWTP-1
17 km: Intake for WTP-1
22km:  WWTP-2













Data collected in Dec 2014

















Figure B.2 Concentrations of acesulfame-K (ACE-K), sucralose (SUC), saccharine 
(SAC), carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), ibuprofen 
(IBU), gemfibrozil (GEM) and naproxen (NAP) as a function of sampling distance. The 

































































































17 km: Intake for WTP-1
22km:  WWTP-2
CAF data on right y axis in orange 






















Data collected in Dec 2014
Data collected in Aug 2012





Figure B.3 Concentrations of acesulfame-K (ACE-K), sucralose (SUC), saccharine (SAC), 
carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), ibuprofen (IBU), gemfibrozil 
(GEM), and naproxen (NAP) as a function of Cl- concentration. The method detection limits of 
ACE-K, SUC, SAC, and CAF were too low to appear in the figure. 
   
Cl- (mg L-1)



































































Data collected in 2012
Data collected in 2013














17 km: Intake for WTP-1
22km:  WWTP-2
CAF data on right y axis in red 




























































Figure C.2 The XRD patterns of GO/TiO2/CSA nanoparticles. Peaks labelled with A match 
anatase phase TiO2 (JCPDS No. 21-1272), R matches rutile phase TiO2 (JCPDS No. 21-1276), 






Figure C.3 Concentration of ACE-K, SMX, MDA, MDMA, IBU, GEM, NAP, CAF, and CBZ 











Table D.1 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of carbamazepine. kobs is calculated using least-squares regression during two experimental stages. ƚC is the 
input contaminant concentration. 
Contaminant (CAS#), 
pKa, log Kow, and 
structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 
















1 1.1E+01 × C 1.1E+01 2.6E-03 2.8E-04 0.06 0.999 
13 4.9 × C 4.9 1.1E-03 1.2E-04 0.14 0.975 
25 4.4 × C 4.4 1.0E-03 1.1E-04 0.16 0.965 




1 5.4 × C 5.4 1.2E-02 1.8E-04 0.19 0.998 
13 2.5 × C 2.5 5.3E-03 8.2E-05 0.28 0.998 
25 1.9 × C 1.9 4.2E-03 6.4E-05 0.36 0.996 
2 53 0.7 × C 0.7 1.5E-03 2.3E-05 1.0 0.970 
Column 4 
(ZVI + BC) 
1 
1 8.2 × C 8.2 7.2E-03 2.1E-04 0.09 0.999 
13 4.5 × C 4.5 3.9E-03 1.2E-04 0.16 0.966 
25 4.0 × C 4.0 3.5E-03 1.0E-04 0.17 0.970 
2 53 1.3 × C 1.3 1.1E-03 3.3E-05 0.55 0.992 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 
the specific surface area of reactive media (m2 g-1). Specific surface areas of ZVI, BC, and (ZVI + BC) are 9.5, 64.5, and 33.6 m2 g-1.
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Table D.2 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of caffeine. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 






























1 1.6E+01  × C 1.6E+01 3.7E-03 3.9E-04 0.04 0.999 
13 7.2 × C 7.2 1.7E-03 1.8E-04 0.10 0.998 
25 5.1 × C 5.1 1.2E-03 1.2E-04 0.14 0.982 




1 4.8 × C 4.8 1.0E-02 1.6E-04 0.14 0.999 
13 2.8 × C 2.8 6.0E-03 9.4E-05 0.25 0.999 
25 2.2 × C 2.2 4.8E-03 7.4E-05 0.31 0.996 
2 53 1.0  × C 1.0 2.1E-03 3.3E-05 0.70 0.973 
Column 4 
(ZVI + BC) 
1 
1 6.9 × C 6.9 6.0E-03 1.8E-04 0.10 0.996 
13 5.5 × C 5.5 4.8E-03 1.4E-04 0.13 0.989 
25 4.5 × C 4.5 3.9E-03 1.2E-04 0.15 0.973 
2 53 1.7 × C 1.7 1.5E-03 4.5E-05 0.40 0.996 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 







Table D.3 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of sulfamethoxazole. kobs is calculated using least-squares regression during two experimental stages. ƚC is the 
input contaminant concentration. “ ̶ ”  represents not applicable. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 





















1 25 0.2 × C 0.2 ̶ ̶ 3. 6 0.877 




1 4.5E+02 × C 4.5E+02 1.1E-01 1.1E-02 0.002 1.000 
13 4.7E+02 × C 4.7E+02 1.1E-01 1.1E-02 0.001 1.000 
25 4.6E+02 × C 4.6E+02 1.1E-01 1.1E-02 0.001 1.000 




1 1.6 × C 1.6 3.5E-03 5.4E-05 0.43 0.999 
13 1.2 × C 1.2 2.5E-03 3.8E-05 0.60 0.999 
25 1.1 × C 1.1 2.4E-03 3.8E-05 0.61 0.993 
2 53 0.5 × C 0.5 1.1E-03 1.7E-05 1.4 0.991 
Column 4 
(ZVI + BC) 
1 
1 4.5E+02 × C 4.5E+02 4.0E-01 1.2E-02 0.002 1.000 
13 4.7E+02× C 4.7E+02 4.1E-01 1.2E-02 0.001 1.000 
25 4.6E+02 × C 4.6E+02 4.1E-01 1.2E-02 0.001 1.000 
2 53 1.5E+02 × C 1.5E+02 1.3E-01 3.9E-03 0.005 1.000 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.4 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of MDA. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration.  
Contaminant (CAS#), pKa, 
log Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 
















Column 2  
(ZVI) 
1 
1 1.9E+02 × C 1.9E+02 4.3E-02 4.6E-03 0.004 1.000 
13 1.3E+01 × C 1.3E+01 3.0E-03 3.1E-04 0.06 0.999 
25 7.8 × C 7.8 1.8E-03 1.9E-04 0.09 0.998 
2 53 2.4 × C 2.4 5.5E-04 5.8E-05 0.29 0.996 
Column 3  
(BC) 
1 
1 1.1E+01 × C 1.1E+01 2.4E-02 3.7E-04 0.06 0.999 
13 8.1 × C 8.1 1.7E-02 2.7E-04 0.09 0.997 
25 5.1 × C 5.1 1.1E-02 1.7E-04 0.14 0.998 
2 53 3.2 × C 3.2 6.8E-03 1.1E-04 0.22 0.997 
Column 4 
(ZVI + BC) 
1 
1 2.0E+01 × C 2.0E+01 1.8E-02 5.3E-04 0.03 1.000 
13 1.2E+01 × C 1.2E+01 1.0E-02 3.0E-04 0.06 0.999 
25 8.7 × C 8.7 7.6E-03 2.3E-04 0.08 0.999 
2 53 3.9 × C 3.9 3.4E-03 1.0E-04 0.18 0.999 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 







Table D.5 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of MDMA. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration.  
Contaminant (CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 





















1 3.0E+02 × C 3.0E+02 6.9E-02 7.3E-03 0.002 1.000 
13 3.5E+02 × C 3.5E+02 8.2E-02 8.7E-03 0.002 1.000 
25 1.4E+01 × C 1.4E+01 3.2E-03 3.4E-04 0.05 1.000 




1 1.1E+01 × C 1.1E+01 2.3E-02 3.6E-04 0.07 0.999 
13 7.7 × C 7.7 1.7E-02 2.6E-04 0.09 0.998 
25 5.2 × C 5.2 1.1E-02 1.7E-04 0.13 0.997 
2 53 3.1 × C 3.1 6.7E-03 1.0E-04 0.22 0.997 
Column 4 
(ZVI + BC) 
1 
1 2.5E+01 × C 2.5E+01 2.2E-02 6.6E-04 0.03 1.000 
13 1.6E+01 × C 1.6E+01 1.4E-02 4.1E-04 0.04 1.000 
25 1.0E+01 × C 1.0E+01 9.0E-03 2.7E-04 0.07 0.999 
2 53 4.3 × C 4.3 3.8E-03 1.1E-04 0.16 1.000 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 






Table D.6 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of ibuprofen. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration.  
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 


























1 2.6 × C 2.6 6.0E-04 6.3E-05 0.27 0.943 
13 1.2 × C 1.2 2.9E-04 3.0E-05 0.56 0.926 
25 0.9 × C 0.9 2.2E-04 2.3E-05 0.74 0.932 




1 1.9 × C 1.9 4.2E-03 6.5E-05 0.36 0.992 
13 1.2 × C 1.2 2.6E-03 4.0E-05 0.57 0.997 
25 1.1 × C 1.1 2.4E-03 3.7E-05 0.63 0.996 
2 53 0.4 × C 0.4 8.9E-04 1.4E-05 1.7 0.992 
Column 4 
(ZVI + BC) 
1 
1 2.9 × C 2.9 2.5E-03 7.6E-05 0.24 0.978 
13 1.7 × C 1.7 1.5E-03 4.5E-05 0.41 0.958 
25 1.6 × C 1.6 1.4E-03 4.1E-05 0.44 0.952 
2 53 0.5 × C 0.5 4.0E-04 1.2E-05 1.5 0.941 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.7 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of gemfibrozil. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration.  
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 




















1 9.3 × C 9.3 2.2E-03 2.3E-04 0.07 0.999 
13 4.6 × C 4.6 1.1E-03 1.1E-04 0.15 0.969 
25 3.5 × C 3.5 8.2E-04 8.6E-05 0.20 0.954 




1 4.5 × C 4.5 9.7E-03 1.5E-04 0.15 0.997 
13 2.4 × C 2.4 5.1E-03 8.0E-05 0.29 0.995 
25 1.8 × C 1.8 3.8E-03 5.9E-05 0.39 0.996 
2 53 0.6 × C 0.6 1.4E-03 2.1E-05 1.1 0.981 
Column 4 
(ZVI + BC) 
1 
1 5.9 × C 5.9 5.1E-03 1.5E-04 0.12 0.990 
13 3.5 × C 3.5 3.1E-03 9.2E-05 0.20 0.967 
25 2.8 × C 2.8 2.5E-03 7.4E-05 0.24 0.935 
2 53 0.9 × C 0.9 7.6E-04 2.3E-05 0.80 0.989 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.8 First order removal rate constant (kobs, d
-1), mass normalized rate constant (kM, L g
-1 d-1), and surface area normalized rate 
constant (kSA, L m
-2 d-1) of naproxen. kobs is calculated using least-squares regression during two experimental stages. ƚC is the input 
contaminant concentration. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 




L g-1 d-1 
kSA, 



















1 5.7 × C 5.7 1.3E-03 1.4E-04 0.12 0.988 
13 3.1 × C 3.1 7.2E-04 7.6E-05 0.22 0.908 
25 2.8 × C 2.8 6.4E-04 6.8E-05 0.25 0.949 




1 3.7 × C 3.7 8.0E-03 1.2E-04 0.19 0.999 
13 2.0 × C 2.0 4.2E-03 6.6E-05 0.35 0.996 
25 1.7 × C 1.7 3.6E-03 5.6E-05 0.41 0.999 
2 53 0.6 × C 0.6 1.4E-03 2.2E-05 1.1 0.985 
Column 4 
(ZVI + BC) 
1 
1 4.7 × C 4.7 4.1E-03 1.2E-04 0.15 0.978 
13 3.0 × C 3.0 2.6E-03 7.7E-05 0.23 0.959 
25 2.6 × C 2.6 2.2E-03 6.7E-05 0.27 0.977 
2 53 0.7 × C 0.7 6.5E-04 1.9E-05 0.94 0.980 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.9 Removal rate constant kobs, mass normalized rate constant kM, and surface area normalized rate constant kSA of acesulfame-
K. Removal rate constant kobs is calculated using least-squares regression during two experimental stages. ƚC is the input contaminant 
concentration. “ ̶ ” represents no removal of contaminant was observed.  
Contaminant 
(CAS#), pKa, log 
Kow, and 
structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 























1 2.3E-01 × C a 2.3E-01a 5.3E-05a 5.6E-06a 3.1 0.749 
13 1.0E-01 × C a 1.0E-01a 2.4E-05a 2.6E-06a 6.6 0.906 
25 9.8E-02 × C a 9.8E-02a 2.3E-05a 2.4E-06a 7.0 0.874 




1 1.6 E+01b 1.6 E+01b 3.4E-02b 5.3E-04b 3.2 0.864 
13 ̶ ̶ ̶ ̶ ̶ ̶ 
25 ̶ ̶ ̶ ̶ ̶ ̶ 
2 53 ̶ ̶ ̶ ̶ ̶ ̶ 
Column 4 
(ZVI + BC) 
1 
1 5.9b 5.8b 5.1E-03b 1.5E-04b 8.3 0.976 
13 4.2b 4.2b 3.7E-03b 1.1E-04b 12 0.634 
25 4.9b 4.9b 4.3E-03b 1.3E-04b 10 0.835 
2 53 3.2b 3.2b 2.8E-03b 8.3E-05b 17 0.866 
a Removal of ACE-K followed a first order reaction rate, unit of kobs is d
-1, unit of kM is L g
-1d-1, unit of kSA is L m
-2 d-1. 
bRemoval of ACE-K followed a zero order reaction rate, unit of k is µmol ACE-K L-1 d-1 (µg ACE-K L-1 d-1), unit of kM is µmol ACE-
K d-1 g (reactive media)-1 [µg ACE-K d-1 g (reactive media) -1], unit of kSA is µmol ACE-K d
-1 m-2 (µg ACE-K d-1 m-2). 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.10 Zero-order removal rate constant kobs (µmol CYC L
-1 d-1 or µg CYC L-1 d-1), mass normalized rate constant kM  [µmol CYC  
g (reactive media) -1 d-1 or µg CYC g (reactive media)-1 d-1], and surface area normalized rate constant kSA (µmol CYC m
-2 d-1 or µg 
CYC m-2 d-1) of cyclamate. Removal rate constant kobs is calculated using least-squares regression during two experimental stages. ƚC 
is the input contaminant concentration. “ ̶ ” represents no removal of contaminant was observed.  
Contaminant 
(CAS#), pKa, 
log Kow, and 
structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 
kobs, 
µmol L-1 d-1 
(µg L-1 d-1) 
kM, 
µmol g-1 d-1 























1 1.5E+01 1.5E+01 3.6E-03 3.8E-04 3.3 0.697
13 ̶ ̶ ̶ ̶ ̶ ̶ 
25 ̶ ̶ ̶ ̶ ̶ ̶ 




1 8.4 8.4 1.8E-02 2.8E-04 5.8 0.839
13 ̶ ̶ ̶ ̶ ̶ ̶ 
25 ̶ ̶ ̶ ̶ ̶ ̶ 




1 2.0 2.0 1.8E-03 5.2E-05 23 0.624
13 ̶ ̶ ̶ ̶ ̶ ̶ 
25 ̶ ̶ ̶ ̶ ̶ ̶ 
2 53 ̶ ̶ ̶ ̶ ̶ ̶ 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 






Table D.11 Removal rate constant kobs, mass normalized rate constant kM, and surface area normalized rate constant kSA of saccharin. 
Removal rate constant kobs is calculated using least-squares regression during two experimental stages. ƚC is the input contaminant 
concentration. “ ̶ ” represents no removal of contaminant was observed. 
Contaminant 
(CAS#), pKa, 
log Kow, and 
structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 

















1 3.5E+01b 3.5E+01b 8.1E-03b 8.6E-04b 1.5 0.898 
13 4.7b 4.7b 1.1E-03b 1.2E-04b 9.3 0.804 
25 ̶ ̶ ̶ ̶ ̶ ̶ 




1 1.0 × Ca 1.0a 2.2E-03a 3.4E-05a 0.7 0.978 
13 0.5 × Ca 0.5a 9.8E-04a 1.5E-05a 1.5 0.981 
25 2.4E+01b 2.4E+01b 5.2E-02b 8.0E-04b 2.2 0.983 
2 53 2.6b 2.6b 5.6E-03b 8.6E-05b 21 0.828 
Column 4 
(ZVI + BC) 
1 
1 3.4E+01b 3.4E+01b 3.0E-02b 8.9E-04b 1.3 0.969 
13 1.4E+01b 1.4E+01b 1.2E-02b 3.6E-04b 3.1 0.960 
25 1.1E+01b 1.1E+01b 9.4E-03b 2.8E-04b 4.9 0.845 
2 53 2.1b 2.1b 1.9E-03b 5.6E-05b 25 0.701 
a Removal of SAC followed a first order reaction rate, unit of kobs is d
-1, unit of kM is L g
-1 d-1, unit of kSA is L m
-2 d-1. 
b Removal of SAC followed a zero order reaction rate, unit of k is µmol SAC L-1 d-1 (µg SAC L-1 d-1), unit of kM is µmol SAC d
-1 g 
(reactive media)-1 [µg SAC d-1 g (reactive media)-1], unit of kSA is µmol SAC d
-1 m-2 (µg SAC d-1 m-2). 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.12 Removal rate constant kobs, mass normalized rate constant kM, and surface area normalized rate constant kSA of sucralose. 
Removal rate constant kobs is calculated using least-squares regression during two experimental stages. ƚC is the input contaminant 
concentration. “ ̶ ” represents no removal of contaminant was observed. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 
























1 2.1 × Ca 2.1a 4.8E-04a 5.1E-05a 0.3 0.922 
13 1.0 × Ca 1.0a 2.4E-04a 2.5E-05a 0.7 0.927 
25 4.4E+01b 4.4E+01b 1.0E-02b 1.1E-03b 1.4 0.963 




1 1.3 × Ca 1.3a 2.7E-03a 4.2E-05a 0.5 0.999 
13 0.9× Ca 0.9a 1.9E-03a 2.9E-05a 0.8 0.983 
25 0.7 × Ca 0.7a 1.4E-03a 2.2E-05a 1.1 0.983 
2 53 0.2 × Ca 0.2a 4.3E-04a 6.6E-06a 3.5 0.981 
Column 4 
(ZVI + BC) 
1 
1 1.6 × Ca 1.6a 1.4E-03a 4.2E-05a 0.4 0.948 
13 0.9 × Ca 0.9a 8.1E-04a 2.4E-05a 0.8 0.961 
25 0.7 × Ca 0.7a 6.4E-04a 1.9E-05a 1.0 0.942 
2 53 0.2 × Ca 0.2a 1.6E-04a 4.7E-06a 3.9 0.995 
a Removal of SCL followed a first order reaction rate, unit of kobs is d
-1, unit of kM is L g
-1 d-1, unit of kSA is L m
-2 d-1. 
b Removal of SCL followed a zero order reaction rate, unit of k is µmol SCL L-1 d-1 (µg SCL L-1 d-1), unit of kM is µmol SCL d
-1 g 
(reactive media) -1 [µg SCL d-1 g (reactive media) -1], unit of kSA is µmol SCL d
-1 m-2 (µg SCL d-1 m-2). 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.13 Removal rate constant kobs, mass normalized rate constant kM, and surface area normalized rate constant kSA of 
perfluorooctanoic acid (PFOA). Removal rate constant kobs is calculated using least-squares regression during two experimental stages. 
ƚC is the input contaminant concentration. “ ̶ ” represents no removal of contaminant was observed. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 














1 2.2E+01b 2.2E+01b 5.2E-03b 5.5E-04b 1.3 0.821 
13 ̶ ̶ ̶ ̶ ̶ ̶ 
25 ̶ ̶ ̶ ̶ ̶ ̶ 




1 1.0 × Ca 1.0a 2.1E-03a 3.3E-05a 0.7 0.980 
13 0.5 × Ca 0.5a 1.1E-03a 1.8E-05a 1.3 0.987 
25 1.2E+01b 1.2E+01b 2.5E-02b 3.9E-04b 2.3 0.956 
2 53 0.9b 0.9b 1.9E-03b 3.0E-05b 25 0.780 
Column 4 
(ZVI + BC) 
1 
1 2.0E+01 b 2.0E+01b 1.8E-02b 5.3E-04b 1.3 0.935 
13 7.7b 7.7b 6.7E-03b 2.0E-04b 3.3 0.933 
25 2.0b 2.0b 1.7E-03b 5.1E-05b 13 0.725 
2 53 ̶ ̶ ̶ ̶ ̶ ̶ 
a Removal of PFOA followed a first order reaction rate, unit of kobs is d
-1, unit of kM is L g
-1 d-1, unit of kSA is L m
-2 d-1. 
b Removal of PFOA followed a zero order reaction rate, unit of k is µmol PFOA L-1 d-1 (µg PFOA L-1 d-1), unit of kM is µmol PFOA d
-1 
g (reactive media) -1 [µg PFOA d-1 g (reactive media) -1], unit of kSA is µmol PFOA d
-1 m-2 (µg PFOA d-1 m-2). 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 





Table D.14 Removal rate constant kobs, mass normalized rate constant kM, and surface area normalized rate constant kSA of 
perfluorooctane sulfonic acid (PFOS). Removal rate constant kobs is calculated using least-squares regression during two experimental 
stages. ƚC is the input contaminant concentration. “ ̶ ” represents no removal of contaminant was observed. 
Contaminant 
(CAS#), pKa, log 
Kow, and structure 
Column Stage PV 
Removal rateƚ, 
µmol L-1 d-1 
(µg L-1 d-1) 















1 2.0 × Ca 2.0a 4.6E-04a 4.9E-05a 0.4 0.911 
13 0.9 × Ca 0.9a 2.1E-04a 2.3E-05a 0.8 0.834 
25 2.2E+01b 2.2E+01b 5.1E-03b 5.4E-04b 1.5 0.929 




1 1.8 × Ca 1.8a 3.9E-03a 6.0E-05a 0.4 0.989 
13 0.5 × Ca 0.5a 1.2E-03a 1.8E-05a 1.3 0.511 
25 0.9 × Ca 0.9a 1.8E-03a 2.8E-05a 0.8 0.961 
2 53 0.2 × Ca 0.2a 4.6E-04a 7.2E-06a 3.2 0.967 
Column 4 
(ZVI + BC) 
1 
1 2.2 × Ca 2.2a 1.9E-03a 5.7E-05a 0.3 0.974 
13 0.7 × Ca 0.7a 5.8E-04a 1.7E-05a 1.1 0.881 
25 1.1 × Ca 1.1a 9.6E-04a 2.9E-05a 0.6 0.962 
2 53 7.0 b 7.0E+01b 6.1E-03b 1.8E-04b 5.9 0.966 
a Removal of PFOS followed a first order reaction rate, unit of kobs is d
-1, unit of kM is L g
-1 d-1, unit of kSA is L m
-2 d-1. 
b Removal of PFOS followed a zero order reaction rate, unit of k is µmol PFOS L-1 d-1 (µg PFOS L-1 d-1), unit of kM is µmol PFOS d
-1 g 
(reactive media) -1 [µg PFOS d-1 g (reactive media) -1], unit of kSA is µmol PFOS d
-1 m-2 (µg PFOS d-1 m-2). 
KM and KSA were calculated following the expression KM = Kobs/ρm; KSA = Kobs/ρa = KM/as (Johnson et al., 1996). ρm is the mass 
concentrations of reactive media (g L-1 of solution). ρa is the surface area concentrations of reactive media (m
2 L-1 of solution). as is 










Table E.1 Concentrations of F- and acetate in treatment samples (PFOA+ ZVI, Day 90; PFOA+ 
ZVI, Day 120; PFOS+ ZVI, Day 90; PFOS+ ZVI, Day 120) and recoveries of F- and acetate in 
the same sample fortified with F- and acetate. Each sample was fortified with either 0.1mg L-1 F- 
or 1mg L-1 acetate or both of 0.1mg L-1 F- and 1mg L-1 acetate. The IC chromatograms for the 
detection of fluoride (F-) ions are presented in Figures E.1  ̶  E.4. “ ̶ ” indicates the samples were 
not available or analyzed.  
Sample name 
Con. of F-, 
mg L-1 
Con. of 








PFOA + ZVI, Day 90 0.14 0.91 ̶ ̶ 
PFOA + ZVI, Day 90_fortified with F- 0.23 0.90 0.86 ̶ 
PFOA + ZVI, Day 90_fortified  with acetate 0.13 1.71 ̶ 0.79 
PFOA + ZVI, Day 90_fortified with F- and acetate 0.22 1.76 0.80 0.85 
PFOA + ZVI, Day 120 0.14 1.35 ̶ ̶ 
PFOA + ZVI, Day 120_fortified with F- 0.22 1.26 0.79 ̶ 
PFOA + ZVI, Day 120_fortified with acetate 0.15 2.26 ̶ 0.91 
PFOA + ZVI, Day 120_fortified with F- and acetate 0.22 2.20 0.79 0.86 
PFOS + ZVI, Day 90 0.06 1.38 ̶ ̶ 
PFOS + ZVI, Day 90_fortified with F- 0.13 1.22 0.75 ̶ 
PFOS + ZVI, Day 90_fortified with acetate 0.05 2.04 ̶ 0.76 
PFOS + ZVI, Day 90_fortified with F- and acetate 0.14 2.11 0.83 0.73 
PFOS + ZVI, Day 120 0.06 1.49 ̶ ̶ 
PFOS + ZVI, Day 120_fortified with F- 0.15 1.54 0.83 ̶ 
PFOS + ZVI, Day 120_fortified with acetate 0.06 2.50 ̶ 1.01 

























 mg L-1 ac
nd 1 mg L-
292 
ion of fluor
 a) straight 
etate (TR =
1 acetate.  
ide (F-) ions
sample fort




 (TR = 13.7
ified with 0
.53min); c)
0 ̶ 13.76 mi

























 mg L-1 ac





1 acetate.  
ide (F-) ions
 sample for
 15.46 ̶ 15






6 ̶ 13.70 mi





















1 mg L-1 F- a
 
r the detect
I, Day 90): 
 mg L-1 ac





1 acetate.  
ide (F-) ions
sample fort
 15.34 ̶ 15






4 ̶ 13.59 mi






















1 mg L-1 F- a
r the detect
I, Day 120)
 mg L-1 ac









 15.36 ̶ 15






5 ̶ 13.58 mi
.1 mg L-1 F
 straight sa
n) in 
-; b) 
mple 
